Seed plants exhibiting inducible early reproductive development and methods of making same

ABSTRACT

The present invention provides a recombinant nucleic acid molecule containing an inducible regulatory element operably linked to a nucleic acid molecule encoding a floral meristem identity gene product such as APETALA1 (AP1), CAULIFLOWER (CAL) or LEAFY (LFY). The invention also provides a transgenic seed plant, such as an angiosperm or gymnosperm, that contains a recombinant nucleic acid molecule of the invention. The invention further provides methods, such as methods of converting shoot meristem to floral meristem in a transgenic angiosperm and methods of promoting early reproductive development in a seed plant, which use a recombinant nucleic acid molecule of the invention. In addition, the invention provides a nucleic acid molecule encoding a chimeric protein, which contains a nucleic acid molecule encoding a floral meristem identity gene product linked in frame to a nucleic acid molecule encoding a ligand binding domain. The invention also provides a transgenic seed plant, such as an angiosperm or gymnosperm, that contains a nucleic acid molecule encoding a chimeric protein of the invention. Also provided herein are methods, such as methods of converting shoot meristem to floral meristem in a transgenic angiosperm and methods of promoting early reproductive development in a seed plant, which use a nucleic acid molecule encoding a chimeric protein of the invention.

This work was supported by grant DCB-9018749 awarded by the National Science Foundation and by grant USDA 93-37304 awarded by the United States Department of Agriculture. The United States Government has certain rights in this invention.

BACKGROUND OF THE INVENTION

1. Field of the Invention

This invention relates generally to the field of plant genetic engineering and more specifically to genes involved in the regulation of plant reproductive development.

2. Background Information

A flower is the reproductive structure of a flowering plant. Following fertilization, the ovary of the flower becomes a fruit and bears seeds. As a practical consequence, production of fruit and seed-derived crops such as grapes, beans, corn, wheat, rice and hops is dependent upon flowering.

Early in the life cycle of a flowering plant, vegetative growth occurs, and roots, stems and leaves are formed. During the later period of reproductive growth, flowers as well as new shoots or branches develop. However, the factors responsible for the transition from vegetative to reproductive growth, and the onset of flowering, are poorly understood.

A variety of external signals, such as length of daylight and temperature, affect the time of flowering. The time of flowering also is subject to genetic controls that prevent young plants from flowering prematurely. Thus, the pattern of genes expressed in a plant is an important determinant of the time of flowering.

Given these external signals and genetic controls, a relatively fixed period of vegetative growth precedes flowering in a particular plant species. The length of time required for a crop to mature to flowering limits the geographic location in which it can be grown and can be an important determinant of yield. In addition, since the time of flowering determines when a plant is reproductively mature, the pace of a plant breeding program also depends upon the length of time required for a plant to flower.

Traditionally, plant breeding involves generating hybrids of existing plants, which are examined for improved yield or quality. The improvement of existing plant crops through plant breeding is central to increasing the amount of food grown in the world since the amount of land suitable for agriculture is limited. For example, the development of new strains of wheat, corn and rice through plant breeding has increased the yield of these crops grown in underdeveloped countries such as Mexico, India and Pakistan. Unfortunately, plant breeding is inherently a slow process since plants must be reproductively mature before selective breeding can proceed.

For some plant species, the length of time needed to mature to flowering is so long that selective breeding, which requires several rounds of backcrossing progeny plants with their parents, is impractical. For example, perennial trees such as walnut, hickory, oak, maple and cherry do not flower for several years after planting. As a result, breeding of such plant species for insect or disease-resistance or to produce improved wood or fruit, for example, would require decades, even if only a few rounds of selection were performed.

Methods of promoting early reproductive development can make breeding of long generation seed plants such as trees practical for the first time. Methods of promoting early reproductive development also would be useful for shortening growth periods, thereby broadening the geographic range in which a crop such as rice, corn or coffee can be grown. Unfortunately, methods for promoting early reproductive development in a seed plant have not yet been described. Thus, there is a need for methods that promote early reproductive development. The present invention satisfies this need and provides related advantages as well.

SUMMARY OF THE INVENTION

The present invention provides a recombinant nucleic acid molecule containing an inducible regulatory element operably linked to a nucleic acid molecule encoding a floral meristem identity gene product. An inducible regulatory element can be, for example, a copper inducible regulatory element, tetracycline inducible regulatory element, ecdysone inducible regulatory element or heat-shock inducible regulatory element, and a floral meristem identity gene product can be, for example, APETALA1 (AP1), CAULIFLOWER (CAL) or LEAFY (LFY). The invention further provides a transgenic seed plant, such as an angiosperm or gymnosperm, that contains a recombinant nucleic acid molecule of the invention.

The invention also provides a method of converting shoot meristem to floral meristem in an angiosperm by introducing a recombinant nucleic acid molecule of the invention into the angiosperm to produce a transgenic angiosperm; and contacting the transgenic angiosperm with an inducing agent, thereby increasing expression of the floral meristem identity gene product and converting shoot meristem to floral meristem in the transgenic angiosperm. The methods of the invention can be practiced with an inducible regulatory element such as a copper inducible regulatory element, tetracycline inducible regulatory element, ecdysone inducible regulatory element or heat-shock inducible regulatory element.

Also provided herein is a method of promoting early reproductive development in a seed plant by introducing a recombinant nucleic acid molecule of the invention into the seed plant to produce a transgenic seed plant; and contacting the transgenic seed plant with an inducing agent, thereby increasing expression of the floral meristem identity gene product and promoting early reproductive development in the transgenic seed plant. The methods of the invention can be practiced with a seed plant such as an angiosperm or gymnosperm using a floral meristem identity gene product such as AP1, CAL or LFY.

In addition, the present invention provides a nucleic acid molecule encoding a chimeric protein, which contains a nucleic acid molecule encoding a floral meristem identity gene product such as AP1, CAL or LFY linked in frame to a nucleic acid molecule encoding a ligand binding domain. A transgenic seed plant, such as an angiosperm or gymnosperm, that contains a nucleic acid molecule encoding a chimeric protein of the invention also is provided.

The invention further provides a method of converting shoot meristem to floral meristem in an angiosperm by introducing a nucleic acid molecule encoding a chimeric protein of the invention into the angiosperm to produce a transgenic angiosperm, where, under appropriate conditions, the chimeric protein containing a floral meristem identity gene product fused to a ligand binding domain is expressed; and contacting the transgenic angiosperm with cognate ligand, where, upon binding of cognate ligand to the ligand binding domain, floral meristem identity gene product activity is increased, thereby converting shoot meristem to floral meristem in the transgenic angiosperm. A floral meristem identity gene product useful in converting shoot meristem to floral meristem can be, for example, AP1, CAL or LFY, and a ligand binding domain can be, for example, a glucocorticoid receptor ligand binding domain or an ecdysone receptor ligand binding domain.

The invention additionally provides a method of promoting early reproductive development in a seed plant by introducing a nucleic acid molecule encoding a chimeric protein of the invention into the seed plant to produce a transgenic seed plant, where, under appropriate conditions, the chimeric protein containing a floral meristem identity gene product fused to a ligand binding domain is expressed; and contacting the transgenic seed plant with cognate ligand, where, upon binding of the cognate ligand to the ligand binding domain, floral meristem identity gene product activity is increased, thereby promoting early reproductive development in the transgenic seed plant. A floral meristem identity gene product such as AP1, CAL or LFY and a ligand binding domain such as a glucocorticoid receptor ligand binding domain or an ecdysone receptor ligand binding domain are particularly useful in the methods of the invention for promoting early reproductive development.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 illustrates a western-blot analysis of tissues from wild type and mutant Arabidopsis plants with anti-AP1 antisera.

DETAILED DESCRIPTION OF THE INVENTION

The present invention provides a non-naturally occurring seed plant containing a first ectopically expressible nucleic acid molecule encoding a first floral meristem identity gene product, provided that the nucleic acid molecule is not ectopically expressed due to a mutation in an endogenous TERMINAL FLOWER gene. For example, the invention provides a transgenic seed plant containing a first ectopically expressible floral meristem identity gene product such as APETALA1 (AP1), CAULIFLOWER (CAL) or LEAFY (LFY). A transgenic seed plant can be, for example, an angiosperm such as a cereal plant, leguminous plant, oilseed plant, hardwood tree, fruit-bearing plant or ornamental flower or a gymnosperm such as a coniferous tree.

A flower, like a leaf or shoot, is derived from the shoot apical meristem, which is a collection of undifferentiated cells set aside during embryogenesis. The production of vegetative structures, such as leaves or shoots, and of reproductive structures, such as flowers, is temporally segregated, such that a leaf or shoot arises early in a plant life cycle, while a flower develops later. The transition from vegetative to reproductive development is the consequence of a process termed floral induction (Yanofsky, Ann. Rev. Plant Physiol. Plant Mol. Biol. 46:167-188 (1995), which is incorporated herein by reference).

Once induced, shoot apical meristem either persists and produces floral meristem, which gives rise to flowers, and lateral meristem, which gives rise to branches, or is itself converted to floral meristem. Floral meristem differentiates into a single flower having a fixed number of floral organs in a whorled arrangement. Dicots, for example, contain four whorls (concentric rings), in which sepals (first whorl) and petals (second whorl) surround stamens (third whorl) and carpels (fourth whorl).

Although shoot meristem and floral meristem both consist of meristemic tissue, shoot meristem is distinguishable from the more specialized floral meristem. Shoot meristem generally is indeterminate and gives rise to an unspecified number of floral and lateral meristems. In contrast, floral meristem is determinate and gives rise to the fixed number of floral organs that comprise a flower.

By convention herein, a wild-type gene sequence is represented in upper case italic letters (for example, APETALA1), and a wild-type gene product is represented in upper case non-italic letters (APETALA1). Further, a mutant gene allele is represented in lower case italic letters (ap1), and a mutant gene product is represented in lower case non-italic letters (ap1).

Genetic studies have identified a number of genes involved in regulating flower development. These genes can be classified into different groups depending on their function. Flowering time genes, for example, are involved in floral induction and regulate the transition from vegetative to reproductive growth. In comparison, the floral meristem identity genes, which are the subject matter of the present invention as disclosed herein, encode proteins that promote the conversion of shoot meristem to floral meristem in an angiosperm. In addition, floral organ identity genes encode proteins that determine whether sepals, petals, stamens or carpels are formed during floral development (Yanofsky, supra, 1995; Weigel, Ann. Rev. Genetics 29:19-39 (1995), which is incorporated herein by reference). Some of the floral meristem identity gene products also have a role in specifying floral organ identity.

Floral meristem identity genes have been identified by characterizing genetic mutations that prevent or alter floral meristem formation. Among floral meristem identity gene mutations in Arabidopsis thaliana, those in the gene LEAFY (LFY) generally have the strongest effect on floral meristem identity. Mutations in LFY completely transform the basal-most flowers into secondary shoots and have variable effects on later-arising (apical) flowers. In comparison, mutations in the floral meristem identity gene APETALA1 (AP1) result in replacement of a few basal flowers by inflorescence shoots that are not subtended by leaves. An apical flower produced in an ap1 mutant has an indeterminate structure, in which a flower arises within a flower. These mutant phenotypes indicate that both AP1 and LFY contribute to establishing the identity of the floral meristem although neither gene is absolutely required. The phenotype of lfy ap1 double mutants, in which structures with flower-like characteristics are very rare, indicates that LFY and AP1 encode partially redundant activities.

In addition to the LFY and AP1 genes, a third locus that greatly enhances the ap1 mutant phenotype has been identified in Arabidopsis. This locus, designated CAULIFLOWER (CAL), derives its name from the resulting "cauliflower" phenotype, which is strikingly similar to the common garden variety of cauliflower (Kempin et al., Science 267:522-525 (1995), which is incorporated herein by reference). In an ap1 cal double mutant, floral meristem behaves as shoot meristem in that there is a massive proliferation of meristems in the position that normally would be occupied by a single flower. However, an Arabidopsis mutant lacking only CAL, such as cal-1, has a normal phenotype, indicating that AP1 can substitute for the loss of CAL in these plants. In addition, because floral meristem that forms in an ap1 mutant behaves as shoot meristem in an ap1 cal double mutant, CAL can largely substitute for AP1 in specifying floral meristem. These genetic data indicate that CAL and AP1 encode activities that are partially redundant in converting shoot meristem to floral meristem.

Other genetic loci play at least minor roles in specifying floral meristem identity. For example, although a mutation in APETALA2 (AP2) alone does not result in altered inflorescence characteristics, ap2 ap1 double mutants have indeterminate flowers (flowers with shoot-like characteristics; Bowman et al., Development 119:721-743 (1993), which is incorporated herein by reference). Also, mutations in the CLAVATA1 (CLV1) gene result in an enlarged meristem and lead to a variety of phenotypes (Clark et al., Development 119:397-418 (1993)). In a clv1 ap1 double mutant, formation of flowers is initiated, but the center of each flower often develops as an indeterminate inflorescence. Thus, mutations in CLAVATA1 result in the loss of floral meristem identity in the center of wild-type flowers. Genetic evidence also indicates that the gene product of UNUSUAL FLORAL ORGANS (UFO) plays a role in determining the identity of floral meristem. Additional floral meristem identity genes associated with altered floral meristem formation remain to be isolated.

Mutations in another locus, designated TERMINAL FLOWER (TFL), produce phenotypes that generally are reversed as compared to mutations in the floral meristem identity genes. For example, tfl mutants flower early, and the indeterminate ap1 cal and lateral meristems develop as determinate floral meristems (Alvarez et al., Plant J. 2:103-116 (1992)). These characteristics indicate that the TFL promotes maintenance of shoot meristem. TFL also acts directly or indirectly to negatively regulate AP1 and LFY expression in shoot meristem since these AP1 and LFY are ectopically expressed in the shoot meristem of tfl mutants (Gustafson-Brown et al., Cell 76:131-143 (1994); Weigel et al., Cell 69:843-859 (1992)). It is recognized that a plant having a mutation in TFL can have a phenotype similar to a non-naturally occurring seed plant of the invention. Such tfl mutants, however, which have a mutation in an endogenous TERMINAL FLOWER gene, are explicitly excluded from the scope of the present invention.

The results of such genetic studies indicate that several floral meristem identity gene products, including AP1, CAL and LFY, act redundantly to convert shoot meristem to floral meristem in an angiosperm. As disclosed herein, ectopic expression of a single floral meristem identity gene product such as AP1, CAL or LFY is sufficient to convert shoot meristem to floral meristem in an angiosperm. Thus, the present invention provides a non-naturally occurring seed plant such as an angiosperm or gymnosperm that contains a first ectopically expressible nucleic acid molecule encoding a first floral meristem identity gene product, provided that such ectopic expression is not due to a mutation in an endogenous TERMINAL FLOWER gene.

As disclosed herein, an ectopically expressible nucleic acid molecule encoding a floral meristem identity gene product can be, for example, a transgene encoding a floral meristem identity gene product under control of a heterologous gene regulatory element. In addition, such an ectopically expressible nucleic acid molecule can be an endogenous floral meristem identity gene coding sequence that is placed under control of a heterologous gene regulatory element. The ectopically expressible nucleic acid molecule also can be, for example, an endogenous floral meristem identity gene having a modified gene regulatory element such that the endogenous floral meristem identity gene is no longer subject to negative regulation by TFL.

The term "ectopically expressible" is used herein to refer to a nucleic acid molecule encoding a floral meristem identity gene product that can be expressed in a tissue other than a tissue in which it normally is expressed or at a time other than the time at which it normally is expressed, provided that the floral meristem identity gene product is not expressed from its native, naturally occurring promoter. Ectopic expression of a floral meristem identity gene product is a result of the expression of the gene coding region from a heterologous promoter or from a modified variant of its own promoter, such that expression of the floral meristem identity gene product is no longer in the tissue in which it normally is expressed or at the time at which it normally is expressed. An exogenous nucleic acid molecule encoding an AP1 gene product under control of its native, wild type promoter, for example, does not constitute an ectopically expressible nucleic acid molecule encoding a floral meristem identity gene product. However, a nucleic acid molecule encoding an AP1 gene product under control of a constitutive promoter, which results in expression of AP1 in a tissue such as shoot meristem where it is not normally expressed, is an ectopically expressible nucleic acid molecule as defined herein.

Actual ectopic expression of a floral meristem identity gene is dependent on various factors and can be constitutive or inducible expression. For example, AP1, which normally is expressed in floral meristem, is ectopically expressible in the shoot meristem of an angiosperm. As disclosed herein, when a floral meristem identity gene product such as AP1, CAL or LFY is ectopically expressed in shoot meristem in an angiosperm, the shoot meristem is converted to floral meristem and early reproductive development can occur (see Examples I, III and IV).

An ectopically expressible nucleic acid molecule encoding a floral meristem identity gene product can be expressed prior to the time in development at which the corresponding endogenous gene normally is expressed. For example, an Arabidopsis plant grown under continuous light conditions expresses AP1 just prior to day 18, when normal reproductive development (flowering) begins. However, as disclosed herein, AP1 can be ectopically expressed in shoot meristem prior to day 18, resulting in early conversion of shoot meristem to floral meristem and early reproductive development. As disclosed in Example ID, a transgenic Arabidopsis plant that ectopically expresses AP1 in shoot meristem under control of a constitutive promoter can flower at day 10, which is earlier than the time of reproductive development for a non-transgenic plant grown under the same conditions (day 18). It is recognized that in some transgenic seed plants containing, for example, an exogenous nucleic acid molecule encoding AP1 under control of a constitutive promoter, neither the exogenous nor endogenous AP1 will be expressed. Such transgenic plants in which AP1 gene expression is cosuppressed, although not characterized by early reproductive development, also can be valuable as disclosed below.

As used herein, the term "floral meristem identity gene product" means a gene product that promotes conversion of shoot meristem to floral meristem in an angiosperm. As disclosed herein in Examples I, II and III, expression of a floral meristem identity gene product such as AP1, CAL or LFY in shoot meristem can convert shoot meristem to floral meristem in an angiosperm. Furthermore, ectopic expression of a floral meristem identity gene product also can promote early reproductive development (see Example ID).

A floral meristem identity gene product is distinguishable from a late flowering gene product or an early flowering gene product. The use of a late flowering gene product or an early flowering gene product is not encompassed within the scope of the present invention. In addition, reference is made herein to an "inactive" floral meristem identity gene product, as exemplified by the product of the Brassica oleracea var. botrytis CAL gene (BobCAL) (see below). Expression of an inactive floral meristem identity gene product in an angiosperm does not result in the conversion of shoot meristem to floral meristem in the angiosperm. An inactive floral meristem identity gene product such as BobCAL is excluded from the meaning of the term "floral meristem identity gene product" as defined herein.

A floral meristem identity gene product can be, for example, an AP1 gene product having the amino acid sequence of SEQ ID NO: 2, which is a 256 amino acid gene product encoded by the Arabidopsis thaliana AP1 cDNA. The Arabidopsis AP1 cDNA encodes a highly conserved MADS domain, which can function as a DNA-binding domain, and a K domain, which has structural similarity to the coiled-coil domain of keratins and can be involved in protein-protein interactions.

As used herein, the term "APETALA1," "AP1" or "AP1 gene product" means a floral meristem identity gene product that is characterized, in part, by having an amino acid sequence that has at least about 70 percent amino acid identity with the amino acid sequence of SEQ ID NO: 2 in the region from amino acid 1 to amino acid 163 or with the amino acid sequence of SEQ ID NO: 8 in the region from amino acid 1 to amino acid 163. Like other floral meristem identity gene products, AP1 promotes conversion of shoot meristem to floral meristem in an angiosperm. An AP1 gene product useful in the invention can be, for example, Arabidopsis AP1 having the amino acid sequence of SEQ ID NO: 2; Brassica oleracea AP1 having the amino acid sequence of SEQ ID NO: 4; Brassica oleracea var. botrytis AP1 having the amino acid sequence of SEQ ID NO: 6 or Zea mays AP1 having the amino acid sequence of SEQ ID NO: 8.

In wild-type Arabidopsis, AP1 RNA is expressed in flowers but is not detectable in roots, stems or leaves (Mandel et al., Nature 360:273-277 (1992), which is incorporated herein by reference). The earliest detectable expression of AP1 RNA is in young floral meristem at the time it initially forms on the flanks of shoot meristem. Expression of AP1 increases as the floral meristem increases in size; no AP1 expression is detectable in shoot meristem. In later stages of development, AP1 expression ceases in cells that will give rise to reproductive organs of a flower (stamens and carpels), but is maintained in cells that will give rise to non-reproductive organs (sepals and petals; Mandel, supra, 1992). Thus, in nature, AP1 expression is restricted to floral meristem and to certain regions of the flowers that develop from this meristemic tissue.

CAULIFLOWER (CAL) is another example of a floral meristem identity gene product. As used herein, the term "CAULIFLOWER," "CAL" or "CAL gene product" means a floral meristem identity gene product that is characterized, in part, by having an amino acid sequence that has at least about 70 percent amino acid identity with the amino acid sequence of SEQ ID NO: 10 in the region from amino acid 1 to amino acid 160 or with the amino acid sequence of SEQ ID NO: 12 in the region from amino acid 1 to amino acid 160.

A CAL gene product is exemplified by the Arabidopsis CAL gene product, which has the amino acid sequence of SEQ ID NO: 10, or the Brassica oleracea CAL gene product, which has the amino acid sequence of SEQ ID NO: 12. As disclosed herein, CAL, like AP1, contains a MADS domain and a K domain. The MADS domains of CAL and AP1 differ in only five of 56 amino acid residues, where four of the five differences represent conservative amino acid replacements. Over the entire sequence, the Arabidopsis CAL and Arabidopsis AP1 sequences (SEQ ID NOS: 10 and 2) are 76% identical and are 88% similar if conservative amino acid substitutions are allowed.

Similar to the expression pattern of AP1, CAL RNA is expressed in young floral meristem in Arabidopsis. However, in contrast to AP1 expression, which is high throughout sepal and petal development, CAL expression is low in these organs. Thus, in nature, CAL is expressed in floral meristem and, to a lesser extent, in the organs of developed flowers.

The skilled artisan will recognize that, due to the high sequence conservation between AP1 and CAL, a novel ortholog can be categorized as both a CAL and an AP1, as defined herein. However, if desired, an AP1 ortholog can be distinguished from a CAL ortholog by demonstrating a greater similarity to Arabidopsis AP1 than to any other MADS box gene, such as CAL, as set forth in Purugganan et al. (Genetics 140:345-356 (1995), which is incorporated herein by reference). Furthermore, AP1 can be distinguished from CAL by its ability to complement, or restore a wild-type phenotype, when introduced into a strong ap1 mutant. For example, introduction of Arabidopsis AP1 (AGL7) complements the phenotype of the strong ap1-1 mutant; however, introduction of CAL (AGL10) into a cal-1 ap1-1 mutant plant yields the ap1-1 single mutant phenotype, demonstrating that CAL cannot complement the ap1-1 mutation (see, for example, Mandel et al., supra, 1992; Kempin et al., supra, 1995). Thus, AP1 can be distinguished from CAL, if desired, by the ability of a nucleic acid molecule encoding AP1 to complement a strong ap1 mutant such as ap1-1 or ap1-15.

LEAFY (LFY) is yet another example of a floral meristem identity gene product. As used herein, the term "LEAFY" or "LFY" or "LFY gene product" means a floral meristem identity gene product that is characterized, in part, by having an amino acid sequence that has at least about 70 percent amino acid identity with the amino acid sequence of SEQ ID NO: 16. In nature, LFY is expressed in floral meristem as well as during vegetative development. As disclosed herein, ectopic expression in shoot meristem of a floral meristem identity gene product, which normally is expressed in floral meristem, can convert shoot meristem to floral meristem in an angiosperm. Under appropriate conditions, ectopic expression in shoot meristem of a floral meristem identity gene product such as AP1, CAL, LFY, or a combination thereof, can promote early reproductive development.

Flower development in Arabidopsis is recognized in the art as a model for flower development in angiosperms in general. Gene orthologs corresponding to the Arabidopsis genes involved in the early steps of flower formation have been identified in distantly related angiosperm species, and these gene orthologs show remarkably similar patterns of RNA expression. Mutations in gene orthologs also result in phenotypes that correspond to the phenotype produced by a similar mutation in Arabidopsis. For example, orthologs of the Arabidopsis floral meristem identity genes AP1 and LFY and the Arabidopsis organ identity genes AGAMOUS, APETALA3 and PISTILLATA have been isolated from monocots such as maize and, where characterized, reveal the anticipated RNA expression patterns and related mutant phenotypes (Schmidt et al., Plant Cell 5:729-737 (1993); and Veit et al., Plant Cell 5:1205-1215 (1993), each of which is incorporated herein by reference). Furthermore, a gene ortholog can be functionally interchangeable in that it can function across distantly related species boundaries (Mandel et al., Cell 71:133-143 (1992), which is incorporated herein by reference). Taken together, these data suggest that the underlying mechanisms controlling the initiation and proper development of flowers are conserved across distantly related dicot and monocot boundaries.

Floral meristem identity genes in particular are conserved among distantly related angiosperm and gymnosperm species. For example, a gene ortholog of Arabidopsis AP1 has been isolated from Antirrhinum majus (snapdragon; Huijser et al., EMBO J. 11:1239-1249 (1992), which is incorporated herein by reference). As disclosed herein, an ortholog of Arabidopsis AP1 also has been isolated from Brassica oleracea var. botrytis (cauliflower) and Zea Mays (maize; see Example VA). Furthermore, AP1 orthlogs also can be isolated from gymnosperms. Similarly, gene orthologs of Arabidopsis LFY have been isolated from angiosperms such as Antirrhinum majus, tobacco and poplar tree and from gymnosperms such as Douglas fir (Coen et al., Cell, 63:1311-1322 (1990); Kelly et al., Plant Cell 7:225-234 (1995); and Rottmann et al., Cell Biochem. Suppl. 17B: 23 (1993); Strauss et al., Molec. Breed 1:5-26 (1995), each of which is incorporated herein by reference). The conservation of floral meristem identity gene products in non-flowering plants such as coniferous trees indicates that floral meristem identity genes can promote the reproductive development of gymnosperms as well as angiosperms.

The characterization of ap1 and lfy mutants also indicates that floral meristem identity gene products such as AP1 and LFY function similarly in distantly related plant species. For example, a mutation in the Antirrhinum AP1 ortholog results in a phenotype similar to the Arabidopsis ap1 indeterminate flower within a flower phenotype (Huijser et al., supra, 1992). In addition, a mutation in the Antirrhinum LFY ortholog results in a phenotype similar to the Arabidopsis Ify mutant phenotype (Coen et al., supra, 1995)

A floral meristem identity gene product also can function across species boundaries. For example, introduction of a nucleic acid molecule encoding Arabidopsis LFY into a heterologous seed plant such as tobacco or aspen results in early reproductive development (Weigel and Nilsson, Nature 377:495-500 (1995), which is incorporated herein by reference). As disclosed herein, a nucleic acid molecule encoding an Arabidopsis AP1 gene product (SEQ ID NO: 1) or an Arabidopsis CAL gene product (SEQ ID NO: 9) can be introduced into a heterologous seed plant such as corn, wheat, rice or pine and, upon ectopic expression, can promote early reproductive development in the transgenic seed plant. Furthermore, as disclosed herein, the conserved nature of the AP1, CAL and LFY coding sequences among diverse seed plant species allows a nucleic acid molecule encoding a floral meristem identity gene product isolated from essentially any seed plant to be introduced into essentially any other seed plant, wherein, upon appropriate expression of the introduced nucleic acid molecule in the seed plant, the floral meristem identity gene product promotes early reproductive development in the seed plant.

If desired, a novel AP1, CAL or LFY coding sequence can be isolated from a seed plant using a nucleotide sequence as a probe and methods well known in the art of molecular biology (Sambrook et al. (eds.), Molecular Clonina: A Laboratory Manual (Second Edition), Plainview, N.Y.: Cold Spring Harbor Laboratory Press (1989), which is incorporated herein by reference). As exemplified herein and discussed in detail below (see Example VA), an AP1 ortholog from Zea Mays (maize; SEQ ID NO: 7) was isolated using the Arabidopsis AP1 cDNA (SEQ ID NO: 1) as a probe.

In one embodiment, the invention provides a non-naturally occurring seed plant that contains a first ectopically expressible nucleic acid molecule encoding a floral meristem identity gene product, provided that the first nucleic acid molecule is not ectopically expressed due to a mutation in an endogenous TERMINAL FLOWER gene, and that is characterized by early reproductive development. As used herein, the term "characterized by early reproductive development," when used in reference to a non-naturally occurring seed plant of the invention, means a non-naturally occurring seed plant that forms reproductive structures earlier than the time when reproductive structures form on a corresponding naturally occurring seed plant that is grown under the same conditions and that does not ectopically express a floral meristem identity gene product. For example, the reproductive structure of an angiosperm is a flower, and the reproductive structure of a coniferous plant is a cone. For a particular-naturally occurring seed plant, reproductive development occurs at a well-defined time that depends, in part, on genetic factors as well as on environmental conditions, such as day length and temperature. Thus, given a defined set of environmental condition and lacking ectopic expression of a floral meristem identity gene product, a naturally occurring seed plant will undergo reproductive development at a relatively fixed time.

It is recognized that various transgenic plants that are characterized by early reproductive development have been described previously. Such transgenic plants, as discussed herein, are distinguishable from a non-naturally occurring seed plant of the invention or are explicitly excluded from the present invention. The product of a "late-flowering gene" can promote early reproductive development. However, a late flowering gene product is not a floral meristem identity gene product since it does not specify the conversion of shoot meristem to floral meristem in an angiosperm. Therefore, a transgenic plant expressing a late-flowering gene product is distinguishable from a non-naturally occurring seed plant of the invention. For example, a transgenic plant expressing the late-flowering gene, CONSTANS (CO), flowers earlier than the corresponding wild type plant, but does not contain an ectopically expressible nucleic acid molecule encoding a floral meristem identity gene product (Putterill et al., Cell 80:847-857 (1995)). Thus, the early-flowering transgenic plant described by Putterill et al. is not a non-naturally occurring seed plant as defined herein.

Early reproductive development also has been observed in a transgenic tobacco plant expressing an exogenous rice MADS domain gene. Although the product of the rice MADS domain gene promotes early reproductive development, it does not specify the identity of floral meristem and, thus, cannot convert shoot meristem to floral meristem in an angiosperm (Chung et al., Plant Mol. Biol. 26:657-665 (1994)). Therefore, an early-flowering transgenic plant containing this rice MADS domain gene, like an early-flowering transgenic plant containing CONSTANS, is distinguishable from an early-flowering non-naturally occurring seed plant of the invention.

Mutations in a class of genes known as "early-flowering genes" also produce plants characterized by early reproductive development. Such early-flowering genes include, for example, EARLY FLOWERING 1-3 (ELF1, ELF2, ELF3); EMBRYONIC FLOWER 1,2 (EMF1, EMF2); LONG HYPOCOTYL 1,2 (HY1, HY2); PHYTOCHROME B (PHYB), SPINDLY (SPY) and TERMINAL FLOWER (TFL) (Weigel, supra, 1995). The wild type product of an early-flowering gene retards reproductive development and is distinguishable from a floral meristem identity gene product in that an early-flowering gene product does not promote conversion of shoot meristem to floral meristem in an angiosperm. A plant that flowers early due to the loss of an early-flowering gene product function is distinct from a non-naturally occurring seed plant of the invention characterized by early reproductive development since such a plant does not contain an ectopically expressible nucleic acid molecule encoding a floral meristem identity gene product.

An Arabidopsis plant having a mutation in the TERMINAL FLOWER (TFL) gene is characterized by early reproductive development and by the conversion of shoots to flowers (Alvarez et al., Plant J. 2:103-116 (1992), which is incorporated herein by reference). However, TFL is not a floral meristem identity gene product, as defined herein. Specifically, it is the loss of TFL that promotes conversion of shoot meristem to floral meristem. Since the function of TFL is to antagonize formation of floral meristem, a tfl mutant, which lacks functional TFL, converts shoot meristem to floral meristem prematurely. Although TFL is not a floral meristem identity gene product and does not itself convert shoot meristem to floral meristem, the loss of TFL can result in a plant with an ectopically expressed floral meristem identity gene product. However, such a tfl mutant, in which a mutation in an endogenous TERMINAL FLOWER gene results in conversion of shoot meristem to floral meristem, is excluded explicitly from the present invention.

As used herein, the term "transgenic" refers to a seed plant that contains in its genome an exogenous nucleic acid molecule, which can be derived from the same or a different plant species. The exogenous nucleic acid molecule can be a gene regulatory element such as a promoter, enhancer or other regulatory element or can contain a coding sequence, which can be linked to a heterologous gene regulatory element.

As used herein, the term "seed plant" means an angiosperm or a gymnosperm. The term "angiosperm," as used herein, means a seed-bearing plant whose seeds are borne in a mature ovary (fruit). An angiosperm commonly is recognized as a flowering plant. The term "gymnosperm," as used herein, means a seed-bearing plant with seeds not enclosed in an ovary.

Angiosperms are divided into two broad classes based on the number of cotyledons, which are seed leaves that generally store or absorb food. Thus, a monocotyledonous angiosperm is an angiosperm having a single cotyledon, and a dicotyledonous angiosperm is an angiosperm having two cotyledons. Angiosperms are well known and produce a variety of useful products including materials such as lumber, rubber, and paper; fibers such as cotton and linen; herbs and medicines such as quinine and vinblastine; ornamental flowers such as roses and orchids; and foodstuffs such as grains, oils, fruits and vegetables.

Angiosperms encompass a variety of flowering plants, including, for example, cereal plants, leguminous plants, oilseed plants, hardwood trees, fruit-bearing plants and ornamental flowers, which general classes are not necessarily exclusive. Such angiosperms include for example, a cereal plant, which produces an edible grain cereal. Such cereal plants include, for example, corn, rice, wheat, barley, oat, rye, orchardgrass, guinea grass, sorghum and turfgrass. In addition, a leguminous plant is an angiosperm that is a member of the pea family (Fabaceae) and produces a characteristic fruit known as a legume. Examples of leguminous plants include, for example, soybean, pea, chickpea, moth bean, broad bean, kidney bean, lima bean, lentil, cowpea, dry bean, and peanut. Examples of legumes also include alfalfa, birdsfoot trefoil, clover and sainfoin. An oilseed plant also is an angiosperm with seeds that are useful as a source of oil. Examples of oilseed plants include soybean, sunflower, rapeseed and cottonseed.

An angiosperm also can be a hardwood tree, which is a perennial woody plant that generally has a single stem (trunk). Examples of such trees include alder, ash, aspen, basswood (linden), beech, birch, cherry, cottonwood, elm, eucalyptus, hickory, locust, maple, oak, persimmon, poplar, sycamore, walnut and willow. Trees are useful, for example, as a source of pulp, paper, structural material and fuel.

An angiosperm also can be a fruit-bearing plant, which produces a mature, ripened ovary (usually containing seeds) that is suitable for human or animal consumption. For example, hops are a member of the mulberry family prized for their flavoring in malt liquor. Fruit-bearing angiosperms also include grape, orange, lemon, grapefruit, avocado, date, peach, cherry, olive, plum, coconut, apple and pear trees and blackberry, blueberry, raspberry, strawberry, pineapple, tomato, cucumber and eggplant plants. An ornamental flower is an angiosperm cultivated for its decorative flower. Examples of commercially important ornamental flowers include rose, orchid, lily, tulip and chrysanthemum, snapdragon, camellia, carnation and petunia plants. The skilled artisan will recognize that the methods of the invention can be practiced using these or other angiosperms, as desired.

Gymnosperms encompass four divisions: cycads, ginkgo, conifers and gnetophytes. The conifers are the most widespread of living gymnosperms and frequently are cultivated for structural wood or for pulp or paper. Conifers include redwood trees, pines, firs, spruces, hemlocks, Douglas firs, cypresses, junipers and yews. The skilled artisan will recognize that the methods of the invention can be practiced with these and other gymnosperms.

As used herein, the term "non-naturally occurring seed plant" means a seed plant containing a genome that has been modified by man. A transgenic seed plant, for example, is a non-naturally occurring seed plant that contains an exogenous nucleic acid molecule and, therefore, has a genome that has been modified by man. Furthermore, a seed plant that contains, for example, a mutation in an endogenous floral meristem identity gene regulatory element as a result of calculated exposure to a mutagenic agent also contains a genome that has been modified by man. In contrast, a seed plant containing a spontaneous or naturally occurring mutation is not a "non-naturally occurring seed plant" and, therefore, is not encompassed within the invention.

In various embodiments, the present invention rovides a non-naturally occurring seed plant containing a first ectopically expressible nucleic acid molecule encoding a first floral meristem identity gene product, provided that the first nucleic acid molecule is not ectopically expressed due to a mutation in an endogenous TERMINAL FLOWER gene. If desired, a non-naturally occurring seed plant of the invention can contain a second ectopically expressible nucleic acid molecule encoding a second floral meristem identity gene product that is different from the first floral meristem identity gene product, provided that the first or second nucleic acid molecule is not ectopically expressed due to a mutation in an endogenous TERMINAL FLOWER gene.

An ectopically expressible nucleic acid molecule encoding a floral meristem identity gene product can be expressed, as desired, either constitutively or inducibly. Such an ectopically expressible nucleic acid molecule encoding a floral meristem identity gene product can be an endogenous floral meristem identity gene that has, for example, a mutation in a gene regulatory element. An ectopically expressible nucleic acid molecule encoding a floral meristem identity gene product also can be an endogenous nucleic acid molecule encoding a floral meristem identity gene product that is linked to an exogenous, heterologous gene regulatory element that confers ectopic expression. In addition, an ectopically expressible nucleic acid molecule encoding a floral meristem identity gene product can be an exogenous nucleic acid molecule that encodes a floral meristem identity gene product under control of a heterologous gene regulatory element.

A non-naturally occurring seed plant of the invention can contain an endogenous floral meristem identity gene having a modified gene regulatory element. The term "modified gene regulatory element," as used herein in reference to the regulatory element of a floral meristem identity gene, means a regulatory element having a mutation that results in ectopic expression of the linked endogenous floral meristem identity gene. Such a gene regulatory element can be, for example, a promoter or enhancer element and can be positioned 5' or 3' to the coding sequence or within an intronic sequence of the floral meristem identity gene. A modified gene regulatory element can have, for example, a nucleotide insertion, deletion or substitution that is produced, for example, by chemical mutagenesis using a mutagen such as ethylmethane sulfonate or by insertional mutagenesis using a transposable element. A modified gene regulatory element can be a functionally inactivated binding site for TFL or a functionally inactivated binding site for a gene product regulated by TFL, such that modification of the gene regulatory element results in ectopic expression of the linked floral meristem identity gene product, for example, in the shoot meristem of an angiosperm.

The present invention also provides a transgenic seed plant containing a first exogenous gene promoter that regulates a first ectopically expressible nucleic acid molecule encoding a first floral meristem identity gene product and a second exogenous gene promoter that regulates a second ectopically expressible nucleic acid molecule encoding a second floral meristem identity gene product.

The present invention further provides a transgenic seed plant containing a first exogenous ectopically expressible nucleic acid molecule encoding a first floral meristem identity gene product and a second exogenous gene promoter that regulates a second ectopically expressible nucleic acid molecule encoding a second floral meristem identity gene product, provided that the first nucleic acid molecule is not ectopically expressed due to a mutation in an endogenous TERMINAL FLOWER gene.

In addition, the invention provides a transgenic seed plant containing a first exogenous ectopically expressible nucleic acid molecule encoding a first floral meristem identity gene product, provided that the first second nucleic acid molecule is not ectopically expressed due to a mutation in an endogenous TERMINAL FLOWER gene, and further containing a second exogenous ectopically expressible nucleic acid molecule encoding a second floral meristem identity gene product, where the first floral meristem identity gene product is different from the second floral meristem identity gene product.

As disclosed herein, ectopic expression of two different floral meristem identity gene products can be particularly useful. A transgenic Arabidopsis line constitutively expressing AP1 under control of the cauliflower mosaic virus 35S promoter (see Example I) was crossed with a transgenic Arabidopsis line constitutively expressing LFY under control of the cauliflower mosaic virus 35S promoter (see Example III), and the resulting progeny were analyzed. A fraction of the progeny flowered were characterized by enhanced early reproductive development as compared to the early reproductive development of 35S-AP1 transgenic lines or 35S-LFY transgenic lines. PCR-based analyses demonstrated that all of the transgenic plants that were characterized by enhanced early reproductive development contained both the 35S-AP1 and 35S-LFY transgenes. These results indicate that ectopic expression of the combination of AP1 and LFY in a seed plant can result in enhanced early reproductive development as compared to the early reproductive development obtained by ectopic expression of AP1 or LFY alone. Thus, by using a combination of two different floral meristem identity gene products, plant breeding, for example, can be accelerated further as compared to the use of a single floral meristem identity gene product.

A useful combination of first and second floral meristem identity gene products can be, for example, AP1 and LFY, CAL and LFY, or AP1 and CAL. A particularly useful combination of first and second floral meristem identity gene products is the combination of AP1 with LFY, as disclosed above, or the combination of CAL with LFY. Where a transgenic seed plant of the invention contains first and second exogenous nucleic acid molecules encoding different floral meristem identity gene products, it will be recognized that the order of introducing the first and second nucleic acid molecules into the seed plant is not important for purposes of the present invention. Thus, a transgenic seed plant of the invention having, for example, AP1 as a first floral meristem identity gene product and LFY as a second floral meristem identity gene product is equivalent to a transgenic seed plant having LFY as a first floral meristem identity gene product and AP1 as a second floral meristem identity gene product.

The invention also provides methods of converting shoot meristem to floral meristem in an angiosperm by ectopically expressing a first ectopically expressible nucleic acid molecule encoding a first floral meristem identity gene product in the angiosperm. Thus, the invention provides, for example, a method of converting shoot meristem to floral meristem in an angiosperm by introducing an exogenous, ectopically expressible nucleic acid molecule encoding a floral meristem identity gene product into the angiosperm, thereby producing a transgenic angiosperm. A floral meristem identity gene product such as AP1, CAL or LFY, or a chimeric protein containing, in part, a floral meristem identity gene product, as disclosed below, is useful in converting shoot meristem to floral meristem according to the methods of the invention.

As used herein, the term "introducing," when sed in reference to a nucleic acid molecule and a seed plant such as an angiosperm or a gymnosperm, means transferring an exogenous nucleic acid molecule into the seed plant. For example, an exogenous nucleic acid molecule encoding a floral meristem identity gene product can be introduced into a seed plant by a variety of methods including Agrobacterium-mediated transformation or direct gene transfer methods such as electroporation or microprojectile-mediated transformation.

Transformation methods based upon the soil bacterium Agrobacterium tumefaciens, known as "agro-infection," are useful for introducing a nucleic acid molecule into a broad range of angiosperms and gymnosperms. The wild type form of Agrobacterium contains a Ti (tumor-inducing) plasmid that directs production of tumorigenic crown gall growth on host plants. Transfer of the tumor-inducing T-DNA region of the Ti plasmid to a plant genome requires the Ti plasmid-encoded virulence genes as well as T-DNA borders, which are a set of direct DNA repeats that delineate the region to be transferred. Agrobacterium-based vector is a modified form of a Ti plasmid, in which the tumor inducing functions are replaced by nucleic acid sequence of interest to be introduced into the plant host.

Current protocols for Agrobacterium-mediated transformation employ cointegrate vectors or, preferably, binary vector systems in which the components of the Ti plasmid are divided between a helper vector, which resides permanently in the Agrobacterium host and carries the virulence genes, and a shuttle vector, which contains the gene of interest bounded by T-DNA sequences. A variety of binary vectors are well known in the art and are commercially available from, for example, Clontech (Palo Alto, Calif.). Methods of coculturing Agrobacterium with cultured plant cells or wounded tissue such as leaf tissue, root explants, hypocotyledons, stem pieces or tubers, for example, also are well known in the art (Glick and Thompson (eds.), Methods in Plant Molecular Biology and Biotechnology, Boca Raton, Fla.: CRC Press (1993), which is incorporated herein by reference). Wounded cells within the plant tissue that have been infected by Agrobacterium can develop organs de novo when cultured under the appropriate conditions; the resulting transgenic shoots eventually give rise to transgenic plants containing the exogenous nucleic acid molecule of interest, as described in Example I.

Agrobacterium-mediated transformation has been used to produce a variety of transgenic seed plants (see, for example, Wang et al. (eds), Transformation of Plants and Soil Microorganisms, Cambridge, UK: University Press (1995), which is incorporated herein by reference). For example, Agrobacterium-mediated transformation can be used to produce transgenic crudiferous plants such as Arabidopsis, mustard, rapeseed and flax; transgenic leguminous plants such as alfalfa, pea, soybean, trefoil and white clover; and transgenic solanaceous plants such as eggplant, petunia, potato, tobacco and tomato. In addition, Agrobacterium-mediated transformation can be used to introduce exogenous nucleic acids into apple, aspen, belladonna, black currant, carrot, celery, cotton, cucumber, grape, horseradish, lettuce, morning glory, muskmelon, neem, poplar, strawberry, sugar beet, sunflower, walnut and asparagus plants (see, for example, Glick and Thompson, supra, 1993).

Microprojectile-mediated transformation also is a well known method of introducing an exogenous nucleic acid molecule into a variety of seed plant species. This method, first described by Klein et al., Nature 327:70-73 (1987), which is incorporated herein by reference, relies on microprojectiles such as gold or tungsten that are coated with the desired nucleic acid molecule by precipitation with calcium chloride, spermidine or PEG. The microprojectile particles are accelerated at high speed into seed plant tissue using a device such as the Biolistic™ PD-1000 (Biorad, Hercules, Calif.).

Microprojectile-mediated delivery or "particle bombardment" is especially useful to transform seed plants that are difficult to transform or regenerate using other methods. Microprojectile-mediated transformation has been used, for example, to generate a variety of transgenic seed plant species, including cotton, tobacco, corn, hybrid poplar and papaya (see, for example, Glick and Thompson, supra, 1993). The transformation of important cereal crops such as wheat, oat, barley, sorghum and rice also has been achieved using microprojectile-mediated delivery (Duan et al., Nature Biotech. 14:494-498 (1996); Shimamoto, Curr. Opin. Biotech. 5:158-162 (1994), each of which is incorporated herein by reference). A rapid transformation regeneration system for the production of transgenic plants, such as transgenic wheat, in two to three months also can be useful in producing a transgenic seed plant of the invention (European Patent No. EP 0 709 462 A2, Application number 95870117.9, filed Oct. 25 1995, which is incorporated herein by reference).

Thus, a variety of methods for introducing a nucleic acid molecule into a seed plant are well known in the art. Important crop species such as rice, for example, have been transformed using microprojectile delivery, Agrobacterium-mediated transformation or protoplast transformation (Hiei et al., The Plant J. 6(2):271-282 (1994); Shimamoto, Science 270:1772-1773 (1995), each of which is incorporated herein by reference). Fertile transgenic maize has been obtained, for example, by microparticle bombardment (see Wang et al., supra, 1995). As discussed above, barley, wheat, oat and other small-grain cereal crops also have been transformed, for example, using microparticle bombardment (see Wang et al., supra, 1995).

Methods of transforming forest trees including both angiosperms and gymnosperms also are well known in the art. Transgenic angiosperms such as members of the genus Populus, which includes aspens and poplars, have been generated using Agrobacterium-mediated transformation, for example. In addition, transgenic Populus and sweetgum, which are of interest for biomass production for fuel, also have been produced. Transgenic gymnosperms, including conifers such as white spruce and larch, also have been obtained, for example, using microprojectile bombardment (Wang et al., supra, 1995). The skilled artisan will recognize that Agrobacterium-mediated or microprojectile-mediated transformation, as disclosed herein, or other methods known in the art can be used to introduce a nucleic acid molecule encoding a floral meristem identity gene product into a seed plant according to the methods of the invention.

The term "converting shoot meristem to floral meristem," as used herein, means promoting the formation of flower progenitor tissue where shoot progenitor tissue otherwise would be formed in the angiosperm. As a result of the conversion of shoot meristem to floral meristem, flowers form in an angiosperm where shoots normally would form. The conversion of shoot meristem to floral meristem can be identified using well known methods, such as scanning electron microscopy, light microscopy or visual inspection (see, for example, Mandel and Yanofsky, Plant Cell 7:1763-1771 (1995), which is incorporated herein by reference or Weigel and Nilsson, supra, 1995).

Provided herein are methods of converting shoot meristem to floral meristem in an angiosperm by introducing a first ectopically expressible nucleic acid molecule encoding a first floral meristem identity gene product and a second ectopically expressible nucleic acid molecule encoding a second floral meristem identity gene product into the angiosperm, where the first floral meristem identity gene product is different from the second floral meristem identity gene product. As discussed above, first and second floral meristem identity gene products useful in converting shoot meristem to floral meristem in an angiosperm can be, for example, AP1 and LFY, CAL and LFY, or AP1 and CAL.

Also provided herein are methods of promoting early reproductive development in a seed plant by ectopically expressing a first nucleic acid molecule encoding a first floral meristem identity gene product in the seed plant, provided that the first nucleic acid molecule is not ectopically expressed due to a mutation in an endogenous TERMINAL FLOWER gene. For example, the invention provides a method of promoting early reproductive development in a seed plant by introducing an ectopically expressible nucleic acid molecule encoding a floral meristem identity gene product into the seed plant, thus producing a transgenic seed plant. A floral meristem identity gene product such as AP1, CAL or LFY, or a chimeric protein containing, in part, a floral meristem identity gene product, as disclosed below, is useful in methods of promoting early reproductive development.

The term "promoting early reproductive development," as used herein in reference to a seed plant, means promoting the formation of a reproductive structure earlier than the time when a reproductive structure would form on a corresponding seed plant that is grown under the same conditions and that does not ectopically express a floral meristem identity gene product. As discussed above, the time when reproductive structures form on a particular seed plant that does not ectopically express a floral meristem identity gene product is relatively fixed and depends, in part, on genetic factors as well as environmental conditions, such as day length and temperature. Thus, given a defined set of environmental conditions, a naturally occurring angiosperm, for example, will flower at a relatively fixed time. Similarly, given a defined set of environmental conditions, a naturally occurring coniferous gymnosperm, for example, will produce cones at a relatively fixed time.

As disclosed herein, ectopic expression of a nucleic acid molecule encoding a floral meristem identity gene product in an angiosperm converts shoot meristem to floral meristem in the angiosperm. Furthermore, ectopic expression of a nucleic acid molecule encoding a floral meristem identity gene product such as AP1, CAL or LFY in an angiosperm prior to the time when endogenous floral meristem identity gene products are expressed in the angiosperm can convert shoot meristem to floral meristem precociously, resulting in early reproductive development in the angiosperm, as indicated by early flowering. In the same manner, ectopic expression of a nucleic acid molecule encoding AP1, CAL, or LFY, for example, in a gymnosperm prior to the time when endogenous floral meristem identity gene products are expressed in the gymnosperm results in early reproductive development in the gymnosperm.

For a given seed plant species and particular set of growth conditions, constitutive expression of a floral meristem identity gene product results in a relatively invariant time of early reproductive development, which is the earliest time when all factors necessary for reproductive development are active. For example, as shown in Example ID, constitutive expression of AP1 in transgenic Arabidopsis plants grown under "long-day" light conditions results in early reproductive development at day 10 as compared to the normal time of reproductive development, which is day 18 in non-transgenic Arabidopsis plants grown under the same conditions. Thus, under these conditions, day 10 is the relatively invariant time of early reproductive development for Arabidopsis transgenics that constitutively express a floral meristem identity gene product.

However, in addition to methods of constitutively expressing a floral meristem identity gene product, the present invention provides methods of selecting the time of early reproductive development. As disclosed herein, floral meristem gene product expression or activity can be regulated in response to an inducing agent or cognate ligand, for example, such that the time of early reproductive development can be selected. For example, in Arabidopsis transgenics grown under the conditions described above, the time of early reproductive development need not necessarily be the relatively invariant day 10 at which early reproductive development occurs as a consequence of constitutive floral meristem identity gene product expression. If floral meristem identity gene product expression is rendered dependent upon the presence of an inducing agent, early reproductive development can be selected to occur, for example, on day 14, by contacting the seed plant with an inducing agent on or slightly before day 14.

Thus, the present invention provides recombinant nucleic acid molecules, transgenic seed plant containing such recombinant nucleic acid molecules and methods for selecting the time of early reproductive development. These methods allow a farmer or horticulturist, for example, to determine the time of early reproductive development. The methods of the invention can be useful, for example, in allowing a grower to respond to an approaching storm or impending snap-freeze by selecting the time of early reproductive development such that the crop can be harvested before being harmed by the adverse weather conditions. The methods of the invention for selecting the time of early reproductive development also can be useful to spread out the time period over which transgenic seed plants are ready to be harvested. For example, the methods of the invention can be used to increase floral meristem identity gene product expression in different crop fields at different times, resulting in a staggered time of harvest for the different fields.

Thus, the present invention provides a recombinant nucleic acid molecule containing an inducible regulatory element operably linked to a nucleic acid molecule encoding a floral meristem identity gene product. The floral meristem identity gene product encoded within a recombinant nucleic acid molecule of the invention can be, for example, AP1 or CAL. In addition, the floral meristem identity gene product encoded within a recombinant nucleic acid molecule of the invention can be LFY. As disclosed herein, a recombinant nucleic acid molecule of the invention can contain an inducible regulatory element such as a copper inducible element, tetracycline inducible element, ecdysone inducible element or heat shock inducible element.

The invention also provides a transgenic seed plant containing a recombinant nucleic acid molecule comprising an inducible regulatory element operably linked to a nucleic acid molecule encoding a floral meristem identity gene product. Such a transgenic seed plant can be an angiosperm or gymnosperm and can contain, for example, a recombinant nucleic acid molecule comprising an inducible regulatory element operably linked to a nucleic acid molecule encoding AP1 or CAL. A transgenic seed plant of the invention can contain, for example, a recombinant nucleic acid molecule comprising a copper inducible element, tetracycline inducible element, ecdysone inducible element or heat shock inducible element operably linked to a nucleic acid molecule encoding AP1. In addition, a transgenic seed plant of the invention can contain a recombinant nucleic acid molecule comprising a copper inducible element tetracycline inducible element, ecdysone inducible element or heat shock inducible element operably linked to a nucleic acid molecule encoding CAL. A transgenic seed plant of the invention also can contain a recombinant nucleic acid molecule comprising a copper inducible element, tetracycline inducible element, ecdysone inducible element or heat shock inducible element operably linked to a nucleic acid molecule encoding LFY.

The term "recombinant nucleic acid molecule," as used herein, means a non-naturally occurring nucleic acid molecule that has been manipulated in vitro such that it is genetically distinguishable from a naturally occurring nucleic acid molecule. A recombinant nucleic acid molecule of the invention comprises two nucleic acid molecules that have been manipulated in vitro such that the two nucleic acid molecules are operably linked.

As used herein, the term "inducible regulatory element" means a nucleic acid molecule that confers conditional expression upon an operably linked nucleic acid molecule, where expression of the operably linked nucleic acid molecule is increased in the presence of a particular inducing agent as compared to expression of the nucleic acid molecule in the absence of the inducing agent. In a method of the invention, a useful inducible regulatory element has the following characteristics: confers low level expression upon an operably linked nucleic acid molecule in the absence of an inducing agent; confers high level expression upon an operably linked nucleic acid molecule in the presence of an appropriate inducing agent; and utilizes an inducing agent that does not interfere substantially with the normal physiology of a transgenic seed plant treated with the inducing agent. It is recognized, for example, that, subsequent to introduction into a seed plant, a particularly useful inducible regulatory element is one that confers an extremely low level of expression upon an operably linked nucleic acid molecule in the absence of inducing agent. Such an inducible regulatory element is considered to be tightly regulated.

The term "operably linked," as used in reference to a regulatory element, such as a promoter or inducible regulatory element, and a nucleic acid molecule encoding a floral meristem identity gene product, means that the regulatory element confers regulated expression upon the operably linked nucleic acid molecule encoding the floral meristem identity gene product. Thus, the term operably linked, as used herein in reference to an inducible regulatory element and a nucleic acid molecule encoding a floral meristem identity gene product, means that the inducible regulatory element is linked to the nucleic acid molecule encoding a floral meristem identity gene product such that the inducible regulatory element increases expression of the floral meristem identity gene product in the presence of the appropriate inducing agent. It is recognized that two nucleic acid molecules that are operably linked contain, at a minimum, all elements essential for transcription, including, for example, a TATA box. One skilled in the art knows, for example, that an inducible regulatory element that lacks minimal promoter elements can be combined with a nucleic acid molecule having minimal promoter elements and a nucleic acid molecule encoding a floral meristem identity gene product such that expression of the floral meristem identity gene product can be increased in the presence of the appropriate inducing agent.

A particularly useful inducible regulatory element can be, for example, a copper-inducible promoter (Mett et al., Proc. Natl. Acad, Sci, USA 90:4567-4571 (1993), which is incorporated herein by reference); tetracycline-inducible regulatory element (Gatz et al., Plant J. 2:397-404 (1992); Roder et al., Mol. Gen. Genet. 243:32-38 (1994), each of which is incorporated herein by reference); ecdysone inducible element (Christopherson et al., Proc. Natl. Acad. Sci. USA 89:6314-6318 (1992), which is incorporated herein by reference); or heat shock inducible element (Takahashi et al., Plant Physiol. 99:383-390 (1992), which is incorporated herein by reference). Another useful inducible regulatory element can be a lac operon element, which is used in combination with a constitutively expressed lac repressor to confer, for example, IPTG-inducible expression, as described by Wilde et al., (EMBO J. 11:1251-1259 (1992), which is incorporated herein by reference).

An inducible regulatory element useful in a method of the invention also can be, for example, a nitrate-inducible promoter derived from the spinach nitrite reductase gene (Back et al., Plant Mol. Biol. 17:9 (1991), which is incorporated herein by reference) or a light-inducible promoter, such as that associated with the small subunit of RuBP carboxylase or the LHCP gene families (Feinbaum et al., Mol. Gen. Genet. 226:449 (1991); Lam and Chua, Science 248:471 (1990), each of which is incorporated herein by reference). An inducible regulatory element useful in constructing a transgenic seed plant also can be a salicylic acid inducible element (Uknes et al., Plant Cell 5:159-169 (1993); Bi et al., Plant J. 8:235-245 (1995), each of which is incorporated herein by reference) or a plant hormone-inducible element (Yamaguchi-Shinozaki et al., Plant Mol. Biol. 15:905 (1990); Kares et al., Plant Mol. Biol. 15:225 (1990), each of which is incorporated herein by reference). A human glucocorticoid response element also is an inducible regulatory element that can confer hormone-dependent gene expression in seed plants (Schena et al., Proc. Natl. Acad. Sci. USA 88:10421 (1991), which is incorporated herein by reference).

An inducible regulatory element that is particularly useful for increasing expression of a floral meristem identity gene product in a transgenic seed plant of the invention is a copper inducible regulatory element (see, for example, Mett et al., supra, 1993). Thus, the invention provides a recombinant nucleic acid molecule comprising a copper inducible regulatory element operably linked to a nucleic acid molecule encoding a floral meristem identity gene product and a transgenic seed plant containing such a recombinant nucleic acid molecule. Copper, which is a natural part of the nutrient environment of a seed plant, can be used to increase expression of a nucleic acid molecule encoding a floral meristem identity gene product operably linked to a copper inducible regulatory element. For example, an ACE1 binding site in conjunction with constitutively expressed yeast ACE1 protein confers copper inducible expression upon an operably linked nucleic acid molecule. The ACE1 protein, a metalloresponsive transcription factor, is activated by copper or silver ions, resulting in increased expression of a nucleic acid molecule operably linked to an ACE1 element.

Such a copper inducible regulatory element can be an ACE1 binding site from the metallothionein gene promoter (SEQ ID NO: 21; Furst et al., Cell 55:705-717 (1988), which is incorporated herein by reference). For example, the ACE1 binding site can be combined with the 90 base-pair domain A of the cauliflower mosaic virus 35S promoter and operably linked to a nucleic acid molecule encoding AP1, CAL or LFY to produce a recombinant nucleic acid molecule of the invention. In a transgenic seed plant constitutively expressing ACE1 under control of such a modified CaMV 35S promoter, for example, copper inducible expression is conferred upon an operably linked nucleic acid molecule encoding a floral meristem identity gene product.

The expression of a nucleic acid encoding a floral meristem identity gene product operably linked to a copper inducible regulatory element, such as 5'-AGCTTAGCGATGCGTCTTTTCCGCTGAACCGTTCCAGCAAAAAAGACTAG-3' (SEQ ID NO: 21), can be increased in a transgenic seed plant grown under copper ion-depleted conditions, for example, and contacted with 50 μM copper sulfate in a nutrient solution or with 0.5 μM copper sulfate applied by foliar spraying of the transgenic seed plant (see, for example, Mett et al., supra, 1993). A single application of 0.5 μM copper sulfate can be sufficient to sustain increased floral meristem identity gene product expression over a period of several days. If desired, a transgenic seed plant of the invention also can be contacted with multiple applications of an inducing agent such as copper sulfate.

An inducible regulatory element also can confer tetracycline-dependent floral meristem identity gene expression in a transgenic seed plant of the invention. Thus, the present invention provides a recombinant nucleic acid molecule comprising a tetracycline inducible regulatory element operably linked to a nucleic acid molecule encoding a floral meristem identity gene product as well as a transgenic seed plant into which such a recombinant nucleic acid molecule has been introduced. A tetracycline inducible regulatory element is particularly useful for conferring tightly regulated gene expression as indicated by the observation that a phenotype that results from even low amounts of a gene product expression is suppressed from such an inducible system in the absence of inducing agent (see, for example, Roder et al., supra, 1994).

A transgenic seed plant constitutively expressing Tn10-encoded Tet repressor (TetR), for example, can be contacted with tetracycline to increase expression of a nucleic acid molecule encoding a floral meristem identity gene product operably linked to the cauliflower mosaic virus promoter containing several tet operator sequences (5'-ACTCTATCAGTGATAGAGT-3'; SEQ ID NO: 22) positioned close to the TATA box (see, for example, Gatz, Meth. Cell Biol. 50:411-424 (1995), which is incorporated herein by reference; Gatz et al., supra, 1992). Such a tetracycline-inducible system can increase expression of an operably linked nucleic acid molecule as much as 200 to 500-fold in a transgenic angiosperm or gymnosperm of the invention.

A high level of Tet repressor expression (about 1×10⁶ molecules per cell) is critical for tight regulation. Thus, a seed plant preferably is transformed first with a plasmid encoding the Tet repressor, and screened for high level expression. For example, plasmid pBinTet (Gatz, supra, 1995) contains the Tet repressor coding region, which is expressed under control of the CaMV 35S promoter, and the neomycin phosphotransferase gene for selection of transformants. To screen transformants for a high level of Tet repressor expression, a plasmid containing a reporter gene under control of a promoter with tet operators, such as pTX-Gus-int (Gatz, supra, 1995), can be transiently introduced into a seed plant cell and assayed for activity in the presence and absence of tetracycline. High β-glucouronidase (GUS) expression that is dependent on the presence of tetracycline is indicative of high Tet repressor expression.

A particularly useful tetracycline inducible regulatory element is present in plasmid pBIN-HygTX, which has a CaMV 35S promoter, into which three tet operator sites have been inserted, and an octopine synthase polyadenylation site (Gatz, supra, 1995). A multiple cloning site between the promoter and polyadenylation signal in pBIN-HygTX allows for convenient insertion of a nucleic acid molecule encoding the desired floral meristem identity gene product, and the hygromycin phosphotransferase gene allows for selection of transformants containing the construct. In a preferred embodiment of the invention, previously selected Tet repressor positive cells are transformed with a plasmid such as pBIN-HygTX, into which a nucleic acid molecule encoding a floral meristem identity gene product has been inserted.

To increase floral meristem identity gene product expression using a tetracycline-inducible regulatory element, a transgenic seed plant of the invention can be contacted with tetracycline or, preferably, with chlor-tetracycline (SIGMA), which is a more efficient inducer than tetracycline. In addition, a useful inducing agent can be a tetracycline analog that binds the Tet repressor to function as an inducer but that does not act as an antibiotic (Gatz, supra, 1995). A transgenic seed plant of the invention can be contacted, for example, by watering with about 1 mg/liter chlor-tetracycline or tetracycline. Similarly, a plant grown in hydroponic culture can be contacted with a solution containing about 1 mg/liter chlor-tetracycline or tetracycline (Gatz, supra, 1995). If desired, a transgenic angiosperm or gymnosperm can be contacted repeatedly with chlor-tetracycline or tetracycline every other day for about 10 days (Roder et al., supra, 1994). Floral meristem identity gene product expression is increased efficiently at a tetracycline concentration that does not inhibit the growth of bacteria, indicating that the use of tetracycline as an inducing agent will not present environmental concerns.

An ecdysone inducible regulatory element also can be useful in practicing the methods of the invention. For example, an ecdysone inducible regulatory element can contain four copies of an ecdysone response element having the sequence 5'-GATCCGACAAGGGTTCAATGCACTTGTCA-3' (EcRE; SEQ ID NO: 23) as described in Christopherson et al., supra, 1992. In a transgenic seed plant into which a nucleic acid encoding an ecdysone receptor has been introduced, an ecdysone inducible regulatory element can confer ecdysone-dependent expression on a nucleic acid molecule encoding a floral meristem identity gene product. An appropriate inducing agent for increasing expression of a nucleic acid molecule operably linked to an ecdysone inducible regulatory element can be, for example, α-ecdysone, 20-hydroxyecdysone, polypodine B, ponasterone A, muristerone A or RH-5992, which is an ecdysone agonist that mimics 20-hydroxyecdysone (see, for example, Kreutzweiser et al., Ecotoxicol. Environ. Safety 28:14-24 (1994), which is incorporated herein by reference and Christopherson et al., supra, 1992). Methods for determining an appropriate inducing agent for use with an ecdysone inducible regulatory element are well known in the art. As disclosed herein, compound RH-5992 can be a particularly useful inducing agent for increasing floral meristem gene product expression in a transgenic seed plant containing an ecdysone inducible regulatory element.

An inducible regulatory element also can be derived from the promoter of a heat shock gene, such as HSP81-1 (SEQ ID NO: 24; Takahashi, supra, 1992). Thus, the invention also provides a recombinant nucleic acid molecule comprising a heat shock inducible regulatory element operably linked to a nucleic acid molecule encoding a floral meristem identity gene product and a transgenic seed plant containing such a recombinant nucleic acid molecule. The HSP81-1 promoter (SEQ ID NO: 24) confers low level expression upon an operably linked nucleic acid molecule in parts of roots under unstressed conditions and confers high level expression in most Arabidopsis tissues following heat shock (see, for example, Yabe et al., Plant Cell Physiol. 35:1207-1219 (1994), which is incorporated herein by reference). After growth of Arabidopsis at 23° C., a single heat shock treatment at 37° C. for two hours is sufficient to induce expression of a nucleic acid molecule operably linked to the HSP81-1 gene regulatory element (see Ueda et al., Mol. Gen. Genet. 250:533-539 (1996), which is incorporated herein by reference).

The use of a heat shock inducible regulatory element is particularly useful for a transgenic seed plant of the invention grown in an enclosed environment such as a green house, where temperature can be readily manipulated. The use of a heat shock inducible regulatory element especially is applicable to a transplantable or potted transgenic seed plant of the invention, which can be moved conveniently from an environment having a low temperature to an environment having a high temperature. A transgenic angiosperm or gymnosperm of the invention containing a recombinant nucleic acid molecule comprising a HSP81-1 heat shock regulatory element operably linked to a nucleic acid molecule encoding a floral meristem identity gene product also can be induced, for example, by altering the ambient temperature, watering with heated water or submersing the transgenic seed plant in a sealed plastic bag into a heated water bath (see, for example, Ueda et al., supra, 1996).

A recombinant nucleic acid molecule of the invention comprising an inducible gene regulatory element can be expressed variably in different lines of transgenic seed plants. In some transgenic lines, for example, leaky expression of the introduced recombinant nucleic acid molecule can occur in the absence of the appropriate inducing agent due to phenomena such as position effects (see, for example, Ueda et al., supra, 1996). Thus, a transgenic seed plant containing a recombinant nucleic acid molecule comprising an inducible gene regulatory element operably linked to a nucleic acid encoding a floral meristem identity gene product can be screened, if desired, to obtain a particular transgenic seed plant in which expression of the operably linked nucleic acid molecule is desirably low in the absence of the appropriate inducing agent.

The present invention also provides a method of converting shoot meristem to floral meristem in an angiosperm by introducing into the angiosperm a recombinant nucleic acid molecule comprising an inducible regulatory element operably linked to a nucleic acid molecule encoding a floral meristem identity gene product to produce a transgenic angiosperm, and contacting the transgenic angiosperm with an inducing agent, thereby increasing expression of the floral meristem identity gene product and converting shoot meristem to floral meristem in the transgenic angiosperm. In such a method of the invention, the inducible regulatory element can be, for example, a copper inducible element, tetracycline inducible element, ecdysone inducible element or heat shock inducible element, and the floral meristem identity gene product can be, for example, AP1, CAL or LFY.

In addition, the invention provides a method of promoting early reproductive development in a seed plant such as an angiosperm or gymnosperm by introducing into the seed plant a recombinant nucleic acid molecule comprising an inducible regulatory element operably linked to a nucleic acid molecule encoding a floral meristem identity gene product to produce a transgenic seed plant, and contacting the transgenic seed plant with an inducing agent, thereby increasing expression of the floral meristem identity gene product and promoting early reproductive development in the transgenic seed plant. In a method of the invention for promoting early reproductive development in a seed plant, the inducible regulatory element can be, for example, a copper inducible element, tetracycline inducible element, ecdysone inducible element or heat shock inducible element, and the floral meristem identity gene product can be, for example, AP1, CAL or LFY.

The term "inducing agent," as used herein, means a substance or condition that effects increased expression of a nucleic acid molecule operably linked to a particular inducible regulatory element as compared to the level of expression of the nucleic acid molecule in the absence of the inducing agent. An inducing agent can be, for example, a naturally occurring or synthetic chemical or biological molecule such as a simple or complex organic molecule, a peptide, a protein or an oligonucleotide that increases expression of a nucleic acid molecule operably linked to a particular inducible regulatory element. An example of such an inducing agent is a compound such as copper sulfate, tetracycline or an ecdysone. An inducing agent also can be a condition such as heat of a certain temperature or light of a certain wavelength. When used in reference to a particular inducible regulatory element, an "appropriate" inducing agent means an inducing agent that results in increased expression of a nucleic acid molecule operably linked to the particular inducible regulatory element.

An inducing agent of the invention can be used alone or in solution or can be used in conjunction with an acceptable carrier that can serve to stabilize the inducing agent or to promote absorption of the inducing agent by a seed plant. If desired, a transgenic seed plant of the invention can be contacted with an inducing agent in combination with an unrelated substance such as a plant nutrient, pesticide or insecticide.

One skilled in the art can readily determine the optimum concentration of an inducing agent needed to produce increased expression of a nucleic acid molecule operably linked to an inducible regulatory element in a transgenic seed plant of the invention. For conveniently determining the optimum concentration of inducing agent from a range of useful concentrations, one skilled in the art can operably link the particular inducible regulatory element to a nucleic acid molecule encoding a reporter gene product such as β-glucouronidase (GUS) and assay for reporter gene product activity in the presence of various concentrations of inducing agent (see, for example, Jefferson et al., EMBO J. 6:3901-3907 (1987), which is incorporated herein by reference).

As used herein, the term "contacting," in reference to a transgenic seed plant of the invention, means exposing the transgenic seed plant to an inducing agent, or to a cognate ligand as disclosed below, such that the agent can induce expression of a nucleic acid molecule operably linked to the particular inducible regulatory element. A transgenic seed plant such as an angiosperm or gymnosperm, which contains a recombinant nucleic acid molecule of the invention, can be contacted with an inducing agent in a variety of manners. Expression of a floral meristem identity gene product can be increased conveniently, for example, by spraying a transgenic seed plant with an aqueous solution containing an appropriate inducing agent or by adding an appropriate inducing agent to the water supply of a transgenic seed plant grown using irrigation or to the water supply of a transgenic seed plant grown hydroponically. A transgenic seed plant containing a recombinant nucleic acid molecule of the invention also can be contacted by spraying the seed plant with an inducing agent in aerosol form. In addition, a transgenic seed plant can be contacted with an appropriate inducing agent by adding the agent to the soil or other solid nutrient media in which the seed plant is grown, whereby the inducing agent is absorbed into the seed plant. Other modes of contacting a transgenic seed plant with an inducing agent, such as injecting or immersing the seed plant in a solution containing an inducing agent, are well known in the art. For an inducing agent that is temperature or light, for example, contacting can be effected by altering the temperature or light to which the transgenic seed plant is exposed, or, if desired, by moving the transgenic seed plant from an environment of one temperature or light source to an environment having the appropriate inducing temperature or light source.

If desired, a transgenic seed plant of the invention can be contacted individually with an inducing agent. Furthermore, a group of transgenic seed plants that, for example, are located together in a garden plot, hot house or field, can be contacted en masse with an inducing agent, such that floral meristem identity gene product expression is increased coordinately in all transgenic seed plants of the group.

A transgenic seed plant of the invention can be contacted with an inducing agent using one of several means. For example, a transgenic seed plant can be contacted with an inducing agent by non-automated means such as with a hand held spraying apparatus. Such manual means can be useful when the methods of the invention are applied to particularly delicate or valuable seed plant varieties or when it is desirable, for example, to promote early reproductive development in a particular transgenic seed plant without promoting early reproductive development in a neighboring transgenic seed plant. Furthermore, a transgenic seed plant of the invention can be contacted with an inducing agent by mechanical means such as with a conventional yard "sprinkler" for a transgenic seed plant grown, for example, in a garden; a mechanical spraying system in a green house; traditional farm machinery for spraying field crops; or "crop dusting" for conveniently contacting an entire field of transgenic seed plants with a particulate or gaseous inducing agent. The skilled practitioner, whether home gardener or commercial farmer, recognizes that these and other manual or mechanical means can be used to contact a transgenic seed plant with an inducing agent according to the methods of the invention.

Furthermore, it is recognized that a transgenic seed plant of the invention can be contacted with a single treatment of an inducing agent or, if desired, can be contacted with multiple applications of the inducing agent. In a preferred embodiment of the invention, a transgenic seed plant of the invention is contacted once with an inducing agent to effectively increase floral meristem identity gene product expression, thereby promoting early reproductive development in the transgenic seed plant. Similarly, a transgenic angiosperm of the invention preferably is contacted once with an inducing agent to effectively increase floral meristem identity gene product expression and convert shoot meristem to floral meristem in the transgenic angiosperm.

A single application of an inducing agent is preferable when a transient increase in floral meristem identity gene product expression from a recombinant nucleic acid molecule of the invention promotes irreversible early reproductive development in a seed plant. In many seed plant species, early reproductive development is irreversible. Transient expression of a floral meristem identity gene product from an introduced recombinant nucleic acid molecule, for example, results in sustained ectopic expression of endogenous floral meristem identity gene products, resulting in irreversible early reproductive development. For example, ectopic expression of AP1 in a transgenic plant induces endogenous LFY gene expression, and ectopic expression of LFY induces endogenous AP1 gene expression (Mandel and Yanofsky, Nature 377:522-524 (1995), which is incorporated herein by reference; Weigel and Nilsson, supra, 1995). Genetic studies also indicate that CAL can act directly or indirectly to increase expression of AP1 and LFY. Thus, ectopic expression of CAL from an exogenous nucleic acid molecule, for example, can induce endogenous AP1 and LFY expression (see Bowman et al., supra, 1993). Enhanced expression of endogenous AP1, LFY or CAL following a transient increase in expression of an introduced floral meristem identity gene product induced by a single application of an inducing agent can make repeated applications of an inducing agent unnecessary.

In some seed plants, however, such as angiosperms characterized by the phenomenon of floral reversion, repeated applications of the inducing agent can be desirable. In species such as impatiens, an initiated flower can revert into a shoot such that the center of the developing flower behaves as an indeterminate shoot (see, for example, Battey and Lyndon, Ann. Bot. 61:9-16 (1988), which is incorporated by reference herein). Thus, to prevent floral reversion in species such as impatiens, repeated applications of an inducing agent can be useful. Repeated applications of an inducing agent, as well as single applications, are encompassed within the scope of the present invention.

The invention further provides a nucleic acid molecule encoding a chimeric protein, which comprises a nucleic acid molecule encoding a floral meristem identity gene product such as AP1, CAL or LFY linked in frame to a nucleic acid molecule encoding a ligand binding domain. Expression of a chimeric protein of the invention in a seed plant is useful because the ligand binding domain renders the activity of a linked gene product dependent on the presence of cognate ligand. Specifically, in a chimeric protein of the invention, floral meristem gene product activity is increased in the presence of cognate ligand, as compared to activity in the absence of cognate ligand.

A nucleic acid molecule encoding a chimeric protein of the invention comprises a nucleic acid molecule encoding a floral meristem identity gene product, such as a nucleic acid molecule having the nucleic acid sequence SEQ ID NO: 1, SEQ ID NO: 9 or SEQ ID NO: 15, which encodes AP1, CAL or LFY, respectively, any of which is linked in frame to a nucleic acid molecule encoding a ligand binding domain. The expression of such a nucleic acid molecule results in the production of a chimeric protein containing a floral meristem identity gene product fused to a ligand binding domain. Thus, the invention also provides a chimeric protein containing a floral meristem identity gene product fused to a ligand binding domain and an antibody that specifically binds such a chimeric protein.

The invention further provides a transgenic seed plant, such as angiosperm or gymnosperm, that contains a nucleic acid molecule encoding a chimeric protein of the invention. The invention provides, for example, a transgenic seed plant containing a nucleic acid molecule encoding a chimeric protein, which comprises a nucleic acid molecule encoding AP1, CAL or LFY linked in frame to a nucleic acid molecule encoding a ligand binding domain. A particularly useful transgenic seed plant contains a nucleic acid molecule encoding AP1 linked in frame to a nucleic acid molecule encoding an ecdysone receptor ligand binding domain or a glucocorticoid receptor ligand binding domain. The invention also provides a transgenic seed plant containing a nucleic acid molecule encoding a chimeric protein, which comprises a nucleic acid molecule encoding CAL linked in frame to a nucleic acid molecule encoding an ecdysone receptor ligand binding domain or a glucocorticoid receptor ligand binding domain. In addition, there is provided a transgenic seed plant containing a nucleic acid molecule encoding a chimeric protein, which comprises a nucleic acid molecule encoding LFY linked in frame to a nucleic acid molecule encoding an ecdysone receptor ligand binding domain or a glucocorticoid receptor ligand binding domain.

Any floral meristem identity gene product, as defined herein, is useful in a chimeric protein of the invention. Thus, a nucleic acid molecule encoding Arabidopsis thaliana AP1 (SEQ ID NO: 2), Brassica oleracea AP1 (SEQ ID NO: 4), Brassica oleracea var. Botrytis AP1 (SEQ ID NO: 8) or Zea mays AP1 (SEQ ID NO: 10), each of which have activity in converting shoot meristem to floral meristem, can be used to construct a nucleic acid molecule encoding a chimeric protein of the invention. Similarly, a nucleic acid molecule encoding, for example, Arabidopsis thaliana CAL (SEQ ID NO: 10), Brassica oleracea CAL (SEQ ID NO: 12), or a nucleic acid molecule encoding Arabidopsis thaliana LFY (SEQ ID NO: 16) is useful when linked in frame to a nucleic acid molecule encoding a ligand binding domain to produce a nucleic acid molecule encoding a ligand-dependent chimeric protein of the invention.

A ligand binding domain useful in a chimeric protein of the invention is a domain that, when fused in frame to a heterologous gene product, renders the activity of the fused gene product dependent on cognate ligand such that the activity of the fused gene product is increased in the presence of cognate ligand as compared to its activity in the absence of ligand. Such a ligand binding domain can be a steroid binding domain such as the ligand binding domain of an ecdysone receptor, glucocorticoid receptor, estrogen receptor, progesterone receptor, androgen receptor, thyroid receptor, vitamin D receptor or retinoic acid receptor. A particularly useful ligand binding domain is the ecdysone receptor ligand binding domain contained within amino acids 329 to 878 of the Drosophila ecdysone receptor (SEQ ID NO: 18); Koelle et al., Cell 67:59-77 (1991); Thummel, Cell 83:871-877 (1995), each of which is incorporated herein by reference) or a glucocorticoid receptor ligand binding domain, encompassed, for example, within amino acids 512 to 795 of the rat glucocorticoid receptor (SEQ ID NO: 20; Miesfeld et al., Cell 46:389-399 (1986), which is incorporated herein by reference).

A chimeric protein of the invention containing an ecdysone receptor ligand binding domain has floral meristem identity gene product activity that can be increased in the presence of ecdysone ligand. Similarly, a chimeric protein of the invention containing a glucocorticoid receptor ligand binding domain has floral meristem identity gene product activity that is increased in the presence of glucocorticoid ligand. It is well known that in a chimeric protein containing a heterologous gene product such as adenovirus E1A, c-myc, c-fos, the HIV-1 Rev transactivator, MyoD or maize regulatory factor R fused to the rat glucocorticoid receptor ligand binding domain, activity of the fused heterologous gene product can be increased by glucocorticoid ligand (Eilers et al., Nature 340:66 (1989); Superti-Furga et al., Proc. Natl. Acad. Sci., U.S.A. 88:5114 (1991); Hope et al., Proc. Natl. Acad. Sci., U.S.A. 87:7787 (1990); Hollenberg et al., Proc. Natl. Acad. Sci., U.S.A. 90:8028 (1993), each of which is incorporated herein by reference).

A nucleic acid molecule encoding a chimeric protein of the invention can be introduced into a seed plant where, under appropriate conditions, the chimeric protein is expressed. In such a transgenic seed plant, floral meristem identity gene product activity can be increased by contacting the transgenic seed plant with cognate ligand. For example, activity of a heterologous protein fused to a rat glucocorticoid receptor ligand binding domain (amino acids 512 to 795) expressed under the control of the constitutive cauliflower mosaic virus 35S promoter in Arabidopsis was low in the absence of glucocorticoid ligand; whereas, upon contacting the transformed plants with a synthetic glucocorticoid, dexamethasone, activity of the protein was increased greatly (Lloyd et al., Science 266:436-439 (1994), which is incorporated herein by reference). As disclosed herein, a ligand binding domain fused to a floral meristem identity gene product renders the activity of a fused floral meristem identity gene product ligand-dependent such that, upon contacting the transgenic seed plant with cognate ligand, floral meristem identity gene product activity is increased.

Methods for constructing a nucleic acid molecule encoding a chimeric protein of the invention are routine and well known in the art (Sambrook et al., supra, 1989). Methods of constructing, for example, a nucleic acid encoding an AP1-glucocorticoid receptor ligand binding domain chimeric protein are described in Example IV. For example, the skilled artisan recognizes that a stop codon encoded by the nucleic acid molecule must be removed and that the two nucleic acid molecules must be linked in frame such that the reading frame of the 3' nucleic acid molecule coding sequence is preserved. Methods of transforming a seed plant such as an angiosperm or gymnosperm with a nucleic acid molecule are disclosed above and well known in the art (see examples I, II and III; see, also, Mohoney et al., U.S. Pat. No. 5,463,174, and Barry et al., U.S. Pat. No. 5,463,175, each of which is incorporated herein by reference).

As used herein, the term "linked in frame," when used in reference to two nucleic acid molecules that make up a nucleic acid molecule encoding a chimeric protein, means that the two nucleic acid molecules are linked in the correct reading frame such that, under appropriate conditions, a full-length chimeric protein is expressed. In particular, a 5' nucleic acid molecule, which encodes the amino-terminal portion of the chimeric protein, must be linked to a 3' nucleic acid molecule, which encodes the carboxyl-terminal portion of the chimeric protein, such that the carboxyl-terminal portion of the chimeric protein is translated in the correct reading frame. One skilled in the art would recognize that a nucleic acid molecule encoding a chimeric protein of the invention can comprise, for example, a 5' nucleic acid molecule encoding a floral meristem identity gene product linked in frame to a 3' nucleic acid molecule encoding a ligand binding domain or can comprise a 5' nucleic acid molecule encoding a ligand binding domain linked in frame to a 3' nucleic acid molecule encoding a floral meristem identity gene product. Preferably, a nucleic acid molecule encoding a chimeric protein of the invention comprises a 5' nucleic acid molecule encoding a floral meristem identity gene product linked in frame to a 3' nucleic acid molecule encoding a ligand binding domain.

In a transgenic angiosperm containing a chimeric protein of the invention, conversion of shoot meristem to floral meristem can be induced by contacting the transgenic angiosperm with a cognate ligand that is absorbed by the angiosperm and binds the chimeric protein within its ligand binding domain. Thus, the present invention provides a method of converting shoot meristem to floral meristem in an angiosperm by introducing into the angiosperm a nucleic acid molecule encoding a chimeric protein to produce a transgenic angiosperm, where, under appropriate conditions, the chimeric protein containing a floral meristem identity gene product fused to a ligand binding domain is expressed; and contacting the transgenic angiosperm with cognate ligand, where, upon binding of the cognate ligand to the ligand binding domain, floral meristem identity gene product activity is increased, thereby converting shoot meristem to floral meristem in the transgenic angiosperm.

The present invention provides, for example, a method of converting shoot meristem to floral meristem in an angiosperm by introducing into the angiosperm a nucleic acid molecule encoding a chimeric protein, which comprises a nucleic acid molecule encoding AP1, CAL or LFY linked in frame to a nucleic acid molecule encoding an ecdysone receptor ligand binding domain, to produce a transgenic angiosperm, where, under appropriate conditions, the chimeric protein is expressed; and contacting the transgenic angiosperm with ecdysone ligand, where, upon binding of the ecdysone ligand to the ecdysone receptor ligand binding domain, floral meristem identity gene product activity is increased, thereby converting shoot meristem to floral meristem in the transgenic angiosperm. Similarly, the invention provides, for example, a method of converting shoot meristem to floral meristem in an angiosperm by introducing into the angiosperm a nucleic acid molecule encoding a chimeric protein, which comprises a nucleic acid molecule encoding AP1, CAL or LFY linked in frame to a nucleic acid molecule encoding a glucocorticoid receptor ligand binding domain, to produce a transgenic angiosperm, where, under appropriate conditions, the chimeric protein is expressed; and contacting the transgenic angiosperm with glucocorticoid ligand, where, upon binding of the glucocorticoid ligand to the glucocorticoid receptor ligand binding domain, floral meristem identity gene product activity is increased, thereby converting shoot meristem to floral meristem in the transgenic angiosperm.

In addition, the invention provides a method of promoting early reproductive development in a seed plant by introducing into the seed plant a nucleic acid molecule encoding a chimeric protein of the invention to produce a transgenic seed plant, where, under appropriate conditions, the chimeric protein containing a floral meristem identity gene product fused to a ligand binding domain is expressed; and contacting the transgenic seed plant with cognate ligand, where, upon binding of the cognate ligand to the ligand binding domain, floral meristem identity gene product activity is increased, thereby promoting early reproductive development in the transgenic seed plant. The methods of the invention can be practiced with numerous seed plant varieties. The seed plant can be, for example, an angiosperm such as a cereal plant, leguminous plant, hardwood tree or coffee plant, or can be a gymnosperm such as a pine, fir, spruce or redwood tree.

There is provided, for example, a method of promoting early reproductive development in a seed plant by introducing into the seed plant a nucleic acid molecule encoding a chimeric protein, which comprises a nucleic acid molecule encoding a floral meristem identity gene product linked in frame to a nucleic acid molecule encoding an ecdysone receptor ligand binding domain, to produce a transgenic seed plant, where, under appropriate conditions, the chimeric protein is expressed; and contacting the transgenic seed plant with ecdysone ligand, where, upon binding of the ecdysone ligand to the ecdysone receptor ligand binding domain, floral meristem identity gene product activity is increased, thereby promoting early reproductive development in the transgenic seed plant. Similarly, the invention provides, for example, a method of promoting early reproductive development in a seed plant by introducing into the seed plant a nucleic acid molecule encoding a chimeric protein, which comprises a nucleic acid molecule encoding AP1, CAL or LFY linked in frame to a nucleic acid molecule encoding a glucocorticoid receptor ligand binding domain, to produce a transgenic seed plant, where, under appropriate conditions, the chimeric protein is expressed; and contacting the transgenic seed plant with glucocorticoid ligand, where, upon binding of the glucocorticoid ligand to the glucocorticoid receptor ligand binding domain, floral meristem identity gene product activity is increased, thereby promoting early reproductive development in the transgenic seed plant.

As used herein, the term "ligand" means a naturally occurring or synthetic chemical or biological molecule such as a simple or complex organic molecule, a peptide, a protein or an oligonucleotide that specifically binds a ligand binding domain. In the methods of the present invention, a ligand can be used alone or in solution or can be used in conjunction with an acceptable carrier that can serve to stabilize the ligand or promote absorption of the ligand by a seed plant. If desired, a transgenic seed plant of the invention can be contacted with a ligand for increasing floral meristem identity gene product activity in combination with an unrelated molecule such as a plant nutrient, pesticide or insecticide. When used in reference to a particular ligand binding domain, the term "cognate ligand" means a ligand that, under suitable conditions, specifically binds the particular ligand binding domain.

One skilled in the art readily can determine the optimum concentration of cognate ligand needed to bind a ligand binding domain and increase floral meristem identity gene product activity in a transgenic seed plant of the invention. Generally, a concentration of about 1 nM to 10 μM cognate ligand is useful for increasing floral meristem identity gene product activity in a transgenic seed plant expressing a chimeric protein of the invention. Preferably, a concentration of about 100 nM to 1 μM cognate ligand is useful for increasing floral meristem identity gene product activity in a transgenic seed plant containing a chimeric protein of the invention (see, for example, Christopherson et al., Proc. Natl. Acad. Sci. USA 89:6314-6318 (1992), which is incorporated herein by reference; also, see Lloyd et al., supra, 1994). For example, a concentration of about 100 nM to 1 μM dexamethasone can be useful for increasing floral meristem identity gene product activity in a transgenic seed plant of the invention containing a nucleic acid molecule encoding a chimeric protein, which comprises a nucleic acid molecule encoding a floral meristem identity gene product, such as AP1 or CAL, linked in frame to a nucleic acid molecule encoding a glucocorticoid receptor ligand binding domain, as described in Example IV.

As discussed above, a transgenic seed plant of the invention, such as a transgenic seed plant expressing a chimeric protein of the invention, can be contacted in a variety of manners. A transgenic seed plant can be contacted with cognate ligand, for example, by spraying the seed plant with a gaseous ligand or with solution such as an aqueous solution containing the appropriate ligand; or by adding the cognate ligand to the water supply of a seed plant grown using irrigation or grown hydroponically; or by adding the cognate ligand to the oil or other solid nutrient medium in which a seed plant is grown, whereby the cognate ligand is absorbed into the seed plant to increase floral meristem identity gene product activity. A transgenic seed plant expressing a chimeric protein of the invention also can be contacted with a cognate ligand in aerosol form. In addition, a transgenic seed plant can be contacted with cognate ligand by injecting the seed plant or by immersing the seed plant in a solution containing the cognate ligand.

A transgenic seed plant expressing a chimeric protein of the invention can be contacted individually with cognate ligand, or a group of transgenic seed plants can be contacted en masse to increase floral meristem gene product activity synchronously in all seed plants of the group. Furthermore, a variety of means can be used to contact a transgenic seed plant of the invention with cognate ligand to increase floral meristem identity gene product activity. A transgenic seed plant can be contacted with cognate ligand using, for example, a hand held spraying apparatus; conventional yard "sprinkler"; mechanical spraying system, such as an overhead spraying system in a green house; traditional farm machinery, or "crop dusting." As discussed above in regard to the application of inducing agents, the methods of the invention can be practiced using these and other manual or mechanical means to contact a transgenic seed plant with single or multiple applications of cognate ligand.

The nucleic acid molecules encoding floral meristem identity gene products provided herein also can be useful in generating sterile transgenic seed plants and in methods of producing reproductive sterility in seed plants. The methods of the invention involve cosuppression metholodology, where a nucleic acid molecule in the sense orientation is introduced into a seed plant to suppress expression of a homologous endogenous gene, or involve antisense metholodology. Thus, the present invention provides cosuppression and antisense methods of producing reproductively sterile transgenic seed plants as well as the two types of sterile transgenic seed plants produced by these methods.

A method of the invention for producing a reproductively sterile transgenic seed plant has a variety of uses including safely growing transgenic trees in close contact with interfertile wild trees, increasing wood production and reducing allergenic pollen production. A method for producing reproductive sterility in seed plants, which is useful for transgene containment, can allow, for example, the introduction of transgenic trees into the environment. Of particular concern to the introduction of transgenic trees into the environment is the possibility of enhanced "weediness" or the movement of transgenes by cross-fertilization into gene pools of wild relatives. Most commercially grown forest trees, for example, are grown in close proximity to interfertile wild populations, and gene flow within and among tree populations usually is extensive, making the probability of transgene escape from plantations of fertile transgenic trees high. Regulatory agencies have based approval of transgenic tree planting on sexual isolation of the transgenic species; for example, approval of two field tests for transgenic poplars by the Animal and Plant Health Inspection Service (APHIS) was contingent on the trees not being allowed to flower (see, for example, Strauss et al., Molec. Breed 1:5-26 (1995), which is incorporated herein by reference). Thus, transgene containment through, for example, the use of sterile transgenic trees is central to the usefulness of improved transgenic varieties.

Methods of producing reproductively sterile seed plants also can be useful for increasing wood production, since substantial energy and nutrients are committed to reproductive development in trees. For example, in trees such as radiata pine, white spruce, balsam fir and Douglas fir, reduced growth, as measured by height or stem volume, is correlated with the early production of cones (Strauss et al., supra, 1995). Thus, the methods of the invention, which prevent flowering or cone development, for example, by producing reproductive sterility, are useful for growing substantially larger trees, thus increasing wood production.

A method for producing reproductively sterile seed plants also can be useful for alleviating allergies caused by tree pollen. For example, in Japan many people suffer from allergies caused by the most commonly planted forest tree, the conifer sugi (Strauss et al., supra, 1995). The methods of the invention, therefore, can be advantageous for preventing pollen formation in seed plants such as the conifer sugi.

Cosuppression, which relies on expression of a nucleic acid molecule in the sense orientation, is a well known methodology that produces coordinate silencing of the introduced nucleic acid molecule and the homologous endogenous gene (see, for example, Flavell, Proc. Natl. Acad. Sci., USA 91:3490-3496 (1994), which is incorporated herein by reference; Kooter and Mol, supra, 1993). Although the mechanism of cosuppression is unknown, cosuppression is induced most strongly by a large number of transgene copies or by overexpression of transgene RNA; cosuppression also can be enhanced by modification of the transgene such that it fails to be translated. Cosuppression has been used successfully to produce sterile plants; for example, a sense nucleic acid molecule containing a full-length fbp1 coding sequence under control of the strong CaMV 35S promoter has been introduced into petunia. Two of twenty-one transformants exhibited an abnormal phenotype and contained multiple copies of the fbp1 transgene. Furthermore, fbp1 expression was undetectable in these sterile transgenic plants, indicating that expression of endogenous fbp1 was suppressed (Angenent et al., The Plant Journal 4:101-112 (1993), which is incorporated herein by reference).

Antisense nucleic acid molecules, which can act by reducing mRNA translation or by increasing mRNA degradation, for example, also can suppress gene expression of diverse genes and seed plant species (see, for example, Kooter and Mol, Current Opin. Biol. 4:166-171 (1993), which is incorporated herein by reference; see also Strauss et al., supra, 1995). Antisense nucleic acid molecules previously have been used to successfully suppress the expression of a homologous endogenous gene, thereby generating sterile plants. For example, an antisense chalcone synthase gene under control of the CaMV 35S promoter with an anther-specific enhancer sequence effectively suppressed endogenous chalcone synthase expression levels, resulting in male sterility in transgenic petunia plants (van der Meer et al., The Plant Cell Vol 4:253-262 (1992), which is incorporated herein by reference). Similarly, the full-length tomato TM5 MADS box gene, when placed in antisense orientation under control of the CaMV 35S promoter, was used to produce sterile transgenic tomato plants (Pnuell et al., The Plant Cell Vol. 6, 175-186 (1994), which is incorporated herein by reference). Antisense nucleic acid molecules encoding floral meristem identity gene products similarly can be used to produce reproductive sterility in seed plants; however, by preventing reproductive development at the earliest stage, the methods of the invention result in an advantageous energy savings.

Thus, the present invention provides a sterile transgenic seed plant such as an angiosperm or gymnosperm containing one or more sense or antisense nucleic acid molecules encoding a floral meristem identity gene product, or a fragment thereof, such that expression of AP1 and LFY gene products, including expression of endogenous AP1 and LFY gene products, is suppressed in the transgenic seed plant. The invention also provides, for example, a sterile transgenic seed plant containing a sense or antisense nucleic acid molecule encoding AP1, or a fragment thereof; a sense or antisense nucleic acid molecule encoding CAL, or a fragment thereof; and a sense or antisense nucleic acid molecule encoding LFY, or a fragment thereof, such that expression of AP1 and LFY gene products, including expression of endogenous AP1 and LFY gene products, is suppressed in the transgenic seed plant. The invention further provides a sterile transgenic seed plant containing a sense or antisense nucleic acid molecule encoding AP1, or a fragment thereof, and a sense or antisense nucleic acid molecule encoding LFY, or a fragment thereof, such that expression of AP1 and LFY gene products, including expression of endogenous AP1 and LFY gene products, is suppressed in the transgenic seed plant.

The present invention also provides methods of producing reproductive sterility in a seed plant such as a tree by introducing into a seed plant one or more sense or antisense nucleic acid molecules encoding a floral meristem identity gene product, or a fragment thereof, to produce a transgenic seed plant, such that expression of AP1 and LFY gene products, including expression of endogenous AP1 and LFY gene products, is suppressed in the transgenic seed plant. In a preferred embodiment of the invention, there are provided methods of producing reproductive sterility in a seed plant by introducing into a seed plant a sense or antisense nucleic acid molecule encoding AP1, or a fragment thereof; a sense or antisense nucleic acid molecule encoding CAL, or a fragment thereof; and a sense or antisense nucleic acid molecule encoding LFY, or a fragment thereof, to produce a transgenic seed plant, such that expression of AP1 and LFY gene products, including expression of endogenous AP1 and LFY gene products, is suppressed in the transgenic seed plant. In another embodiment, the invention provides methods of producing reproductive sterility in a seed plant by introducing into a seed plant a sense or antisense nucleic acid molecule encoding AP1, or a fragment thereof, and a sense or antisense nucleic acid molecule encoding LFY, or a fragment thereof, to produce a transgenic seed plant, such that expression of AP1 and LFY gene products, including expression of endogenous AP1 and LFY gene products, is suppressed in the transgenic seed plant.

Sterile seed plants that lack expression of functional AP1 and LFY gene products have been described previously. For example, a non-flowering Arabidopsis lfy ap1 double mutant has been described in which flowers were transformed into shoot-like structures (see, for example, Bowman et al., supra, 1993, and Weigel, supra, 1995). However, in contrast to previously described methods of generating sterile seed plants using mutagenesis, a methodology that is cumbersome or unfeasible in higher plants, the present invention provides a convenient method of producing reproductive sterility in a seed plant using sense or antisense nucleic acid molecules encoding floral meristem identity gene products.

The methods of the invention for producing reproductive sterility rely upon introducing into a seed plant one or more sense or antisense nucleic acid molecules encoding a floral meristem identity gene product, or a fragment thereof, such that expression of AP1 and LFY gene products, including expression of endogenous AP1 and LFY gene products, is suppressed in the transgenic seed plant. The skilled artisan will recognize that effective suppression of endogenous AP1 and LFY gene product expression depends upon the one or more introduced nucleic acid molecules having a high percentage of homology with the corresponding endogenous gene loci.

The homology requirement for effective suppression using sense or antisense nucleic acid molecules can be determined empirically. In general, a minimum of about 80-90% nucleic acid sequence identity is preferred for effective suppression of endogenous floral meristem identity gene product expression. Thus, a nucleic acid molecule encoding a gene ortholog from the family or genus of the seed plant species into which the nucleic acid molecule is to be introduced is preferable in practicing the methods of the invention. More preferably, a nucleic acid molecule encoding a gene ortholog from the same seed plant species into which the nucleic acid molecule is to be introduced is used in the methods of the invention. Although a highly homologous nucleic acid molecule is preferred in the methods of the invention, the sense or antisense nucleic acid molecule need not contain the entire coding sequence of the floral meristem identity gene sequence to be suppressed. Thus, a sense or antisense nucleic acid molecule encoding only a fragment of AP1, CAL or LFY coding sequence, for example, also can be useful in the methods of the invention.

As used herein in reference to a nucleic acid molecule encoding a floral meristem identity gene product, the terms "sense" and "antisense" have their commonly understood meanings.

As used herein in reference to a nucleic acid molecule encoding a floral meristem identity gene product, the term "fragment" means a portion of the nucleic acid sequence containing at least about 50 base pairs to the full-length of the nucleic acid molecule encoding the floral meristem identity gene product. In contrast to an active fragment, as defined herein, a fragment of a nucleic acid molecule encoding a floral meristem identity gene product need not encode a functional portion of a gene product.

In the methods of the invention for producing reproductive sterility, the sense or antisense nucleic acid molecule is expressed under control of a strong promoter that is expressed, at least in part, in floral meristem. The constitutive cauliflower mosaic virus 35S promoter (Odell et al., supra, 1985), for example, or other strong promoters as disclosed herein, can be useful in the methods of the invention. In addition, an RNA polymerase III promoter can be useful in methods of producing reproductive sterility using an antisense nucleic acid molecule (see, for example, Bourque and Folk, Plant Mol. Biol. 19:641-647 (1992), which is incorporated herein by reference).

The present invention also provides novel substantially purified nucleic acid molecules encoding floral meristem identity gene products. The invention provides a substantially purified nucleic acid molecule encoding Brassica oleracea AP1 having the amino acid sequence SEQ ID NO: 4; a substantially purified nucleic acid molecule encoding Brassica oleracea var. botrytis AP1 having the amino acid sequence SEQ ID NO: 6; or a substantially purified nucleic acid molecule encoding Zea mays AP1 having the amino acid sequence SEQ ID NO: 8. In addition, the invention provides a substantially purified nucleic acid molecule that encodes a Brassica oleracea AP1, Brassica oleracea var. botrytis AP1 or Zea mays AP1 and that contains additional 5' or 3' noncoding sequence. For example, a substantially purified nucleic acid molecule having a nucleotide sequence such as SEQ ID NO: 3, SEQ ID NO: 5 or SEQ ID NO: 7 is provided.

As used herein in reference to a particular nucleic acid molecule or gene product, the term "substantially purified" means that the particular nucleic acid molecule or gene product is in a form that is relatively free from contaminating lipids, unrelated gene products, unrelated nucleic acids or other cellular material normally associated with the particular nucleic acid molecule or gene product in a cell.

The present invention also provides a nucleotide sequence having at least ten contiguous nucleotides of a nucleic acid molecule encoding Brassica oleracea AP1, Brassica oleracea var. botrytis AP1 or Zea mays AP1, provided that said nucleotide sequence is not present in a nucleic acid molecule encoding a MADS domain containing protein. In particular, such a nucleotide sequence can have at least ten contiguous nucleotides of a nucleic acid molecule encoding an AP1 gene product having the amino acid sequence of SEQ ID NO: 4, SEQ ID NO: 6 or SEQ ID NO: 8. A nucleotide sequence of the invention can have, for example, at least ten contiguous nucleotides of the nucleic acid sequence of SEQ ID NO: 3, SEQ ID NO: 5 or SEQ ID NO: 7.

As used herein, the term "contiguous," as used in reference to the nucleotides of a nucleic acid molecule means that the nucleotides of the nucleic acid molecule follow continuously in sequence. Thus, a nucleotide sequence of the invention has at least ten contiguous nucleotides of one of the recited nucleic acid molecules without any extraneous intervening nucleotides.

Explicitly excluded from a nucleotide sequence of the present invention is a nucleotide sequence having at least ten contiguous nucleotides that is present in a nucleic acid molecule encoding a MADS domain containing protein. MADS domain containing proteins are well known in the art as described in Purugganan et al., supra, 1995.

In general, a nucleotide sequence of the invention can range in size from about 10 nucleotides to the full-length of a CDNA. Such a nucleotide sequence can be chemically synthesized, using routine methods or can be purchased from a commercial source. In addition, such a nucleotide sequence can be obtained by enzymatic methods such as random priming methods, polymerase chain reaction (PCR) methods or by standard restriction endonuclease digestion, followed by denaturation (Sambrook et al., supra, 1989).

A nucleotide sequence of the invention can be useful, for example, as a primer for PCR (Innis et al. (ed.) PCR Protocols: A Guide to Methods and Applications, San Diego, Calif.: Academic Press, Inc. (1990)). Such a nucleotide sequence generally contains from about 10 to about 50 nucleotides.

A nucleotide sequence of the invention also can be useful in screening a cDNA or genomic library to obtain a related nucleotide sequence. For example, a cDNA library that is prepared from rice or wheat can be screened with a nucleotide sequence having at least ten contiguous nucleotides of the nucleic acid molecule encoding Zea mays AP1 (SEQ ID NO: 7) in order to isolate a rice or wheat ortholog of AP1. Generally, a nucleotide sequence useful for screening a cDNA or genomic library contains at least about 14 to 16 contiguous nucleotides depending, for example, on the hybridization conditions to be used. A nucleotide sequence containing at least 18 to 20 nucleotides, or containing at least 21 to 25 nucleotides, also can be useful.

A nucleotide sequence having at least ten contiguous nucleotides of a nucleic acid molecule encoding Zea mays AP1 (SEQ ID NO: 7) also can be used to screen a Zea mays cDNA library to isolate a sequence that is related to but distinct from AP1. Similarly, a nucleotide sequence having at least ten contiguous nucleotides of a nucleic acid molecule encoding Brassica oleracea AP1 (SEQ ID NO: 3) or a nucleotide sequence having at least ten contiguous nucleotides of a nucleic acid molecule encoding Brassica oleracea var. botrytis AP1 (SEQ ID NO: 5) can be used to screen a Brassica oleracea or Brassica oleracea var. botrytis cDNA library to isolate a novel sequence that is related to but distinct from AP1. In addition, a nucleotide sequence of the invention can be useful in analyzing RNA levels or patterns of expression, as by northern blotting or by in situ hybridization to a tissue section. Such a nucleotide sequence also can be used in Southern blot analysis to evaluate gene structure and identify the presence of related gene sequences.

The invention also provides a vector containing a nucleic acid molecule encoding a Brassica oleracea AP1 gene product, Brassica oleracea var. botrytis AP1 gene product or Zea mays AP1 gene product. A vector can be a cloning vector or an expression vector and provides a means to transfer an exogenous nucleic acid molecule into a host cell, which can be a prokaryotic or eukaryotic cell. Such vectors are well known and include plasmids, phage vectors and viral vectors. Various vectors and methods for introducing such vectors into a cell are described, for example, by Sambrook et al., supra, 1989, and by Glick and Thompson, supra, 1993).

The invention further provides a method of producing an AP1 gene product by expressing a nucleic acid molecule encoding an AP1 gene product. Thus, a Brassica oleracea AP1 gene product can be produced according to a method of the invention by expressing a nucleic acid molecule having the amino acid sequence of SEQ ID NO: 4 or by expressing a nucleic acid molecule having the nucleic acid sequence of SEQ ID NO: 3. Similarly, a Brassica oleracea var. botrytis AP1 gene product can be produced according to a method of the invention by expressing a nucleic acid molecule having the amino acid sequence of SEQ ID NO: 6 or by expressing a nucleic acid molecule having the nucleic acid sequence of SEQ ID NO: 5. A Zea mays AP1 gene product can be produced by expressing a nucleic acid molecule having the amino acid sequence of SEQ ID NO: 8 or by expressing a nucleic acid molecule having the nucleic acid sequence of SEQ ID NO: 7.

The invention also provides a substantially purified AP1 gene product, such as a substantially purified Brassica oleracea AP1 gene product having amino acid sequence SEQ ID NO: 4; a substantially purified Brassica oleracea var. botrytis AP1 gene product having amino acid sequence SEQ ID NO: 6; or a substantially purified Zea mays AP1 gene product having amino acid sequence SEQ ID NO: 8. As used herein, the term "gene product" is used in its broadest sense and includes proteins, polypeptides and peptides, which are related in that each consists of a sequence of amino acids joined by peptide bonds. For convenience, the terms "gene product," "protein" and "polypeptide" are used interchangeably. While no specific attempt is made to distinguish the size limitations of a protein and a peptide, one skilled in the art would understand that proteins generally consist of at least about 50 to 100 amino acids and that peptides generally consist of at least two amino acids up to a few dozen amino acids. The term gene product as used herein includes any such amino acid sequence.

An active fragment of a floral meristem identity gene product also can be useful in the methods of the invention. As used herein, the term "active fragment," means a polypeptide portion of a floral meristem identity gene product that can convert shoot meristem to floral meristem in an angiosperm. An active fragment of an AP1 gene product can consist, for example, of an amino acid sequence that is derived from SEQ ID NO: 2, SEQ ID NO: 4, SEQ ID NO: 6 or SEQ ID NO: 8 and has activity in converting shoot meristem to floral meristem in an angiosperm. An active fragment can be, for example, an amino terminal, carboxyl terminal or internal fragment of Zea mays AP1 (SEQ ID NO: 8) that has activity in converting shoot meristem to floral meristem in an angiosperm. The skilled artisan will recognize that an active fragment of a floral meristem identity gene product, as defined herein, can be useful in the methods of the invention for converting shoot meristem to floral meristem in an angiosperm, for producing early reproductive development in a seed plant, or for producing reproductive sterility in a seed plant.

Such an active fragment can be produced using well known recombinant DNA methods (Sambrook et al., supra, 1989). Similarly, an active fragment can be, for example, an amino terminal, carboxyl terminal or internal fragment of Arabidopsis thaliana CAL (SEQ ID NO: 10) or Brassica oleracea CAL (SEQ ID NO: 12) that has activity, for example, in converting shoot meristem to floral meristem in an angiosperm. The product of the BobCAL gene (SEQ ID NO: 24), which is truncated at amino acid 150, lacks activity in converting shoot meristem to floral meristem and, therefore, is an example of a polypeptide portion of a CAL floral meristem identity gene product that is not an "active fragment" of a floral meristem identity gene product.

An active fragment of a floral meristem identity gene product, which can convert shoot meristem to floral meristem in an angiosperm, can be identified using the methods described in Examples I, II and III. Briefly, an angiosperm such as Arabidopsis can be transformed with a nucleic acid molecule encoding a portion of a floral meristem identity gene product in order to determine whether the portion can convert shoot meristem to floral meristem and, therefore, is an active fragment of a floral meristem identity gene product.

The invention further provides an antibody that specifically binds an AP1 gene product having the amino acid sequence of Brassica oleracea AP1 (SEQ ID NO: 4); the amino acid sequence of Brassica oleracea var. botrytis AP1 (SEQ ID NO: 6); or the amino acid sequence of Zea mays AP1 (SEQ ID NO: 8). As used herein, the term "antibody" is used in its broadest sense to include naturally occurring and non-naturally occurring polyclonal and monoclonal antibodies, as well as a polypeptide fragment of an antibody that retains a specific binding activity of at least about 1×10⁵ M⁻¹, and preferably about 1×10⁶ M⁻¹, for an AP1 gene product having amino acid sequence SEQ ID NO: 4, SEQ ID NO: 6 or SEQ ID NO: 8. One skilled in the art would know that an antibody fragment such as a Fab, F(ab')₂ or Fv fragment can retain specific binding activity for an AP1 gene product and, thus, is included within the definition of an antibody. A non-naturally occurring antibody, or fragment thereof, such as a chimeric antibody or humanized antibody also is included within the meaning of the term antibody. Such a non-naturally occurring antibody can be constructed using solid phase peptide synthesis, produced recombinantly or obtained, for example, by screening a combinatorial library consisting of variable heavy chains and variable light chains as described by Huse et al., Science 246:1275-1281 (1989), which is incorporated herein by reference.

An antibody "specific for" a gene product, or that "specifically binds" a gene product, binds with substantially higher affinity to that gene product than to an unrelated gene product. An antibody specific for a gene product also can have specificity for a related gene product. For example, an antibody specific for a Zea mays AP1 gene product also can specifically bind an Arabidopsis thaliana AP1 gene product or a Brassica oleracea AP1 gene product.

An antibody that specifically binds a Zea mays AP1 gene product (SEQ ID NO: 8), for example, can be prepared using a Zea mays AP1 fusion protein or a synthetic peptide encoding a portion of Zea mays AP1 (SEQ ID NO: 8) as an immunogen. One skilled in the art would know that purified Zea mays AP1 gene product, which can be prepared from a natural source or produced recombinantly according to a method of the invention, or a fragment of a Zea mays AP1 gene product, including a peptide portion of Zea mays AP1 such as a synthetic peptide, can be used as an immunogen. For example, preparation of antisera that specifically binds an AP1 gene product is described in Example VI using a GST-AP1 fusion protein containing amino acids 190 to 251 of AP1 as an immunogen. In addition, a non-immunogenic fragment or synthetic peptide derived from Zea mays AP1, for example, can be made immunogenic by coupling the non-immunogenic fragment or peptide (hapten) to a carrier molecule such as bovine serum albumin (BSA) or keyhole limpet hemocyanin (KLH). In addition, various other carrier molecules and methods for coupling a hapten to a carrier molecule are well known in the art as described, for example, by Harlow and Lane, Antibodies: A Laboratory Manual (Cold Spring Harbor Laboratory Press, 1988), which is incorporated herein by reference.

The invention also provides an expression vector containing a nucleic acid molecule encoding a floral meristem identity gene product such as AP1, CAL or LFY operably linked to a heterologous regulatory element. Expression vectors are well known in the art and provide a means to transfer and express an exogenous nucleic acid molecule into a host cell. Thus, an expression vector contains, for example, transcription start and stop sites such as a TATA sequence and a poly-A signal sequence, as well as a translation start site such as a ribosome binding site and a stop codon, if not present in the coding sequence.

As used herein, the term "heterologous regulatory element" means a regulatory element derived from a different gene than the gene encoding the floral meristem identity gene product to which it is operably linked. A vector containing a floral meristem identity gene, however, contains a nucleic acid molecule encoding a floral meristem identity gene product operably linked to a homolgous regulatory element. Such a vector does not contain a nucleic acid molecule encoding a floral meristem identity gene product operably linked to a heterologous regulatory element and, thus, is not an expression vector of the invention.

The invention further provides a plant expression vector containing a floral meristem identity gene product operably linked to a heterologous regulatory element. For example, a plant expression vector containing a nucleic acid molecule encoding an AP1 gene product having at least about 70 percent amino acid identity with an amino acid sequence of Arabidopsis thaliana AP1 (SEQ ID NO: 2) in the region from amino acid 1 to amino acid 163 or with the amino acid sequence of Zea mays AP1 (SEQ ID NO: 8) in the region from amino acid 1 to amino acid 163 is provided. A plant expression vector containing a floral meristem identity gene product operably linked to a constitutive regulatory element, such as the cauliflower mosaic virus 35S promoter, is provided. In addition, a plant expression vector containing a floral meristem identity gene product operably linked to an inducible regulatory element is provided.

A useful plant expression vector can contain a constitutive regulatory element for expression of an exogenous nucleic acid molecule in all or most tissues of a seed plant. The use of a constitutive regulatory element can be particularly advantageous because expression from the element is relatively independent of developmentally regulated or tissue-specific factors. For example, the cauliflower mosaic virus 35S promoter (CaMV 35S) is a well-characterized constitutive regulatory element that produces a high level of expression in all plant tissues (Odell et al., Nature 313:810-812 (1985), which is incorporated herein by reference). Furthermore, the CaMV 35S promoter can be particularly useful due to its activity in numerous different seed plant species (Benfey and Chua, Science 250:959-966 (1990), which is incorporated herein by reference; Odell et al., supra, 1985). Other constitutive regulatory elements useful for expression in a seed plant include, for example, the cauliflower mosaic virus 19S promoter; the Figwort mosaic virus promoter (Singer et al., Plant Mol. Biol. 14:433 (1990), which is incorporated herein by reference); and the nopaline synthase (nos) gene promoter (An, Plant Physiol. 81:86 (1986), which is incorporated herein by reference).

In addition, an expression vector of the invention can contain a regulated gene regulatory element such as a promoter or enhancer element. A particularly useful regulated promoter is a tissue-specific promoter such as the shoot meristem-specific CDC2 promoter (Hemerly et al., Plant Cell 5:1711-1723 (1993), which is incorporated herein by reference), or the AGL8 promoter, which is active in the ap1 cal shoot meristem immediately after the transition to flowering (Mandel and Yanofsky, supra, 1995). The promoter of the SHOOTMERISTEMLESS gene, which is expressed exclusively in the shoot meristem beginning within an embryo and throughout the angiosperm life cycle, also can be a particularly useful tissue-specific gene regulatory element (see Long et al., Nature 379:66-69 (1996), which is incorporated herein by reference).

An appropriate regulatory element such as a promoter is selected depending on the desired pattern or level of expression of a nucleic acid molecule linked thereto. For example, a constitutive promoter, which is active in all tissues, would be appropriate if expression of a gene product in all plant tissues is desired. In addition, a developmentally regulated or tissue-specific regulatory element can be useful to direct floral meristem identity gene expression to specific tissues, for example. As discussed above, inducible expression also can be particularly useful to manipulate the timing of gene expression such that, for example, a population of transgenic seed plants of the invention that contain an expression vector comprising a floral meristem identity gene linked to an inducible regulatory element can undergo early reproductive development at essentially the same time. Selecting the time of reproductive development can be useful, for example, in manipulating the time of crop harvest.

Using nucleic acid molecules encoding AP1 provided herein, the skilled artisan can isolate, if desired, a novel ortholog of AP1. For example, one would choose a region of AP1 that is highly conserved among known AP1 sequences such as a region that is highly conserved between Arabidopsis AP1 (SEQ ID NO: 1) and Zea mays AP1 (GenBank accession number L46400; SEQ ID NO: 7) to screen a cDNA or genomic library of interest for a novel AP1 ortholog. One can use a full-length Arabidopsis AP1 (SEQ ID NO: 1), for example, to isolate a novel ortholog of AP1 (see Example V). If desired, the region encoding the MADS domain, which is common to a number of genes, can be excluded, from the sequence used as a probe. Similarly, the skilled artisan knows that a nucleic acid molecule encoding a full-length CAL cDNA such as Arabidopsis CAL (SEQ ID NO: 9) or Brassica oleracea CAL (SEQ ID NO: 11) can be useful in isolating a novel CAL ortholog.

For example, the Arabidopsis AP1 cDNA (SEQ ID NO: 1) can be used as a probe to identify and isolate a novel AP1 ortholog. Using a nucleotide sequence derived from a conserved region of SEQ ID NO: 1, SEQ ID NO: 3, SEQ ID NO: 5 or SEQ ID NO: 7, for example, a nucleic acid molecule encoding a novel AP1 ortholog can be isolated from other plant species. Using methods such as those described by Purugganan et al., supra, 1995, one can readily confirm that the newly isolated molecule is an AP1 ortholog. Thus, a nucleic acid molecule encoding an AP1 gene product, which has at least about 70 percent amino acid identity with the amino acid sequence of SEQ ID NO: 2 (Arabidopsis AP1) in the region from amino acid 1 to amino acid 163 or with the amino acid sequence of SEQ ID NO: 8 (Zea mays AP1) in the region from amino acid 1 to amino acid 163 can be isolated and identified using well known methods.

Similarly, in order to isolate an ortholog of CAL, one can choose a region of CAL that is highly conserved among known CAL cDNAs, such as a region conserved between Arabidopsis CAL (SEQ ID NO: 9) and Brassica oleracea CAL (SEQ ID NO: 11). The Arabidopsis CAL cDNA (SEQ ID NO: 9) or Brassica oleracea CAL cDNA (SEQ ID NO: 11), or a nucleotide fragment thereof, can be used to identify and isolate a novel CAL ortholog using methods such as those described in Example V. In order to identify related MADS domain genes, a nucleotide sequence derived from the MADS domain of AP1 or CAL, for example, can be useful to isolate a related gene sequence encoding this DNA-binding motif.

Hybridization conditions for isolating a gene ortholog, for example, are relatively stringent such that non-specific hybridization is minimized. Appropriate hybridization conditions can be determined empirically, or can be estimated based, for example, on the relative G+C content of the probe and the number of mismatches between the probe and target sequence, if known. Hybridization conditions can be adjusted as desired by varying, for example, the temperature of hybridizing or the salt concentration (Sambrook, supra, 1989).

The invention also provides a kit for converting shoot meristem to floral meristem in an angiosperm, which contains a plant expression vector having a nucleic acid molecule encoding a floral meristem identity gene product. A kit for promoting early reproductive development in a seed plant, which contains a plant expression vector having a nucleic acid molecule encoding a floral meristem identity gene product, also is provided. If desired, such kits can contain appropriate reagents to facilitate high efficiency transformation of a seed plant with a plant expression vector of the invention. Furthermore, if desired, a control vector lacking a floral meristem identity gene can be included in the kits to determine, for example, the efficiency of transformation.

The following examples are intended to illustrate but not limit the present invention.

EXAMPLE I Conversion of Shoot Meristem to Floral Meristem and Early Reproductive Development in an APETALA1 Transgenic Plant

This example describes methods for producing a transgenic Arabidopsis plant containing ectopically expressed AP1.

A. Ectopic Expression of APETALA1 Converts Inflorescence Shoots into Flowers

Transgenic plants that constitutively express AP1 from the cauliflower mosaic virus 35S (CaMV 35S) promoter were produced to determine whether ectopic AP1 expression was sufficient to convert shoot meristem to floral meristem. The AP1 coding sequence was placed under control of the CaMV 35S promoter (Odell et al., supra, 1985) as follows. Bam HI linkers were ligated to the Hinc II site of the full-length AP1 complementary DNA (Mandel et al., supra, (1992), which is incorporated herein by reference) in pAM116, and the resulting Bam HI fragment was fused to the CaMV 35S promoter (Jack et al., Cell 76:703-716 (1994), which is incorporated herein by reference) in pCGN18 to create pAM563.

Transgenic 35S-AP1Arabidopsis plants of the Columbia ecotype were generated by selecting kanamycin-resistant plants after Agrobacterium-mediated plant transformation using the in planta method (Bechtold et al., C.R. Acad. Sci. Paris 316:1194-1199 (1993), which is incorporated herein by reference). All analyses were performed in subsequent generations. Approximately 120 independent transgenic lines that displayed the described phenotypes were obtained.

Remarkably, in 35S-AP1 transgenic plants, the normally indeterminate shoot apex prematurely terminated as a floral meristem and formed a terminal flower. Generally, lateral meristems that normally would produce inflorescence shoots also were converted into solitary flowers. These results demonstrate that ectopic expression of AP1 in shoot meristem is sufficient to convert shoot meristem to floral meristem, even though AP1 normally is not absolutely required to specify floral meristem identity.

B. LEAFY is not Required for the Conversion of Inflorescence Shoots to Flowers in an APETALA1 Transgenic Plant

To determine whether the 35S-AP1 transgene causes ectopic LFY activity, and whether ectopic LFY activity is required for the conversion of shoot meristem to floral meristem, the 35S-AP1 transgene was introduced into Arabidopsis lfy mutants. The 35S-AP1 transgene was crossed into the strong lfy-6 mutant background and the F₂ progeny were analyzed.

Mutant lfy plants containing the 35S-AP1 transgene displayed the same conversion of apical and lateral shoot meristem to floral meristem as was observed in transgenics containing wild type LFY. However, the resulting flowers had the typical lfy mutant phenotype, in which floral organs developed as sepaloid and carpelloid structures, with an absence of petals and stamens. These results demonstrate that LFY is not required for the conversion of shoot meristem to floral meristem in a transgenic angiosperm that ectopically expresses AP1.

C. APETALA1 is not Sufficient to Specify Organ Fate

As well as being involved in the early step of specifying floral meristem identity, AP1 also is involved in specifying sepal and petal identity at a later stage in flower development. Although AP1 RNA initially is expressed throughout the young flower primordium, it is later excluded from stamen and carpel primordia (Mandel et al., supra, 1992). Since the CaMV 35S promoter is active in all floral organs, 35S-AP1 transgenic plants are likely to ectopically express AP1 in stamens and carpels. However, the normal stamens and carpels 35S-AP1 in transgenic plants indicate that AP1 is not sufficient to specify sepal and petal organ fate.

D. Ectopic Expression of APETALA1 causes Early Reproductive Development

In addition to its ability to alter inflorescence meristem identity, ectopic expression of AP1 also influences the vegetative phase of plant growth. Wild-type Arabidopsis plants have a vegetative phase during which a basal rosette of leaves is produced, followed by the transition to reproductive growth. The transition from vegetative to reproductive growth was measured both in terms of the number of days post-germination until the first visible flowers were observed, and by counting the number of leaves. Under continuous light, wild-type and 35S-AP1 transgenic plants flowered after producing 9.88±1.45 and 4.16±0.97 leaves, respectively. Under short-day growth conditions (8 hours light, 16 hours dark, 24° C.), wild-type and 35S-AP1 transgenic plants flowered after producing 52.42±3.47 and 7.4±1.18 leaves, respectively.

Under continuous light growth conditions, flowers appear on wild-type Arabidopsis plants after approximately 18 days, whereas the 35S-AP1 transgenic plants flowered after an average of only 10 days. Furthermore, under short-day growth conditions, flowering is delayed in wild-type Arabidopsis plants until approximately 10 weeks after germination, whereas 35S-AP1 transgenic plants flowered in less than about five weeks. Thus, ectopic AP1 expression significantly reduced the time of reproductive development, as indicated by the time of flowering. Ecotopic AP1 expression also reduced the delay of flowering caused by short day growth conditions.

EXAMPLE II Conversion of Inflorescence Shoots into Flowers in an CAULIFLOWER Transgenic Plant

This example describes methods for producing a transgenic Arabidopsis plant that ectopically expresses CAL.

Transgenic Arabidopsis plants that ectopically express CAL in shoot meristem were generated. The full-length CAL cDNA was inserted downstream of the CaMV 35S promoter in the Eco RI site of pMON530 (Monsanto Co., St. Louis, Mo.) This plasmid was introduced into Agrobacterium strain ASE and used to transform the Columbia ecotype of Arabidopsis using the modified vacuum infiltration method described by Bechtold et al., supra, 1993. The 96 transgenic lines that harbored the 35S-CAL construct had a range of weak to strong phenotypes. Transgenic plants with the strongest phenotypes (27 lines) had a phenotype that closely resembled the tfl mutant phenotype.

The apical and lateral inflorescence shoots of 35S-CAL transgenic plants were converted into flowers. Furthermore, the 35S-CAL transgenic plants were characterized by early reproductive development, as indicated by an early flowering phenotype. These results demonstrate that ectopic expression of CAL is sufficient for the conversion of shoots to flowers and for promoting early reproductive development.

EXAMPLE III Conversion of Shoots into Flowers and Early Reproductive Development in a LEAFY Transgenic Plant

This example describes methods for producing transgenic Arabidopsis ectopically expressing LFY and transgenic aspen ectopically expressing LFY.

A. Conversion of Arabidopsis Shoots and Early Arabidopsis Reproductive Development by LEAFY

Transgenic Arabidopsis plants were generated by transforming Arabidopsis with LFY under the control of the CaMV 35S promoter (Odell et al., supra, (1985)). A LFY complementary DNA (Weigel et al, Cell 69:843-859 (1992), which is incorporated herein by reference) was inserted into a T-DNA transformation vector containing a CaMV 35S promoter and a 3' nos cassette (Jack et al., supra, 1994). Transformed seedlings were selected for kanamycin resistance. Several hundred Arabidopsis transformants in three different genetic backgrounds (Nossen, Wassilewskija and Columbia) were recovered, and several lines were characterized in detail.

High levels of LFY RNA expression were detected by northern blot analysis in 35S-LFY transgenics. In general, Nossen lines had weaker phenotypes, especially when grown under short day conditions. The 35S-LFY transgene of line DW151.117 (ecotype Wassilewskija) was introgressed into the erecta background by backcrossing to a Landsberg erecta strain. Plants were grown under 16 hours light and 8 hours dark. The 35S-LFY transgene provided at least as much LFY activity as the endogenous gene and completely suppressed the lfy mutant phenotype when crossed into the background of the lfy-6 null allele.

Most 35S-LFY transgenic plants lines demonstrated a very similar, dominant and heritable phenotype. Secondary shoots that arose in lateral positions were consistently replaced by solitary flowers, and higher-order shoots were absent. Although the number of rosette leaves was unchanged from the wild type, 35S-LFY plants flowered earlier than wild type: the solitary flowers in the axils of the rosette leaves developed and opened precociously. In addition, the primary shoot terminated with a flower. In 35S-LFY transgenics having the most extreme phenotypes, a terminal flower was formed immediately above the rosette. This gain of function phenotype (conversion of shoots to flowers) is the opposite of the lfy loss of function phenotype (conversion of flowers to shoots). These results demonstrate that LFY encodes a developmental switch that is both sufficient and necessary to convert shoot meristem to flower meristem in an angiosperm.

The effects of constitutive LFY expression differ for primary and secondary shoot meristems. Secondary meristems were transformed into flower meristem, apparently as soon as it developed, and produced only a single, solitary flower. In contrast, primary shoot meristem produced leaves and lateral flowers before being consumed in the formation of a terminal flower. These developmental differences indicate that a meristem must acquire competence to respond to the activity of a floral meristem identity gene such as LFY.

B. Conversion of Aspen Shoots by LEAFY

Given that constitutive expression of LFY induced early reproductive development as indicated by precocious flowering during the vegetative phase of Arabidopsis, the effect of LFY on the flowering of other seed plant species was examined. The perennial tree, hybrid aspen, is derived from parental species that flower naturally only after 8-20 years of growth (Schopmeyer (ed.), USDA Agriculture Handbook 450: Seeds of Woody Plants in the United States, Washington D.C., USA: U.S. Government Printing Office, pp. 645-655 (1974)). 35S-LFY transgenic aspen plants were obtained by Agrobacterium-mediated transformation of stem segments and subsequent regeneration of transgenic shoots in tissue culture.

Hybrid aspen was transformed exactly as described by Nilsson et al. (Transgen. Res. 1:209-220 (1992), which is incorporated herein by reference). Levels of LFY RNA expression were similar to those of 35S-LFY Arabidopsis, as determined by northern blot analysis. The number of vegetative leaves varied between different regenerating shoots, and those with a higher number of vegetative leaves formed roots, allowing for transfer to the greenhouse. Individual flowers were removed either from primary transformants that had been transferred to the greenhouse, or from catkins collected in spring, 1995, at Carlshem, Umea, Sweden) from a tree whose age was determined by counting the number of annual rings in a core extracted with an increment borer at 1.5 meters above ground level. Flowers were fixed in formaldehyde/acetic acid/ethanol and destained in ethanol before photography.

The overall phenotype of 35S-LFY transgenic aspen was similar to that of 35S-LFY Arabidopsis. In wild-type plants of both species, flowers normally are formed in lateral positions on inflorescence shoots. In aspen, these inflorescence shoots, called catkins, arise from the leaf axils of adult trees. In both 35S-LFY Arabidopsis and 35S-LFY aspen, solitary flowers were formed instead of shoots in the axils of vegetative leaves. Moreover, as in Arabidopsis, the secondary shoots of transgenic aspen were more severely affected than the primary shoot.

Regenerating 35S-LFY aspen shoots initially produced solitary flowers in the axils of normal leaves. However, the number of vegetative leaves was limited, and the shoot meristem was prematurely consumed in the formation of an aberrant terminal flower. Early reproductive development as demonstrated by precocious flowering was specific to 35S-LFY transformants and was not observed in non-transgenic controls. Furthermore, not a single instance of precocious flower development has been observed in more than 1,500 other lines of transgenic aspen generated with various constructs from 1989 to 1995 at the Swedish University of Agricultural Sciences. These results demonstrate that a floral meristem identity gene product can promote early reproductive development in a heterologous angiosperm species.

EXAMPLE IV Dexamethasone-inducible Floral Meristem Identity Gene Activity in Transgenic Plants

This example describes the construction and characterization of an AP1-glucocorticoid receptor ligand binding domain chimera and its dexamethasone-inducible activity in Arabidopsis.

A. Construction and Characterization of an AP1-glucocorticoid Receptor Ligand Binding Domain Chimera

A nucleic acid molecule encoding an AP1-glucocorticoid receptor ligand binding domain chimera was prepared as follows. Primers corresponding to the translation initiation and termination codons of AP1 were synthesized for PCR amplification of the Arabidopsis AP1 cDNA. Primer 5'-GGATCCGGATCAAAAATGGGAAGGGGTAG-3' (SEQ ID NO: 25) contains a translation initiation codon, which is indicated by underlining. Primer 5'-GGATCCGCTGCGGCGAAGCAGCCAAGGTTG-3' (SEQ ID NO: 26) contains a modified translation termination site, which is indicated by underlining and allows the nucleic acid molecule encoding AP1 to be linked in frame to the nucleic acid molecule encoding the glucocorticoid receptor (GR) ligand binding domain.

The full length Arabidopsis AP1 cDNA in pAM116 (see Example I) was used as the template for PCR amplification with primers SEQ ID NOS: 25 and 26, each of which contain a Bam H1 site. The resulting Bam HI fragment, which encodes the full-length Arabidopsis AP1 cDNA except for the translation termination codon, was cloned into the unique Bam HI site of the GR fusion vector constructed by Lloyd et al., supra, 1994. DNA sequence analyses confirmed that the construct contained the predicted nucleotide sequence.

The resulting AP1-GR construct was introduced into Agrobacterium strain ASE, and ap1-15 mutant plants were transformed using the vacuum infiltration method described in Example I. Approximately 100 independently derived lines were selected in kanamycin for further analysis.

B. Dexamethasone-inducible Activity of an AP1-glucocorticoid Receptor Ligand Binding Domain Chimera in Arabidopsis

Kanamycin-resistant transgenic Arabidopsis lines are analyzed in subsequent generations for AP1 activity. After application of dexamethasone to transgenic plants, AP1 activity is monitored by visual inspection for 1) flowering that is earlier than wild-type or 2) partial or complete rescue of the ap1 mutant phenotype.

To assay for dexamethasone-inducible activity, plants are watered with varying concentrations of dexamethasone. A range of dexamethasone concentrations are tested to determine overall levels of AP1 activity and to determine the resulting phenotypes. A concentration of 1 μM or less dexamethasone preferably is used for induction of AP1 activity.

In addition, dexamethasone is applied directly to plants by spraying. Spraying, like watering, leads to a significant induction of AP1 activity, resulting in the corresponding rescue of the ap1 mutant phenotype and early reproductive development. Although a single application of dexamethasone is sufficient to increase AP1 activity and promote early reproductive development, dexamethasone is applied either once, or repeatedly, and the treatments compared for any observed differences under long or short day conditions as disclosed below.

Dexamethasone is applied to plants at various times post-germination. For example, a large number of AP1-GR transgenic Arabidopsis plants are grown, some of which are treated with dexamethasone on day 1 post-germination, some on day 2, etc., all the way up until and beyond the time at which Arabidopsis plants normally flower. These analyses include plants grown under long day, short day, and under a variety of temperatures. For example, Arabidopsis plants, which typically are grown at 25° C., also can be analyzed for AP1 activity at 20° C. and 15° C. (see, for example, Bowman et al. (ed.), Arabidopsis: An Atlas of Morphology and Development, New York: Springer (1994), which is incorporated by reference herein).

EXAMPLE V Identification and Characterization of the Zea mays APETALA1 cDNA

This example describes the isolation and characterization of Zea mays ZAP1 complementary DNA, which is an ortholog of the Arabidopsis floral meristem identity gene AP1.

A. Identification and Characterization of a Nucleic Acid Sequence Encoding ZAP1

The utility of using a cloned floral homeotic gene from Arabidopsis to identify the putative ortholog in maize has been demonstrated previously (Schmidt et al., supra, (1993), which is incorporated herein by reference). As described in Mena et al. (Plant J. 8(6):845-854 (1995)), the maize ortholog of the Arabidopsis AP1 floral meristem identity gene, was isolated by screening a Zea mays ear cDNA library using the Arabidopsis AP1 cDNA (SEQ ID NO: 1) as a probe. A cDNA library was prepared from wild-type immature ears as described by Schmidt et al., supra, 1993, and screened using the Arabidopsis AP1 cDNA SEQ ID NO: 1 as the probe. Low-stringency hybridizations with the AP1 probe were conducted as described previously for the isolation of ZAG1 using the AG cDNA as a probe (Schmidt et al., supra, 1993). Positive plaques were isolated and cDNAs were recovered in Bluescript by in vivo excision. Double-stranded sequencing was performed using the Sequenase Version 2.0 kit (U.S. Biochemical, Cleveland, Ohio) according to the manufacturer's protocol.

The nucleotide sequence and deduced amino acid sequence of the ZAP1 cDNA are provided as SEQ ID NOS: 7 and 8. The deduced amino acid sequence for ZAP1 shares 89% identity with Arabidopsis AP1 through the MADS domain (amino acids 1 to 57) and 70% identity through the first 160 amino acids, which includes the K domain. The high level of amino acid sequence identity between ZAP1 and AP1 (SEQ ID NOS: 8 and 2), as well as the expression pattern of ZAP1 in maize florets (see below), indicate that ZAP1 is the maize ortholog of Arabidopsis AP1.

B. RNA Expression Pattern of ZAP1

Total RNA was isolated from different maize tissues as described by Cone et al., Proc. Natl. Acad. Sci., USA 83:9631-9635 (1986), which is incorporated herein by reference. RNA was prepared from ears or tassels at early developing stages (approximately 2 cm in size), husk leaves from developing ear shoots, shoots and roots of germinated seedlings, leaves from 2 to 3 week old plants and endosperm, and embryos at 18 days after pollination. Mature floral organs were dissected from ears at the time of silk emergence or from tassels at several days pre-emergence. To study expression patterns in the mature female flower, carpels were isolated and the remaining sterile organs were pooled and analyzed together. In the same way, stamens were dissected and collected from male florets and the remaining organs (excluding the glumes) were pooled as one sample.

RNA concentration and purity was determined by absorbance at 260/280 nM, and equal amounts (10 μg) were fractionated on formaldehyde-agarose gels. Gels were stained in a solution of 0.125 μg ml⁻¹ acridine orange to confirm the integrity of the RNA samples and the uniformity of gel loading, then RNA was blotted on to Hybond-N® membranes (Amersham International, Arlington Heights, Ill.) according to the manufacturer's instructions. Prehybridization and hybridization solutions were prepared as previously described (Schmidt et al., Science 238:960-963 (1987), which is incorporated herein by reference). The probe for ZAP1 RNA expression studies was a 445 bp Sac I/Nsi I fragment from the 3' end of the cDNA. Southern blot analyses were conducted to establish conditions for specific hybridization of this probe. No cross-hybridization was detected using hybridization at 60° C. in 50% formamide and washes at 65° C. in 0.1×SSC and 0.5% SDS.

The strong sequence similarity between ZAP1 and AP1 indicated that ZAP1 was the ortholog of this Arabidopsis floral meristem identity gene. As a first approximation of whether the pattern of ZAP1 expression paralleled that of AP1, a blot of total RNA from vegetative and reproductive organs was hybridized with a gene-specific fragment of the ZAP1 cDNA (nucleotides 370 to 820 of SEQ ID NO: 7). ZAP1 RNA was detected only in male and female inflorescences and in the husk leaves that surround the developing ear. No ZAP1 RNA expression was detectable in RNA isolated from root, shoot, leaf, endosperm, or embryo tissue. The restriction of ZAP1 expression to terminal and axillary inflorescences is consistent with ZAP1 being the Arabidopsis AP1 ortholog.

Male and female florets were isolated from mature inflorescences, and the reproductive organs were separated from the remainder of the floret. RNA was isolated from the reproductive and the sterile portions of the florets. ZAP1 RNA expression was not detected in maize stamens or carpels, whereas high levels of ZAP1 RNA were present in developing ear and tassel florets from which stamens and carpels had been removed. Thus, the exclusion of ZAP1 expression from stamens and carpels and its inclusion in the RNA of the non-reproductive portions of the floret (lodicules, lemma and palea) is similar to the pattern of expression of AP1 in flowers of Arabidopsis.

EXAMPLE VI

Production and Characterization of Anti-AP1 Antisera

This example demonstrates the production and characterization of antisera that specifically binds the Arabidopsis AP1 gene product.

Western blotting was performed with plant tissue extracts and crude antisera from rabbits immunized with a GST-AP1 fusion protein encoding amino acids 190 to 251 of Arabidopsis thaliana AP1 (SEQ ID NO: 2). The C-terminal region of AP1 spanning amino acids 190 to 251 does not include the MADS domain, which is common to a number of proteins. As shown in FIG. 1, the anti-AP1 sera reacted with a 90 kDa protein in inflorescence tissue extracts prepared from wild type Arabidopsis thaliana (Landsburg ecotype). As expected, this reactivity was absent from Arabidopsis mutants lacking AP1 such as ap1-1 or ap1-15 (compare lanes 3 and 4 to lane 2).

AP1 expression was reduced significantly in inflorescence tissue extracts from the Arabidopsis ap2-2 mutant as compared to wild type plants, indicating that AP2 normally functions to increase or maintain the level of AP1 RNA or protein expression (see lanes 2 and 5). Similarly, reduced AP1 expression in lfy-6 mutant plants indicates that LFY normally functions to enhance expression of AP1 at the RNA or protein level (see lanes 2 and 6). In contrast to the results seen in ap2-2 or lfy-6 mutant inflorescences, AP1 protein expression in inflorescence tissue from ag-2 mutants is enhanced strikingly as compared to the level of AP1 protein seen in wild type inflorescences (see lanes 1 and 2). These results indicate that the AGAMOUS gene product (AG) negatively regulates AP1 RNA or protein expression.

Western analysis further demonstrated that AP1 protein expression is specific to inflorescence tissue since AP1 reactivity is absent from leaf tissue prepared from wild type Arabidopsis plants (Columbia ecotype; lane 7). In transgenic plants constitutively expressing AP1 from the CaMV promoter, however, AP1 protein expression readily was detectable in leaf tissue as shown in lane 8. Reactivity of the anti-AP1 antisera in 35S-AP1 transgenic leaves but not in wild type Arabidopsis leaves confirmed the specificity of the anti-AP1 sera.

Specificity of the anti-AP1 sera also was demonstrated by specific binding of the antisera to AP1 but not to the closely related CAL gene product. For example, inflorescence tissue extract from an ap1-1 or ap1-15 mutant plant (lane 3 or 4, respectively), which contains CAL but not AP1, was not reactive with the anti-AP1 rabbit sera. These data indicate that the anti-AP1 sera does not react with the CAL gene product.

For production of anti-AP1 sera, a Sty I fragment of the Arabidopsis thaliana AP1 CDNA, which encodes amino acids 190 to 251, was gel purified, blunt ended with Klenow fragment and ligated into the Sma I site of pGEX3X (Pharmacia, Piscataway, N.J.) to make pGEX-AP1₁₉₀₋₂₅₁ for expression of a GST-AP1₁₉₀₋₂₅₁ fusion protein. DH5αE. coli were transformed with the resulting vector by standard techniques (Sambrook, supra, 1989).

A bacterial culture of a pGEX-AP1₁₉₀₋₂₅₁ transformant was grown to an OD₆₀₀ of 0.5, and GST-AP1₁₉₀₋₂₅₁ expression was induced by addition of 1 mM IPTG. The GST-AP1₁₉₀₋₂₅₁ bacterial pellet was harvested after three hours growth at 37° C., washed once with phosphate-buffered saline (PBS; pH 7.2) and lysed by two cycles of freeze-thawing. The cell lysate was resuspended in one-fiftieth of the culture volume in ice cold EB (2 mM EDTA, 2 mM DTT, 1 mM PMSF, 5 μg/ml leupeptin, 7.5 μg/ml pepstatin, 1% aprotinin in PBS pH 7.2) with 2 mg/ml lysozyme and incubated on ice for 30 minutes. Triton X-100 was added to 1%, and the solution was sonicated mildly. The extract was clarified by two successive centrifugations of 1 and 15 minutes, respectively, at 13,000×g in a microfuge.

The GST-AP1₁₉₀₋₂₅₁ fusion protein was purified from the bacterial extract as follows. Glutathione-Sepharose beads (150 μl), which had been pre-equilibrated in EB with 1% Triton X-100, were added to 1 ml of soluble extract in an Eppendorf tube and incubated on a rotating wheel for 60 minutes at 4° C. The beads were washed five times in 1 ml EB with 1% Triton X-100; resuspended in protein sample buffer and loaded on a preparative SDS-PAGE gel (Laemmli, Nature 227:680-685 (1970), which is incorporated herein by reference). Following electrophoresis, the gel was stained for five minutes in 0.05%. Coomassie R250 (Fisher Scientific, Pittsburgh, Pa.) in distilled water and subsequently destained in distilled water. GST-AP1₁₉₀₋₂₅₁ fusion protein was cut out of the gel and electroeluted in 0.5× transfer buffer for 3 hours at 100 V as described in Harlow and Lane, supra, 1988. The GST-AP1₁₉₀₋₂₅₁ fusion protein was emulsified with Freund's adjuvant and injected into rabbits by Immunodynamics (La Jolla, Calif.).

Crude rabbit serum was used for western analysis at a dilution of 1 to 2000. Binding was detected using a secondary antibody coupled to peroxidase (Promega, Madison, Wis.; 1 to 2500 dilution) and revealed using an enhanced chemiluminesence kit (Amersham).

Plant protein extracts for western analysis were prepared by homogenizing 100 μl plant tissue with 200 μl 2XFSB (Laemmli, supra, 1970) in a Kontes microfuge tube with a pistil. The extract was denatured in boiling water bath for 5 minutes, sonicated for 1 minute and clarified by two successive spins of 5 and 15 minutes in a microfuge at 13,000×g prior to electophoresis.

EXAMPLE VII Cosuppression of AP1 Activity

This example demonstrates the use of cosuppression to inhibit endogenous AP1 activity in Arabidopsis.

The full length AP1 cDNA from pAM116 (see Example I) was inserted into the Eco RI site of pMON530, and the resulting construct was introduced into Agrobacterium strain ASE. Wild type Arabidopsis was transformed as described in Example I and analyzed for ap1 mutant phenotypes. In this way, a large number of independently generated cosuppressed lines were generated. Each of the cosuppressed lines had a phenotype similar or identical to ap1-1 mutant plants, which lack AP1 activity, indicating that the activity of both the introduced and endogenous copies of AP1 was suppressed. Analysis of AP1 expression levels by RNA in situ hybridization demonstrated that AP1 expression was reduced and delayed in the cosuppressed transgenic lines having the ap1 mutant phenotype. Futhermore, in a samll fraction of the cosuppressed transgenic lines, a enhanced phenotype resembling the cauliflower phenotype was observed. This enhanced phenotype indicated that introduction of an AP1 construct can supress expression of both endogenous AP1 and CAL.

Although the invention has been described with reference to the examples above, it should be understood that various modifications can be made without departing from the spirit of the invention. Accordingly, the invention is limited only by the following claims.

    __________________________________________________________________________     #             SEQUENCE LISTING                                                    - -  - - (1) GENERAL INFORMATION:                                              - -    (iii) NUMBER OF SEQUENCES: 26                                           - -  - - (2) INFORMATION FOR SEQ ID NO:1:                                      - -      (i) SEQUENCE CHARACTERISTICS:                                                  (A) LENGTH: 1057 base - #pairs                                                 (B) TYPE: nucleic acid                                                         (C) STRANDEDNESS: double                                                       (D) TOPOLOGY: linear                                                  - -     (ix) FEATURE:                                                                   (A) NAME/KEY: CDS                                                              (B) LOCATION: 124..893                                                - -     (ix) FEATURE:                                                                   (A) NAME/KEY: misc.sub.-- - #feature                                           (B) LOCATION: 1..1057                                                          (D) OTHER INFORMATION: - #/note= "product = Arabidopsis                            thaliana - #AP1."                                                - -     (xi) SEQUENCE DESCRIPTION: SEQ ID NO:1:                                - - CTTTCCAATT GGTTCATACC AAAGTCTGAG CTCTTCTTTA TATCTCTCTT GT -              #AGTTTCTT     60                                                                  - - ATTGGGGGTC TTTGTTTTGT TTGGTTCTTT TAGAGTAAGA AGTTTCTTAA AA -             #AAGGATCA    120                                                                  - - AAA ATG GGA AGG GGT AGG GTT CAA TTG AAG AG - #G ATA GAG AAC AAG         ATC      168                                                                         Met Gly Arg Gly Arg Val Gln Leu - #Lys Arg Ile Glu Asn Lys Ile                  1            - #   5               - #   10               - #   15        - - AAT AGA CAA GTG ACA TTC TCG AAA AGA AGA GC - #T GGT CTT TTG AAG AAA           216                                                                        Asn Arg Gln Val Thr Phe Ser Lys Arg Arg Al - #a Gly Leu Leu Lys Lys                             20 - #                 25 - #                 30               - - GCT CAT GAG ATC TCT GTT CTC TGT GAT GCT GA - #A GTT GCT CTT GTT GTC           264                                                                        Ala His Glu Ile Ser Val Leu Cys Asp Ala Gl - #u Val Ala Leu Val Val                         35     - #             40     - #             45                   - - TTC TCC CAT AAG GGG AAA CTC TTC GAA TAC TC - #C ACT GAT TCT TGT ATG           312                                                                        Phe Ser His Lys Gly Lys Leu Phe Glu Tyr Se - #r Thr Asp Ser Cys Met                     50         - #         55         - #         60                       - - GAG AAG ATA CTT GAA CGC TAT GAG AGG TAC TC - #T TAC GCC GAA AGA CAG           360                                                                        Glu Lys Ile Leu Glu Arg Tyr Glu Arg Tyr Se - #r Tyr Ala Glu Arg Gln                 65             - #     70             - #     75                           - - CTT ATT GCA CCT GAG TCC GAC GTC AAT ACA AA - #C TGG TCG ATG GAG TAT           408                                                                        Leu Ile Ala Pro Glu Ser Asp Val Asn Thr As - #n Trp Ser Met Glu Tyr             80                 - # 85                 - # 90                 - # 95        - - AAC AGG CTT AAG GCT AAG ATT GAG CTT TTG GA - #G AGA AAC CAG AGG CAT           456                                                                        Asn Arg Leu Lys Ala Lys Ile Glu Leu Leu Gl - #u Arg Asn Gln Arg His                            100  - #               105  - #               110               - - TAT CTT GGG GAA GAC TTG CAA GCA ATG AGC CC - #T AAA GAG CTT CAG AAT           504                                                                        Tyr Leu Gly Glu Asp Leu Gln Ala Met Ser Pr - #o Lys Glu Leu Gln Asn                        115      - #           120      - #           125                   - - CTG GAG CAG CAG CTT GAC ACT GCT CTT AAG CA - #C ATC CGC ACT AGA AAA           552                                                                        Leu Glu Gln Gln Leu Asp Thr Ala Leu Lys Hi - #s Ile Arg Thr Arg Lys                    130          - #       135          - #       140                       - - AAC CAA CTT ATG TAC GAG TCC ATC AAT GAG CT - #C CAA AAA AAG GAG AAG           600                                                                        Asn Gln Leu Met Tyr Glu Ser Ile Asn Glu Le - #u Gln Lys Lys Glu Lys                145              - #   150              - #   155                           - - GCC ATA CAG GAG CAA AAC AGC ATG CTT TCT AA - #A CAG ATC AAG GAG AGG           648                                                                        Ala Ile Gln Glu Gln Asn Ser Met Leu Ser Ly - #s Gln Ile Lys Glu Arg            160                 1 - #65                 1 - #70                 1 -       #75                                                                               - - GAA AAA ATT CTT AGG GCT CAA CAG GAG CAG TG - #G GAT CAG CAG AAC         CAA      696                                                                     Glu Lys Ile Leu Arg Ala Gln Gln Glu Gln Tr - #p Asp Gln Gln Asn Gln                           180  - #               185  - #               190               - - GGC CAC AAT ATG CCT CCC CCT CTG CCA CCG CA - #G CAG CAC CAA ATC CAG           744                                                                        Gly His Asn Met Pro Pro Pro Leu Pro Pro Gl - #n Gln His Gln Ile Gln                        195      - #           200      - #           205                   - - CAT CCT TAC ATG CTC TCT CAT CAG CCA TCT CC - #T TTT CTC AAC ATG GGT           792                                                                        His Pro Tyr Met Leu Ser His Gln Pro Ser Pr - #o Phe Leu Asn Met Gly                    210          - #       215          - #       220                       - - GGT CTG TAT CAA GAA GAT GAT CCA ATG GCA AT - #G AGG AGG AAT GAT CTC           840                                                                        Gly Leu Tyr Gln Glu Asp Asp Pro Met Ala Me - #t Arg Arg Asn Asp Leu                225              - #   230              - #   235                           - - GAA CTG ACT CTT GAA CCC GTT TAC AAC TGC AA - #C CTT GGC TGC TTC GCC           888                                                                        Glu Leu Thr Leu Glu Pro Val Tyr Asn Cys As - #n Leu Gly Cys Phe Ala            240                 2 - #45                 2 - #50                 2 -       #55                                                                               - - GCA TG AAGCATTTCC ATATATATAT TTGTAATCGT CAACAATAAA AAC - #AGTTTGC             943                                                                       Ala                                                                             - - CACATACATA TAAATAGTGG CTAGGCTCTT TTCATCCAAT TAATATATTT TG -              #GCAAATGT   1003                                                                  - - TCGATGTTCT TATATCATCA TATATAAATT AGCAGGCTCC TTTCTTTTTT TG - #TA              1057                                                                        - -  - - (2) INFORMATION FOR SEQ ID NO:2:                                      - -      (i) SEQUENCE CHARACTERISTICS:                                                  (A) LENGTH: 256 amino - #acids                                                 (B) TYPE: amino acid                                                           (D) TOPOLOGY: linear                                                  - -     (ii) MOLECULE TYPE: protein                                            - -     (xi) SEQUENCE DESCRIPTION: SEQ ID NO:2:                                - - Met Gly Arg Gly Arg Val Gln Leu Lys Arg Il - #e Glu Asn Lys Ile Asn         1               5 - #                 10 - #                 15               - - Arg Gln Val Thr Phe Ser Lys Arg Arg Ala Gl - #y Leu Leu Lys Lys Ala                    20     - #             25     - #             30                   - - His Glu Ile Ser Val Leu Cys Asp Ala Glu Va - #l Ala Leu Val Val Phe                35         - #         40         - #         45                       - - Ser His Lys Gly Lys Leu Phe Glu Tyr Ser Th - #r Asp Ser Cys Met Glu            50             - #     55             - #     60                           - - Lys Ile Leu Glu Arg Tyr Glu Arg Tyr Ser Ty - #r Ala Glu Arg Gln Leu        65                 - # 70                 - # 75                 - # 80        - - Ile Ala Pro Glu Ser Asp Val Asn Thr Asn Tr - #p Ser Met Glu Tyr Asn                        85 - #                 90 - #                 95               - - Arg Leu Lys Ala Lys Ile Glu Leu Leu Glu Ar - #g Asn Gln Arg His Tyr                   100      - #           105      - #           110                   - - Leu Gly Glu Asp Leu Gln Ala Met Ser Pro Ly - #s Glu Leu Gln Asn Leu               115          - #       120          - #       125                       - - Glu Gln Gln Leu Asp Thr Ala Leu Lys His Il - #e Arg Thr Arg Lys Asn           130              - #   135              - #   140                           - - Gln Leu Met Tyr Glu Ser Ile Asn Glu Leu Gl - #n Lys Lys Glu Lys Ala       145                 1 - #50                 1 - #55                 1 -       #60                                                                               - - Ile Gln Glu Gln Asn Ser Met Leu Ser Lys Gl - #n Ile Lys Glu Arg         Glu                                                                                              165  - #               170  - #               175              - - Lys Ile Leu Arg Ala Gln Gln Glu Gln Trp As - #p Gln Gln Asn Gln Gly                   180      - #           185      - #           190                   - - His Asn Met Pro Pro Pro Leu Pro Pro Gln Gl - #n His Gln Ile Gln His               195          - #       200          - #       205                       - - Pro Tyr Met Leu Ser His Gln Pro Ser Pro Ph - #e Leu Asn Met Gly Gly           210              - #   215              - #   220                           - - Leu Tyr Gln Glu Asp Asp Pro Met Ala Met Ar - #g Arg Asn Asp Leu Glu       225                 2 - #30                 2 - #35                 2 -       #40                                                                               - - Leu Thr Leu Glu Pro Val Tyr Asn Cys Asn Le - #u Gly Cys Phe Ala         Ala                                                                                              245  - #               250  - #               255              - -  - - (2) INFORMATION FOR SEQ ID NO:3:                                      - -      (i) SEQUENCE CHARACTERISTICS:                                                  (A) LENGTH: 794 base - #pairs                                                  (B) TYPE: nucleic acid                                                         (C) STRANDEDNESS: double                                                       (D) TOPOLOGY: linear                                                  - -     (ii) MOLECULE TYPE: cDNA                                               - -     (ix) FEATURE:                                                                   (A) NAME/KEY: CDS                                                              (B) LOCATION: 36..794                                                 - -     (ix) FEATURE:                                                                   (A) NAME/KEY: misc.sub.-- - #feature                                           (B) LOCATION: 1..794                                                           (D) OTHER INFORMATION: - #/note= "product = Brassica oleracea                       AP1."                                                            - -     (xi) SEQUENCE DESCRIPTION: SEQ ID NO:3:                                - - TCTTAGAGGA AATAGTTCCT TTAAAAGGGA TAAAA ATG GGA AGG - #GGT AGG GTT             53                                                                                           - #                  - #   Met Gly Arg Gly Arg Val                             - #                  - #     1             - #  5             - - CAG TTG AAG AGG ATA GAA AAC AAG ATC AAT AG - #A CAA GTG ACA TTC TCG           101                                                                        Gln Leu Lys Arg Ile Glu Asn Lys Ile Asn Ar - #g Gln Val Thr Phe Ser                         10     - #             15     - #             20                   - - AAA AGA AGA GCT GGT CTT ATG AAG AAA GCT CA - #T GAG ATC TCT GTT CTG           149                                                                        Lys Arg Arg Ala Gly Leu Met Lys Lys Ala Hi - #s Glu Ile Ser Val Leu                     25         - #         30         - #         35                       - - TGT GAT GCT GAA GTT GCG CTT GTT GTC TTC TC - #C CAT AAG GGG AAA CTC           197                                                                        Cys Asp Ala Glu Val Ala Leu Val Val Phe Se - #r His Lys Gly Lys Leu                 40             - #     45             - #     50                           - - TTT GAA TAC TCC ACT GAT TCT TGT ATG GAG AA - #G ATA CTT GAA CGC TAT           245                                                                        Phe Glu Tyr Ser Thr Asp Ser Cys Met Glu Ly - #s Ile Leu Glu Arg Tyr             55                 - # 60                 - # 65                 - # 70        - - GAG AGA TAC TCT TAC GCC GAG AGA CAG CTT AT - #A GCA CCT GAG TCC GAC           293                                                                        Glu Arg Tyr Ser Tyr Ala Glu Arg Gln Leu Il - #e Ala Pro Glu Ser Asp                             75 - #                 80 - #                 85               - - TCC AAT ACG AAC TGG TCG ATG GAG TAT AAT AG - #G CTT AAG GCT AAG ATT           341                                                                        Ser Asn Thr Asn Trp Ser Met Glu Tyr Asn Ar - #g Leu Lys Ala Lys Ile                         90     - #             95     - #            100                   - - GAG CTT TTG GAG AGA AAC CAG AGG CAC TAT CT - #T GGG GAA GAC TTG CAA           389                                                                        Glu Leu Leu Glu Arg Asn Gln Arg His Tyr Le - #u Gly Glu Asp Leu Gln                    105          - #       110          - #       115                       - - GCA ATG AGC CCT AAG GAA CTC CAG AAT CTA GA - #G CAA CAG CTT GAT ACT           437                                                                        Ala Met Ser Pro Lys Glu Leu Gln Asn Leu Gl - #u Gln Gln Leu Asp Thr                120              - #   125              - #   130                           - - GCT CTT AAG CAC ATC CGC TCT AGA AAA AAC CA - #A CTT ATG TAC GAC TCC           485                                                                        Ala Leu Lys His Ile Arg Ser Arg Lys Asn Gl - #n Leu Met Tyr Asp Ser            135                 1 - #40                 1 - #45                 1 -       #50                                                                               - - ATC AAT GAG CTC CAA AGA AAG GAG AAA GCC AT - #A CAG GAA CAA AAC         AGC      533                                                                     Ile Asn Glu Leu Gln Arg Lys Glu Lys Ala Il - #e Gln Glu Gln Asn Ser                           155  - #               160  - #               165               - - ATG CTT TCC AAG CAG ATT AAG GAG AGG GAA AA - #C GTT CTT AGG GCG CAA           581                                                                        Met Leu Ser Lys Gln Ile Lys Glu Arg Glu As - #n Val Leu Arg Ala Gln                        170      - #           175      - #           180                   - - CAA GAG CAA TGG GAC GAG CAG AAC CAT GGC CA - #T AAT ATG CCT CCG CCT           629                                                                        Gln Glu Gln Trp Asp Glu Gln Asn His Gly Hi - #s Asn Met Pro Pro Pro                    185          - #       190          - #       195                       - - CCA CCC CCG CAG CAG CAT CAA ATC CAG CAT CC - #T TAC ATG CTC TCT CAT           677                                                                        Pro Pro Pro Gln Gln His Gln Ile Gln His Pr - #o Tyr Met Leu Ser His                200              - #   205              - #   210                           - - CAG CCA TCT CCT TTT CTC AAC ATG GGG GGG CT - #G TAT CAA GAA GAA GAT           725                                                                        Gln Pro Ser Pro Phe Leu Asn Met Gly Gly Le - #u Tyr Gln Glu Glu Asp            215                 2 - #20                 2 - #25                 2 -       #30                                                                               - - CAA ATG GCA ATG AGG AGG AAC GAT CTC GAT CT - #G TCT CTT GAA CCC         GGT      773                                                                     Gln Met Ala Met Arg Arg Asn Asp Leu Asp Le - #u Ser Leu Glu Pro Gly                           235  - #               240  - #               245               - - TAT AAC TGC AAT CTC GGC TGC       - #                  - #                      794                                                                      Tyr Asn Cys Asn Leu Gly Cys                                                                250                                                                 - -  - - (2) INFORMATION FOR SEQ ID NO:4:                                      - -      (i) SEQUENCE CHARACTERISTICS:                                                  (A) LENGTH: 253 amino - #acids                                                 (B) TYPE: amino acid                                                           (D) TOPOLOGY: linear                                                  - -     (ii) MOLECULE TYPE: protein                                            - -     (xi) SEQUENCE DESCRIPTION: SEQ ID NO:4:                                - - Met Gly Arg Gly Arg Val Gln Leu Lys Arg Il - #e Glu Asn Lys Ile Asn         1               5 - #                 10 - #                 15               - - Arg Gln Val Thr Phe Ser Lys Arg Arg Ala Gl - #y Leu Met Lys Lys Ala                    20     - #             25     - #             30                   - - His Glu Ile Ser Val Leu Cys Asp Ala Glu Va - #l Ala Leu Val Val Phe                35         - #         40         - #         45                       - - Ser His Lys Gly Lys Leu Phe Glu Tyr Ser Th - #r Asp Ser Cys Met Glu            50             - #     55             - #     60                           - - Lys Ile Leu Glu Arg Tyr Glu Arg Tyr Ser Ty - #r Ala Glu Arg Gln Leu        65                 - # 70                 - # 75                 - # 80        - - Ile Ala Pro Glu Ser Asp Ser Asn Thr Asn Tr - #p Ser Met Glu Tyr Asn                        85 - #                 90 - #                 95               - - Arg Leu Lys Ala Lys Ile Glu Leu Leu Glu Ar - #g Asn Gln Arg His Tyr                   100      - #           105      - #           110                   - - Leu Gly Glu Asp Leu Gln Ala Met Ser Pro Ly - #s Glu Leu Gln Asn Leu               115          - #       120          - #       125                       - - Glu Gln Gln Leu Asp Thr Ala Leu Lys His Il - #e Arg Ser Arg Lys Asn           130              - #   135              - #   140                           - - Gln Leu Met Tyr Asp Ser Ile Asn Glu Leu Gl - #n Arg Lys Glu Lys Ala       145                 1 - #50                 1 - #55                 1 -       #60                                                                               - - Ile Gln Glu Gln Asn Ser Met Leu Ser Lys Gl - #n Ile Lys Glu Arg         Glu                                                                                              165  - #               170  - #               175              - - Asn Val Leu Arg Ala Gln Gln Glu Gln Trp As - #p Glu Gln Asn His Gly                   180      - #           185      - #           190                   - - His Asn Met Pro Pro Pro Pro Pro Pro Gln Gl - #n His Gln Ile Gln His               195          - #       200          - #       205                       - - Pro Tyr Met Leu Ser His Gln Pro Ser Pro Ph - #e Leu Asn Met Gly Gly           210              - #   215              - #   220                           - - Leu Tyr Gln Glu Glu Asp Gln Met Ala Met Ar - #g Arg Asn Asp Leu Asp       225                 2 - #30                 2 - #35                 2 -       #40                                                                               - - Leu Ser Leu Glu Pro Gly Tyr Asn Cys Asn Le - #u Gly Cys                                   245  - #               250                                      - -  - - (2) INFORMATION FOR SEQ ID NO:5:                                      - -      (i) SEQUENCE CHARACTERISTICS:                                                  (A) LENGTH: 768 base - #pairs                                                  (B) TYPE: nucleic acid                                                         (C) STRANDEDNESS: double                                                       (D) TOPOLOGY: linear                                                  - -     (ii) MOLECULE TYPE: cDNA                                               - -     (ix) FEATURE:                                                                   (A) NAME/KEY: CDS                                                              (B) LOCATION: 1..766                                                  - -     (ix) FEATURE:                                                                   (A) NAME/KEY: misc.sub.-- - #feature                                           (B) LOCATION: 1..768                                                           (D) OTHER INFORMATION: - #/note= "product = Brassica oleracea                      var. botr - #ytis AP1."                                          - -     (xi) SEQUENCE DESCRIPTION: SEQ ID NO:5:                                - - ATG GGA AGG GGT AGG GTT CAG TTG AAG AGG AT - #A GAA AAC AAG ATC AAT            48                                                                        Met Gly Arg Gly Arg Val Gln Leu Lys Arg Il - #e Glu Asn Lys Ile Asn              1               5 - #                 10 - #                 15               - - AGA CAA GTG ACA TTC TCG AAA AGA AGA GCT GG - #T CTT ATG AAG AAA GCT            96                                                                        Arg Gln Val Thr Phe Ser Lys Arg Arg Ala Gl - #y Leu Met Lys Lys Ala                         20     - #             25     - #             30                   - - CAT GAG ATC TCT GTT CTG TGT GAT GCT GAA GT - #T GCG CTT GTT GTC TTC           144                                                                        His Glu Ile Ser Val Leu Cys Asp Ala Glu Va - #l Ala Leu Val Val Phe                     35         - #         40         - #         45                       - - TCC CAT AAG GGG AAA CTC TTT GAA TAC CCC AC - #T GAT TCT TGT ATG GAG           192                                                                        Ser His Lys Gly Lys Leu Phe Glu Tyr Pro Th - #r Asp Ser Cys Met Glu                 50             - #     55             - #     60                           - - GAG ATA CTT GAA CGC TAT GAG AGA TAC TCT TA - #C GCC GAG AGA CAG CTT           240                                                                        Glu Ile Leu Glu Arg Tyr Glu Arg Tyr Ser Ty - #r Ala Glu Arg Gln Leu             65                 - # 70                 - # 75                 - # 80        - - ATA GCA CCT GAG TCC GAC TCC AAT ACG AAC TG - #G TCG ATG GAG TAT AAT           288                                                                        Ile Ala Pro Glu Ser Asp Ser Asn Thr Asn Tr - #p Ser Met Glu Tyr Asn                             85 - #                 90 - #                 95               - - AGG CTT AAG GCT AAG ATT GAG CTT TTG GAG AG - #A AAC CAG AGG CAC TAT           336                                                                        Arg Leu Lys Ala Lys Ile Glu Leu Leu Glu Ar - #g Asn Gln Arg His Tyr                        100      - #           105      - #           110                   - - CTT GGG GAA GAC TTG CAA GCA ATG AGC CCT AA - #G GAA CTC CAG AAT CTA           384                                                                        Leu Gly Glu Asp Leu Gln Ala Met Ser Pro Ly - #s Glu Leu Gln Asn Leu                    115          - #       120          - #       125                       - - GAG CAA CAG CTT GAT ACT GCT CTT AAG CAC AT - #C CGC TCT AGA AAA AAC           432                                                                        Glu Gln Gln Leu Asp Thr Ala Leu Lys His Il - #e Arg Ser Arg Lys Asn                130              - #   135              - #   140                           - - CAA CTT ATG TAC GAC TCC ATC AAT GAG CTC CA - #A AGA AAG GAG AAA GCC           480                                                                        Gln Leu Met Tyr Asp Ser Ile Asn Glu Leu Gl - #n Arg Lys Glu Lys Ala            145                 1 - #50                 1 - #55                 1 -       #60                                                                               - - ATA CAG GAA CAA AAC AGC ATG CTT TCC AAG CA - #G ATT AAG GAG AGG         GAA      528                                                                     Ile Gln Glu Gln Asn Ser Met Leu Ser Lys Gl - #n Ile Lys Glu Arg Glu                           165  - #               170  - #               175               - - AAC GTT CTT AGG GCG CAA CAA GAG CAA TGG GA - #C GAG CAG AAC CAT GGC           576                                                                        Asn Val Leu Arg Ala Gln Gln Glu Gln Trp As - #p Glu Gln Asn His Gly                        180      - #           185      - #           190                   - - CAT AAT ATG CCT CCG CCT CCA CCC CCG CAG CA - #G CAT CAA ATC CAG CAT           624                                                                        His Asn Met Pro Pro Pro Pro Pro Pro Gln Gl - #n His Gln Ile Gln His                    195          - #       200          - #       205                       - - CCT TAC ATG CTC TCT CAT CAG CCA TCT CCT TT - #T CTC AAC ATG GGA GGG           672                                                                        Pro Tyr Met Leu Ser His Gln Pro Ser Pro Ph - #e Leu Asn Met Gly Gly                210              - #   215              - #   220                           - - CTG TAT CAA GAA GAA GAT CAA ATG GCA ATG AG - #G AGG AAC GAT CTC GAT           720                                                                        Leu Tyr Gln Glu Glu Asp Gln Met Ala Met Ar - #g Arg Asn Asp Leu Asp            225                 2 - #30                 2 - #35                 2 -       #40                                                                               - - CTG TCT CTT GAA CCC GTT TAC AAC TGC AAC CT - #T GGC CGT CGC TGC T             766                                                                       Leu Ser Leu Glu Pro Val Tyr Asn Cys Asn Le - #u Gly Arg Arg Cys                                245  - #               250  - #               255               - - GA                  - #                  - #                  - #                  768                                                                    - -  - - (2) INFORMATION FOR SEQ ID NO:6:                                      - -      (i) SEQUENCE CHARACTERISTICS:                                                  (A) LENGTH: 255 amino - #acids                                                 (B) TYPE: amino acid                                                           (D) TOPOLOGY: linear                                                  - -     (ii) MOLECULE TYPE: protein                                            - -     (xi) SEQUENCE DESCRIPTION: SEQ ID NO:6:                                - - Met Gly Arg Gly Arg Val Gln Leu Lys Arg Il - #e Glu Asn Lys Ile Asn         1               5 - #                 10 - #                 15               - - Arg Gln Val Thr Phe Ser Lys Arg Arg Ala Gl - #y Leu Met Lys Lys Ala                    20     - #             25     - #             30                   - - His Glu Ile Ser Val Leu Cys Asp Ala Glu Va - #l Ala Leu Val Val Phe                35         - #         40         - #         45                       - - Ser His Lys Gly Lys Leu Phe Glu Tyr Pro Th - #r Asp Ser Cys Met Glu            50             - #     55             - #     60                           - - Glu Ile Leu Glu Arg Tyr Glu Arg Tyr Ser Ty - #r Ala Glu Arg Gln Leu        65                 - # 70                 - # 75                 - # 80        - - Ile Ala Pro Glu Ser Asp Ser Asn Thr Asn Tr - #p Ser Met Glu Tyr Asn                        85 - #                 90 - #                 95               - - Arg Leu Lys Ala Lys Ile Glu Leu Leu Glu Ar - #g Asn Gln Arg His Tyr                   100      - #           105      - #           110                   - - Leu Gly Glu Asp Leu Gln Ala Met Ser Pro Ly - #s Glu Leu Gln Asn Leu               115          - #       120          - #       125                       - - Glu Gln Gln Leu Asp Thr Ala Leu Lys His Il - #e Arg Ser Arg Lys Asn           130              - #   135              - #   140                           - - Gln Leu Met Tyr Asp Ser Ile Asn Glu Leu Gl - #n Arg Lys Glu Lys Ala       145                 1 - #50                 1 - #55                 1 -       #60                                                                               - - Ile Gln Glu Gln Asn Ser Met Leu Ser Lys Gl - #n Ile Lys Glu Arg         Glu                                                                                              165  - #               170  - #               175              - - Asn Val Leu Arg Ala Gln Gln Glu Gln Trp As - #p Glu Gln Asn His Gly                   180      - #           185      - #           190                   - - His Asn Met Pro Pro Pro Pro Pro Pro Gln Gl - #n His Gln Ile Gln His               195          - #       200          - #       205                       - - Pro Tyr Met Leu Ser His Gln Pro Ser Pro Ph - #e Leu Asn Met Gly Gly           210              - #   215              - #   220                           - - Leu Tyr Gln Glu Glu Asp Gln Met Ala Met Ar - #g Arg Asn Asp Leu Asp       225                 2 - #30                 2 - #35                 2 -       #40                                                                               - - Leu Ser Leu Glu Pro Val Tyr Asn Cys Asn Le - #u Gly Arg Arg Cys                          245  - #               250  - #               255               - -  - - (2) INFORMATION FOR SEQ ID NO:7:                                      - -      (i) SEQUENCE CHARACTERISTICS:                                                  (A) LENGTH: 1345 base - #pairs                                                 (B) TYPE: nucleic acid                                                         (C) STRANDEDNESS: double                                                       (D) TOPOLOGY: linear                                                  - -     (ii) MOLECULE TYPE: cDNA                                               - -     (ix) FEATURE:                                                                   (A) NAME/KEY: CDS                                                              (B) LOCATION: 149..968                                                - -     (ix) FEATURE:                                                                   (A) NAME/KEY: misc.sub.-- - #feature                                           (B) LOCATION: 1..1345                                                          (D) OTHER INFORMATION: - #/note= "product = Zea mays AP1."            - -     (xi) SEQUENCE DESCRIPTION: SEQ ID NO:7:                                - - GCACGAGTCC TCCTCCTCCT CGCATCCCAC CCCACCCCAC CTTCTCCTTA AA -              #GCTACCTG     60                                                                  - - CCTACCCGGC GGTTGCGCGC CGCAATCGAT CGACCGGAAG AGAAAGAGCA GC -             #TAGCTAGC    120                                                                  - - TAGCAGATCG GAGCACGGCA ACAAGGCG ATG GGG CGC GGC AAG - #GTA CAG CTG            172                                                                                          - #             Met Gly Arg - #Gly Lys Val Gln Leu                             - #               1   - #            5                        - - AAG CGG ATA GAG AAC AAG ATA AAC CGG CAG GT - #G ACC TTC TCC AAG CGC           220                                                                        Lys Arg Ile Glu Asn Lys Ile Asn Arg Gln Va - #l Thr Phe Ser Lys Arg                 10             - #     15             - #     20                           - - CGG AAC GGC CTG CTC AAG AAG GCG CAC GAG AT - #C TCC GTC CTC TGC GAT           268                                                                        Arg Asn Gly Leu Leu Lys Lys Ala His Glu Il - #e Ser Val Leu Cys Asp             25                 - # 30                 - # 35                 - # 40        - - GCC GAG GTC GCC GTC ATC GTC TTC TCC CCC AA - #G GGC AAG CTC TAC GAG           316                                                                        Ala Glu Val Ala Val Ile Val Phe Ser Pro Ly - #s Gly Lys Leu Tyr Glu                             45 - #                 50 - #                 55               - - TAC GCC ACC GAC TCC CGC ATG GAC AAA ATT CT - #T GAA CGC TAT GAG CGA           364                                                                        Tyr Ala Thr Asp Ser Arg Met Asp Lys Ile Le - #u Glu Arg Tyr Glu Arg                         60     - #             65     - #             70                   - - TAT TCC TAT GCT GAA AAG GCT CTT ATT TCA GC - #T GAA TCT GAA AGT GAG           412                                                                        Tyr Ser Tyr Ala Glu Lys Ala Leu Ile Ser Al - #a Glu Ser Glu Ser Glu                     75         - #         80         - #         85                       - - GGA AAT TGG TGC CAC GAA TAC AGG AAA CTG AA - #G GCC AAA ATT GAG ACC           460                                                                        Gly Asn Trp Cys His Glu Tyr Arg Lys Leu Ly - #s Ala Lys Ile Glu Thr                 90             - #     95             - #    100                           - - ATA CAA AAA TGC CAC AAG CAC CTG ATG GGA GA - #G GAT CTA GAG TCT TTG           508                                                                        Ile Gln Lys Cys His Lys His Leu Met Gly Gl - #u Asp Leu Glu Ser Leu            105                 1 - #10                 1 - #15                 1 -       #20                                                                               - - AAT CCC AAA GAG CTC CAG CAA CTA GAG CAG CA - #G CTG GAT AGC TCA         CTG      556                                                                     Asn Pro Lys Glu Leu Gln Gln Leu Glu Gln Gl - #n Leu Asp Ser Ser Leu                           125  - #               130  - #               135               - - AAG CAC ATC AGA TCA AGG AAG AGC CAC CTT AT - #G GCC GAG TCT ATT TCT           604                                                                        Lys His Ile Arg Ser Arg Lys Ser His Leu Me - #t Ala Glu Ser Ile Ser                        140      - #           145      - #           150                   - - GAG CTA CAG AAG AAG GAG AGG TCA CTG CAG GA - #G GAG AAC AAG GCT CTG           652                                                                        Glu Leu Gln Lys Lys Glu Arg Ser Leu Gln Gl - #u Glu Asn Lys Ala Leu                    155          - #       160          - #       165                       - - CAG AAG GAA CTT GCG GAG AGG CAG AAG GCC GT - #C GCG AGC CGG CAG CAG           700                                                                        Gln Lys Glu Leu Ala Glu Arg Gln Lys Ala Va - #l Ala Ser Arg Gln Gln                170              - #   175              - #   180                           - - CAG CAA CAG CAG CAG GTG CAG TGG GAC CAG CA - #G ACA CAT GCC CAG GCC           748                                                                        Gln Gln Gln Gln Gln Val Gln Trp Asp Gln Gl - #n Thr His Ala Gln Ala            185                 1 - #90                 1 - #95                 2 -       #00                                                                               - - CAG ACA AGC TCA TCA TCG TCC TCC TTC ATG AT - #G AGG CAG GAT CAG         CAG      796                                                                     Gln Thr Ser Ser Ser Ser Ser Ser Phe Met Me - #t Arg Gln Asp Gln Gln                           205  - #               210  - #               215               - - GGA CTG CCG CCT CCA CAC AAC ATC TGC TTC CC - #G CCG TTG ACA ATG GGA           844                                                                        Gly Leu Pro Pro Pro His Asn Ile Cys Phe Pr - #o Pro Leu Thr Met Gly                        220      - #           225      - #           230                   - - GAT AGA GGT GAA GAG CTG GCT GCG GCG GCG GC - #G GCG CAG CAG CAG CAG           892                                                                        Asp Arg Gly Glu Glu Leu Ala Ala Ala Ala Al - #a Ala Gln Gln Gln Gln                    235          - #       240          - #       245                       - - CCA CTG CCG GGG CAG GCG CAA CCG CAG CTC CG - #C ATC GCA GGT CTG CCA           940                                                                        Pro Leu Pro Gly Gln Ala Gln Pro Gln Leu Ar - #g Ile Ala Gly Leu Pro                250              - #   255              - #   260                           - - CCA TGG ATG CTG AGC CAC CTC AAT GCA T AAGG - #AGAGGG TCGATGAACA               988                                                                        Pro Trp Met Leu Ser His Leu Asn Ala                                            265                 2 - #70                                                     - - CATCGACCTC CTCTCTCTCT CTCTCTCGTC ATGGATCATG ACGTACGCGT AC -              #CATATGGT   1048                                                                  - - TGCTGTGCCT GCCCCCATCG ATCGCGAGCA ATGGCACGCT CATGCAAGTG AT -             #CATTGCTC   1108                                                                  - - CCCGTTGGTT AAACCCTAGC CTATGTTCAT GGCGTCAGCA ACTAAGCTAA AC -             #TATTGTTA   1168                                                                  - - TGTTTGCAAG AAAGGGTAAA CCCGCTAGCT GTGTAATCTT GTCCAGCTAT CA -             #GTATGCTT   1228                                                                  - - GTTACTGCCC AGTTACCCTT GAATCTAGCG GCGCTTTTGG TGAGAGGGTG CA -             #GTTTACTT   1288                                                                  - - TAAACATGGT TCGTGACTTG CTGTAAATAG TAGTATTAAT CGATTTGGGC AT - #CTAAA           1345                                                                        - -  - - (2) INFORMATION FOR SEQ ID NO:8:                                      - -      (i) SEQUENCE CHARACTERISTICS:                                                  (A) LENGTH: 273 amino - #acids                                                 (B) TYPE: amino acid                                                           (D) TOPOLOGY: linear                                                  - -     (ii) MOLECULE TYPE: protein                                            - -     (xi) SEQUENCE DESCRIPTION: SEQ ID NO:8:                                - - Met Gly Arg Gly Lys Val Gln Leu Lys Arg Il - #e Glu Asn Lys Ile Asn         1               5 - #                 10 - #                 15               - - Arg Gln Val Thr Phe Ser Lys Arg Arg Asn Gl - #y Leu Leu Lys Lys Ala                    20     - #             25     - #             30                   - - His Glu Ile Ser Val Leu Cys Asp Ala Glu Va - #l Ala Val Ile Val Phe                35         - #         40         - #         45                       - - Ser Pro Lys Gly Lys Leu Tyr Glu Tyr Ala Th - #r Asp Ser Arg Met Asp            50             - #     55             - #     60                           - - Lys Ile Leu Glu Arg Tyr Glu Arg Tyr Ser Ty - #r Ala Glu Lys Ala Leu        65                 - # 70                 - # 75                 - # 80        - - Ile Ser Ala Glu Ser Glu Ser Glu Gly Asn Tr - #p Cys His Glu Tyr Arg                        85 - #                 90 - #                 95               - - Lys Leu Lys Ala Lys Ile Glu Thr Ile Gln Ly - #s Cys His Lys His Leu                   100      - #           105      - #           110                   - - Met Gly Glu Asp Leu Glu Ser Leu Asn Pro Ly - #s Glu Leu Gln Gln Leu               115          - #       120          - #       125                       - - Glu Gln Gln Leu Asp Ser Ser Leu Lys His Il - #e Arg Ser Arg Lys Ser           130              - #   135              - #   140                           - - His Leu Met Ala Glu Ser Ile Ser Glu Leu Gl - #n Lys Lys Glu Arg Ser       145                 1 - #50                 1 - #55                 1 -       #60                                                                               - - Leu Gln Glu Glu Asn Lys Ala Leu Gln Lys Gl - #u Leu Ala Glu Arg         Gln                                                                                              165  - #               170  - #               175              - - Lys Ala Val Ala Ser Arg Gln Gln Gln Gln Gl - #n Gln Gln Val Gln Trp                   180      - #           185      - #           190                   - - Asp Gln Gln Thr His Ala Gln Ala Gln Thr Se - #r Ser Ser Ser Ser Ser               195          - #       200          - #       205                       - - Phe Met Met Arg Gln Asp Gln Gln Gly Leu Pr - #o Pro Pro His Asn Ile           210              - #   215              - #   220                           - - Cys Phe Pro Pro Leu Thr Met Gly Asp Arg Gl - #y Glu Glu Leu Ala Ala       225                 2 - #30                 2 - #35                 2 -       #40                                                                               - - Ala Ala Ala Ala Gln Gln Gln Gln Pro Leu Pr - #o Gly Gln Ala Gln         Pro                                                                                              245  - #               250  - #               255              - - Gln Leu Arg Ile Ala Gly Leu Pro Pro Trp Me - #t Leu Ser His Leu Asn                   260      - #           265      - #           270                   - - Ala                                                                        - -  - - (2) INFORMATION FOR SEQ ID NO:9:                                      - -      (i) SEQUENCE CHARACTERISTICS:                                                  (A) LENGTH: 779 base - #pairs                                                  (B) TYPE: nucleic acid                                                         (C) STRANDEDNESS: double                                                       (D) TOPOLOGY: linear                                                  - -     (ii) MOLECULE TYPE: cDNA                                               - -     (ix) FEATURE:                                                                   (A) NAME/KEY: CDS                                                              (B) LOCATION: 10..775                                                 - -     (ix) FEATURE:                                                                   (A) NAME/KEY: unsure                                                           (B) LOCATION: 778..779                                                         (D) OTHER INFORMATION: - #/note= "N = one or more                                   nucleotides. - #"                                                - -     (ix) FEATURE:                                                                   (A) NAME/KEY: misc.sub.-- - #feature                                           (B) LOCATION: 1..779                                                           (D) OTHER INFORMATION: - #/note= "product = Arabidopsis                             thaliana - #CAL."                                                - -     (xi) SEQUENCE DESCRIPTION: SEQ ID NO:9:                                - - TTAAGAGAA ATG GGA AGG GGT AGG GTT GAA TTG AAG - # AGG ATA GAG AAC              48                                                                                  Met Gly Arg Gly Arg - #Val Glu Leu Lys Arg Ile Glu Asn                           1      - #         5         - #         10                         - - AAG ATC AAT AGA CAA GTG ACA TTC TCG AAA AG - #A AGA ACT GGT CTT TTG            96                                                                        Lys Ile Asn Arg Gln Val Thr Phe Ser Lys Ar - #g Arg Thr Gly Leu Leu                 15             - #     20             - #     25                           - - AAG AAA GCT CAG GAG ATC TCT GTT CTT TGT GA - #T GCC GAG GTT TCC CTT           144                                                                        Lys Lys Ala Gln Glu Ile Ser Val Leu Cys As - #p Ala Glu Val Ser Leu             30                 - # 35                 - # 40                 - # 45        - - ATT GTC TTC TCC CAT AAG GGC AAA TTG TTC GA - #G TAC TCC TCT GAA TCT           192                                                                        Ile Val Phe Ser His Lys Gly Lys Leu Phe Gl - #u Tyr Ser Ser Glu Ser                             50 - #                 55 - #                 60               - - TGC ATG GAG AAG GTA CTA GAA CGC TAC GAG AG - #G TAT TCT TAC GCC GAG           240                                                                        Cys Met Glu Lys Val Leu Glu Arg Tyr Glu Ar - #g Tyr Ser Tyr Ala Glu                         65     - #             70     - #             75                   - - AGA CAG CTG ATT GCA CCT GAC TCT CAC GTT AA - #T GCA CAG ACG AAC TGG           288                                                                        Arg Gln Leu Ile Ala Pro Asp Ser His Val As - #n Ala Gln Thr Asn Trp                     80         - #         85         - #         90                       - - TCA ATG GAG TAT AGC AGG CTT AAG GCC AAG AT - #T GAG CTT TTG GAG AGA           336                                                                        Ser Met Glu Tyr Ser Arg Leu Lys Ala Lys Il - #e Glu Leu Leu Glu Arg                 95             - #    100             - #    105                           - - AAC CAA AGG CAT TAT CTG GGA GAA GAG TTG GA - #A CCA ATG AGC CTC AAG           384                                                                        Asn Gln Arg His Tyr Leu Gly Glu Glu Leu Gl - #u Pro Met Ser Leu Lys            110                 1 - #15                 1 - #20                 1 -       #25                                                                               - - GAT CTC CAA AAT CTG GAG CAG CAG CTT GAG AC - #T GCT CTT AAG CAC         ATT      432                                                                     Asp Leu Gln Asn Leu Glu Gln Gln Leu Glu Th - #r Ala Leu Lys His Ile                           130  - #               135  - #               140               - - CGC TCC AGA AAA AAT CAA CTC ATG AAT GAG TC - #C CTC AAC CAC CTC CAA           480                                                                        Arg Ser Arg Lys Asn Gln Leu Met Asn Glu Se - #r Leu Asn His Leu Gln                        145      - #           150      - #           155                   - - AGA AAG GAG AAG GAG ATA CAG GAG GAA AAC AG - #C ATG CTT ACC AAA CAG           528                                                                        Arg Lys Glu Lys Glu Ile Gln Glu Glu Asn Se - #r Met Leu Thr Lys Gln                    160          - #       165          - #       170                       - - ATA AAG GAG AGG GAA AAC ATC CTA AAG ACA AA - #A CAA ACC CAA TGT GAG           576                                                                        Ile Lys Glu Arg Glu Asn Ile Leu Lys Thr Ly - #s Gln Thr Gln Cys Glu                175              - #   180              - #   185                           - - CAG CTG AAC CGC AGC GTC GAC GAT GTA CCA CA - #G CCA CAA CCA TTT CAA           624                                                                        Gln Leu Asn Arg Ser Val Asp Asp Val Pro Gl - #n Pro Gln Pro Phe Gln            190                 1 - #95                 2 - #00                 2 -       #05                                                                               - - CAC CCC CAT CTT TAC ATG ATC GCT CAT CAG AC - #T TCT CCT TTC CTA         AAT      672                                                                     His Pro His Leu Tyr Met Ile Ala His Gln Th - #r Ser Pro Phe Leu Asn                           210  - #               215  - #               220               - - ATG GGT GGT TTG TAC CAA GGA GAA GAC CAA AC - #G GCG ATG AGG AGG AAC           720                                                                        Met Gly Gly Leu Tyr Gln Gly Glu Asp Gln Th - #r Ala Met Arg Arg Asn                        225      - #           230      - #           235                   - - AAT CTG GAT CTG ACT CTT GAA CCC ATT TAC AA - #T TAC CTT GGC TGT TAC           768                                                                        Asn Leu Asp Leu Thr Leu Glu Pro Ile Tyr As - #n Tyr Leu Gly Cys Tyr                    240          - #       245          - #       250                       - - GCC GCT T GANN             - #                  - #                       - #      779                                                                   Ala Ala                                                                            255                                                                         - -  - - (2) INFORMATION FOR SEQ ID NO:10:                                     - -      (i) SEQUENCE CHARACTERISTICS:                                                  (A) LENGTH: 255 amino - #acids                                                 (B) TYPE: amino acid                                                           (D) TOPOLOGY: linear                                                  - -     (ii) MOLECULE TYPE: protein                                            - -     (xi) SEQUENCE DESCRIPTION: SEQ ID NO:10:                               - - Met Gly Arg Gly Arg Val Glu Leu Lys Arg Il - #e Glu Asn Lys Ile Asn         1               5 - #                 10 - #                 15               - - Arg Gln Val Thr Phe Ser Lys Arg Arg Thr Gl - #y Leu Leu Lys Lys Ala                    20     - #             25     - #             30                   - - Gln Glu Ile Ser Val Leu Cys Asp Ala Glu Va - #l Ser Leu Ile Val Phe                35         - #         40         - #         45                       - - Ser His Lys Gly Lys Leu Phe Glu Tyr Ser Se - #r Glu Ser Cys Met Glu            50             - #     55             - #     60                           - - Lys Val Leu Glu Arg Tyr Glu Arg Tyr Ser Ty - #r Ala Glu Arg Gln Leu        65                 - # 70                 - # 75                 - # 80        - - Ile Ala Pro Asp Ser His Val Asn Ala Gln Th - #r Asn Trp Ser Met Glu                        85 - #                 90 - #                 95               - - Tyr Ser Arg Leu Lys Ala Lys Ile Glu Leu Le - #u Glu Arg Asn Gln Arg                   100      - #           105      - #           110                   - - His Tyr Leu Gly Glu Glu Leu Glu Pro Met Se - #r Leu Lys Asp Leu Gln               115          - #       120          - #       125                       - - Asn Leu Glu Gln Gln Leu Glu Thr Ala Leu Ly - #s His Ile Arg Ser Arg           130              - #   135              - #   140                           - - Lys Asn Gln Leu Met Asn Glu Ser Leu Asn Hi - #s Leu Gln Arg Lys Glu       145                 1 - #50                 1 - #55                 1 -       #60                                                                               - - Lys Glu Ile Gln Glu Glu Asn Ser Met Leu Th - #r Lys Gln Ile Lys         Glu                                                                                              165  - #               170  - #               175              - - Arg Glu Asn Ile Leu Lys Thr Lys Gln Thr Gl - #n Cys Glu Gln Leu Asn                   180      - #           185      - #           190                   - - Arg Ser Val Asp Asp Val Pro Gln Pro Gln Pr - #o Phe Gln His Pro His               195          - #       200          - #       205                       - - Leu Tyr Met Ile Ala His Gln Thr Ser Pro Ph - #e Leu Asn Met Gly Gly           210              - #   215              - #   220                           - - Leu Tyr Gln Gly Glu Asp Gln Thr Ala Met Ar - #g Arg Asn Asn Leu Asp       225                 2 - #30                 2 - #35                 2 -       #40                                                                               - - Leu Thr Leu Glu Pro Ile Tyr Asn Tyr Leu Gl - #y Cys Tyr Ala Ala                          245  - #               250  - #               255               - -  - - (2) INFORMATION FOR SEQ ID NO:11:                                     - -      (i) SEQUENCE CHARACTERISTICS:                                                  (A) LENGTH: 756 base - #pairs                                                  (B) TYPE: nucleic acid                                                         (C) STRANDEDNESS: double                                                       (D) TOPOLOGY: linear                                                  - -     (ii) MOLECULE TYPE: cDNA                                               - -     (ix) FEATURE:                                                                   (A) NAME/KEY: CDS                                                              (B) LOCATION: 1..754                                                  - -     (ix) FEATURE:                                                                   (A) NAME/KEY: misc.sub.-- - #feature                                           (B) LOCATION: 1..756                                                           (D) OTHER INFORMATION: - #/note= "product = Brassica oleracea                       CAL."                                                            - -     (xi) SEQUENCE DESCRIPTION: SEQ ID NO:11:                               - - ATG GGA AGG GGT AGG GTT GAA ATG AAG AGG AT - #A GAG AAC AAG ATC AAC            48                                                                        Met Gly Arg Gly Arg Val Glu Met Lys Arg Il - #e Glu Asn Lys Ile Asn              1               5 - #                 10 - #                 15               - - CGA CAA GTG ACG TTT TCG AAA AGA AGA GCT GG - #T CTT TTG AAG AAA GCC            96                                                                        Arg Gln Val Thr Phe Ser Lys Arg Arg Ala Gl - #y Leu Leu Lys Lys Ala                         20     - #             25     - #             30                   - - CAT GAG ATC TCG ATC CTT TGT GAT GCT GAG GT - #T TCC CTT ATT GTC TTC           144                                                                        His Glu Ile Ser Ile Leu Cys Asp Ala Glu Va - #l Ser Leu Ile Val Phe                     35         - #         40         - #         45                       - - TCC CAT AAG GGG AAA CTG TTC GAG TAC TCG TC - #T GAA TCT TGC ATG GAG           192                                                                        Ser His Lys Gly Lys Leu Phe Glu Tyr Ser Se - #r Glu Ser Cys Met Glu                 50             - #     55             - #     60                           - - AAG GTA CTA GAA CAC TAC GAG AGG TAC TCT TA - #C GCC GAG AAA CAG CTA           240                                                                        Lys Val Leu Glu His Tyr Glu Arg Tyr Ser Ty - #r Ala Glu Lys Gln Leu             65                 - # 70                 - # 75                 - # 80        - - AAA GTT CCA GAC TCT CAC GTC AAT GCA CAA AC - #G AAC TGG TCA GTG GAA           288                                                                        Lys Val Pro Asp Ser His Val Asn Ala Gln Th - #r Asn Trp Ser Val Glu                             85 - #                 90 - #                 95               - - TAT AGC AGG CTT AAG GCT AAG ATT GAG CTT TT - #G GAG AGA AAC CAA AGG           336                                                                        Tyr Ser Arg Leu Lys Ala Lys Ile Glu Leu Le - #u Glu Arg Asn Gln Arg                        100      - #           105      - #           110                   - - CAT TAT CTG GGC GAA GAT TTA GAA TCA ATC AG - #C ATA AAG GAG CTA CAG           384                                                                        His Tyr Leu Gly Glu Asp Leu Glu Ser Ile Se - #r Ile Lys Glu Leu Gln                    115          - #       120          - #       125                       - - AAT CTG GAG CAG CAG CTT GAC ACT TCT CTT AA - #A CAT ATT CGC TCG AGA           432                                                                        Asn Leu Glu Gln Gln Leu Asp Thr Ser Leu Ly - #s His Ile Arg Ser Arg                130              - #   135              - #   140                           - - AAA AAT CAA CTA ATG CAC GAG TCC CTC AAC CA - #C CTC CAA AGA AAG GAG           480                                                                        Lys Asn Gln Leu Met His Glu Ser Leu Asn Hi - #s Leu Gln Arg Lys Glu            145                 1 - #50                 1 - #55                 1 -       #60                                                                               - - AAA GAA ATA CTG GAG GAA AAC AGC ATG CTT GC - #C AAA CAG ATA AGG         GAG      528                                                                     Lys Glu Ile Leu Glu Glu Asn Ser Met Leu Al - #a Lys Gln Ile Arg Glu                           165  - #               170  - #               175               - - AGG GAG AGT ATC CTA AGG ACA CAT CAA AAC CA - #A TCA GAG CAG CAA AAC           576                                                                        Arg Glu Ser Ile Leu Arg Thr His Gln Asn Gl - #n Ser Glu Gln Gln Asn                        180      - #           185      - #           190                   - - CGC AGC CAC CAT GTA GCT CCT CAG CCG CAA CC - #G CAG TTA AAT CCT TAC           624                                                                        Arg Ser His His Val Ala Pro Gln Pro Gln Pr - #o Gln Leu Asn Pro Tyr                    195          - #       200          - #       205                       - - ATG GCA TCA TCT CCT TTC CTA AAT ATG GGT GG - #C ATG TAC CAA GGA GAA           672                                                                        Met Ala Ser Ser Pro Phe Leu Asn Met Gly Gl - #y Met Tyr Gln Gly Glu                210              - #   215              - #   220                           - - TAT CCA ACG GCG GTG AGG AGG AAC CGT CTC GA - #T CTG ACT CTT GAA CCC           720                                                                        Tyr Pro Thr Ala Val Arg Arg Asn Arg Leu As - #p Leu Thr Leu Glu Pro            225                 2 - #30                 2 - #35                 2 -       #40                                                                               - - ATT TAC AAC TGC AAC CTT GGT TAC TTT GCC GC - #A T GA                    - #      756                                                                    Ile Tyr Asn Cys Asn Leu Gly Tyr Phe Ala Al - #a                                                245  - #               250                                      - -  - - (2) INFORMATION FOR SEQ ID NO:12:                                     - -      (i) SEQUENCE CHARACTERISTICS:                                                  (A) LENGTH: 251 amino - #acids                                                 (B) TYPE: amino acid                                                           (D) TOPOLOGY: linear                                                  - -     (ii) MOLECULE TYPE: protein                                            - -     (xi) SEQUENCE DESCRIPTION: SEQ ID NO:12:                               - - Met Gly Arg Gly Arg Val Glu Met Lys Arg Il - #e Glu Asn Lys Ile Asn         1               5 - #                 10 - #                 15               - - Arg Gln Val Thr Phe Ser Lys Arg Arg Ala Gl - #y Leu Leu Lys Lys Ala                    20     - #             25     - #             30                   - - His Glu Ile Ser Ile Leu Cys Asp Ala Glu Va - #l Ser Leu Ile Val Phe                35         - #         40         - #         45                       - - Ser His Lys Gly Lys Leu Phe Glu Tyr Ser Se - #r Glu Ser Cys Met Glu            50             - #     55             - #     60                           - - Lys Val Leu Glu His Tyr Glu Arg Tyr Ser Ty - #r Ala Glu Lys Gln Leu        65                 - # 70                 - # 75                 - # 80        - - Lys Val Pro Asp Ser His Val Asn Ala Gln Th - #r Asn Trp Ser Val Glu                        85 - #                 90 - #                 95               - - Tyr Ser Arg Leu Lys Ala Lys Ile Glu Leu Le - #u Glu Arg Asn Gln Arg                   100      - #           105      - #           110                   - - His Tyr Leu Gly Glu Asp Leu Glu Ser Ile Se - #r Ile Lys Glu Leu Gln               115          - #       120          - #       125                       - - Asn Leu Glu Gln Gln Leu Asp Thr Ser Leu Ly - #s His Ile Arg Ser Arg           130              - #   135              - #   140                           - - Lys Asn Gln Leu Met His Glu Ser Leu Asn Hi - #s Leu Gln Arg Lys Glu       145                 1 - #50                 1 - #55                 1 -       #60                                                                               - - Lys Glu Ile Leu Glu Glu Asn Ser Met Leu Al - #a Lys Gln Ile Arg         Glu                                                                                              165  - #               170  - #               175              - - Arg Glu Ser Ile Leu Arg Thr His Gln Asn Gl - #n Ser Glu Gln Gln Asn                   180      - #           185      - #           190                   - - Arg Ser His His Val Ala Pro Gln Pro Gln Pr - #o Gln Leu Asn Pro Tyr               195          - #       200          - #       205                       - - Met Ala Ser Ser Pro Phe Leu Asn Met Gly Gl - #y Met Tyr Gln Gly Glu           210              - #   215              - #   220                           - - Tyr Pro Thr Ala Val Arg Arg Asn Arg Leu As - #p Leu Thr Leu Glu Pro       225                 2 - #30                 2 - #35                 2 -       #40                                                                               - - Ile Tyr Asn Cys Asn Leu Gly Tyr Phe Ala Al - #a                                           245  - #               250                                      - -  - - (2) INFORMATION FOR SEQ ID NO:13:                                     - -      (i) SEQUENCE CHARACTERISTICS:                                                  (A) LENGTH: 756 base - #pairs                                                  (B) TYPE: nucleic acid                                                         (C) STRANDEDNESS: double                                                       (D) TOPOLOGY: linear                                                  - -     (ii) MOLECULE TYPE: cDNA                                               - -     (ix) FEATURE:                                                                   (A) NAME/KEY: CDS                                                              (B) LOCATION: 1..451                                                  - -     (ix) FEATURE:                                                                   (A) NAME/KEY: misc.sub.-- - #feature                                           (B) LOCATION: 1..756                                                           (D) OTHER INFORMATION: - #/note= "product = Brassica oleracea                      var. botr - #ytis CAL."                                          - -     (xi) SEQUENCE DESCRIPTION: SEQ ID NO:13:                               - - ATG GGA AGG GGT AGG GTT GAA ATG AAG AGG AT - #A GAG AAC AAG ATC AAC            48                                                                        Met Gly Arg Gly Arg Val Glu Met Lys Arg Il - #e Glu Asn Lys Ile Asn              1               5 - #                 10 - #                 15               - - AGA CAA GTG ACG TTT TCG AAA AGA AGA GCT GG - #T CTT TTG AAG AAA GCC            96                                                                        Arg Gln Val Thr Phe Ser Lys Arg Arg Ala Gl - #y Leu Leu Lys Lys Ala                         20     - #             25     - #             30                   - - CAT GAG ATC TCG ATT CTT TGT GAT GCT GAG GT - #T TCC CTT ATT GTC TTC           144                                                                        His Glu Ile Ser Ile Leu Cys Asp Ala Glu Va - #l Ser Leu Ile Val Phe                     35         - #         40         - #         45                       - - TCC CAT AAG GGG AAA CTG TTC GAG TAC TCG TC - #T GAA TCT TGC ATG GAG           192                                                                        Ser His Lys Gly Lys Leu Phe Glu Tyr Ser Se - #r Glu Ser Cys Met Glu                 50             - #     55             - #     60                           - - AAG GTA CTA GAA CGC TAC GAG AGG TAC TCT TA - #C GCC GAG AAA CAG CTA           240                                                                        Lys Val Leu Glu Arg Tyr Glu Arg Tyr Ser Ty - #r Ala Glu Lys Gln Leu             65                 - # 70                 - # 75                 - # 80        - - AAA GCT CCA GAC TCT CAC GTC AAT GCA CAA AC - #G AAC TGG TCA ATG GAA           288                                                                        Lys Ala Pro Asp Ser His Val Asn Ala Gln Th - #r Asn Trp Ser Met Glu                             85 - #                 90 - #                 95               - - TAT AGC AGG CTT AAG GCT AAG ATT GAG CTT TG - #G GAG AGG AAC CAA AGG           336                                                                        Tyr Ser Arg Leu Lys Ala Lys Ile Glu Leu Tr - #p Glu Arg Asn Gln Arg                        100      - #           105      - #           110                   - - CAT TAT CTG GGA GAA GAT TTA GAA TCA ATC AG - #C ATA AAG GAG CTA CAG           384                                                                        His Tyr Leu Gly Glu Asp Leu Glu Ser Ile Se - #r Ile Lys Glu Leu Gln                    115          - #       120          - #       125                       - - AAT CTG GAG CAG CAG CTT GAC ACT TCT CTT AA - #A CAT ATT CGC TCC AGA           432                                                                        Asn Leu Glu Gln Gln Leu Asp Thr Ser Leu Ly - #s His Ile Arg Ser Arg                130              - #   135              - #   140                           - - AAA AAT CAA CTA ATG CAC T AGTCCCTCAA CCACCTCCAA - #AGAAAGGAGA                481                                                                         Lys Asn Gln Leu Met His                                                        145                 1 - #50                                                     - - AAGAAATACT GGAGGAAAAC AGCATGCTTG CCAAACAGAT AAAGGAGAGG GA -              #GAGTATCC    541                                                                  - - TAAGGACACA TCAAAACCAA TCAGAGCAGC AAAACCGCAG CCACCATGTA GC -             #TCCTCAGC    601                                                                  - - CGCAACCGCA GTTAAATCCT TACATGGCAT CATCTCCTTT CCTAAATATG GG -             #TGGCATGT    661                                                                  - - ACCAAGGAGA ATATCCAACG GCGGTGAGGA GGAACCGTCT CGATCTGACT CT -             #TGAACCCA    721                                                                  - - TTTACAACTG CAACCTTGGT TACTTTGCCG CATGA       - #                        - #      756                                                                      - -  - - (2) INFORMATION FOR SEQ ID NO:14:                                     - -      (i) SEQUENCE CHARACTERISTICS:                                                  (A) LENGTH: 150 amino - #acids                                                 (B) TYPE: amino acid                                                           (D) TOPOLOGY: linear                                                  - -     (ii) MOLECULE TYPE: protein                                            - -     (xi) SEQUENCE DESCRIPTION: SEQ ID NO:14:                               - - Met Gly Arg Gly Arg Val Glu Met Lys Arg Il - #e Glu Asn Lys Ile         Asn                                                                                1               5 - #                 10 - #                 15              - - Arg Gln Val Thr Phe Ser Lys Arg Arg Ala Gl - #y Leu Leu Lys Lys Ala                    20     - #             25     - #             30                   - - His Glu Ile Ser Ile Leu Cys Asp Ala Glu Va - #l Ser Leu Ile Val Phe                35         - #         40         - #         45                       - - Ser His Lys Gly Lys Leu Phe Glu Tyr Ser Se - #r Glu Ser Cys Met Glu            50             - #     55             - #     60                           - - Lys Val Leu Glu Arg Tyr Glu Arg Tyr Ser Ty - #r Ala Glu Lys Gln Leu        65                 - # 70                 - # 75                 - # 80        - - Lys Ala Pro Asp Ser His Val Asn Ala Gln Th - #r Asn Trp Ser Met Glu                        85 - #                 90 - #                 95               - - Tyr Ser Arg Leu Lys Ala Lys Ile Glu Leu Tr - #p Glu Arg Asn Gln Arg                   100      - #           105      - #           110                   - - His Tyr Leu Gly Glu Asp Leu Glu Ser Ile Se - #r Ile Lys Glu Leu Gln               115          - #       120          - #       125                       - - Asn Leu Glu Gln Gln Leu Asp Thr Ser Leu Ly - #s His Ile Arg Ser Arg           130              - #   135              - #   140                           - - Lys Asn Gln Leu Met His                                                   145                 1 - #50                                                     - -  - - (2) INFORMATION FOR SEQ ID NO:15:                                     - -      (i) SEQUENCE CHARACTERISTICS:                                                  (A) LENGTH: 1500 base - #pairs                                                 (B) TYPE: nucleic acid                                                         (C) STRANDEDNESS: double                                                       (D) TOPOLOGY: linear                                                  - -     (ii) MOLECULE TYPE: cDNA                                               - -     (ix) FEATURE:                                                                   (A) NAME/KEY: CDS                                                              (B) LOCATION: 72..1343                                                - -     (ix) FEATURE:                                                                   (A) NAME/KEY: misc.sub.-- - #feature                                           (B) LOCATION: 1..1500                                                          (D) OTHER INFORMATION: - #/note= "product = Arabidopsis                             thaliana - #LEAFY (LFY)."                                        - -     (xi) SEQUENCE DESCRIPTION: SEQ ID NO:15:                               - - AAAGCAATCT GCTCAAAAGA GTAAAGAAAG AGAGAAAAAG AGAGTGATAG AG -              #AGAGAGAG     60                                                                  - - AAAAATAGAT T ATG GAT CCT GAA GGT TTC ACG AGT - #GGC TTA TTC CGG         TGG     110                                                                                   Met Asp Pro - #Glu Gly Phe Thr Ser Gly Leu Phe Arg Trp                          1   - #            5      - #            10                      - - AAC CCA ACG AGA GCA TTG GTT CAA GCA CCA CC - #T CCG GTT CCA CCT CCG           158                                                                        Asn Pro Thr Arg Ala Leu Val Gln Ala Pro Pr - #o Pro Val Pro Pro Pro                 15             - #     20             - #     25                           - - CTG CAG CAA CAG CCG GTG ACA CCG CAG ACG GC - #T GCT TTT GGG ATG CGA           206                                                                        Leu Gln Gln Gln Pro Val Thr Pro Gln Thr Al - #a Ala Phe Gly Met Arg             30                 - # 35                 - # 40                 - # 45        - - CTT GGT GGT TTA GAG GGA CTA TTC GGT CCA TA - #C GGT ATA CGT TTC TAC           254                                                                        Leu Gly Gly Leu Glu Gly Leu Phe Gly Pro Ty - #r Gly Ile Arg Phe Tyr                             50 - #                 55 - #                 60               - - ACG GCG GCG AAG ATA GCG GAG TTA GGT TTT AC - #G GCG AGC ACG CTT GTG           302                                                                        Thr Ala Ala Lys Ile Ala Glu Leu Gly Phe Th - #r Ala Ser Thr Leu Val                         65     - #             70     - #             75                   - - GGT ATG AAG GAC GAG GAG CTT GAA GAG ATG AT - #G AAT AGT CTC TCT CAT           350                                                                        Gly Met Lys Asp Glu Glu Leu Glu Glu Met Me - #t Asn Ser Leu Ser His                     80         - #         85         - #         90                       - - ATC TTT CGT TGG GAG CTT CTT GTT GGT GAA CG - #G TAC GGT ATC AAA GCT           398                                                                        Ile Phe Arg Trp Glu Leu Leu Val Gly Glu Ar - #g Tyr Gly Ile Lys Ala                 95             - #    100             - #    105                           - - GCC GTT AGA GCT GAA CGG AGA CGA TTG CAA GA - #A GAG GAG GAA GAG GAA           446                                                                        Ala Val Arg Ala Glu Arg Arg Arg Leu Gln Gl - #u Glu Glu Glu Glu Glu            110                 1 - #15                 1 - #20                 1 -       #25                                                                               - - TCT TCT AGA CGC CGT CAT TTG CTA CTC TCC GC - #C GCT GGT GAT TCC         GGT      494                                                                     Ser Ser Arg Arg Arg His Leu Leu Leu Ser Al - #a Ala Gly Asp Ser Gly                           130  - #               135  - #               140               - - ACT CAT CAC GCT CTT GAT GCT CTC TCC CAA GA - #A GAT GAT TGG ACA GGG           542                                                                        Thr His His Ala Leu Asp Ala Leu Ser Gln Gl - #u Asp Asp Trp Thr Gly                        145      - #           150      - #           155                   - - TTA TCT GAG GAA CCG GTG CAG CAA CAA GAC CA - #G ACT GAT GCG GCG GGG           590                                                                        Leu Ser Glu Glu Pro Val Gln Gln Gln Asp Gl - #n Thr Asp Ala Ala Gly                    160          - #       165          - #       170                       - - AAT AAC GGC GGA GGA GGA AGT GGT TAC TGG GA - #C GCA GGT CAA GGA AAG           638                                                                        Asn Asn Gly Gly Gly Gly Ser Gly Tyr Trp As - #p Ala Gly Gln Gly Lys                175              - #   180              - #   185                           - - ATG AAG AAG CAA CAG CAG CAG AGA CGG AGA AA - #G AAA CCA ATG CTG ACG           686                                                                        Met Lys Lys Gln Gln Gln Gln Arg Arg Arg Ly - #s Lys Pro Met Leu Thr            190                 1 - #95                 2 - #00                 2 -       #05                                                                               - - TCA GTG GAA ACC GAC GAA GAC GTC AAC GAA GG - #T GAG GAT GAC GAC         GGG      734                                                                     Ser Val Glu Thr Asp Glu Asp Val Asn Glu Gl - #y Glu Asp Asp Asp Gly                           210  - #               215  - #               220               - - ATG GAT AAC GGC AAC GGA GGT AGT GGT TTG GG - #G ACA GAG AGA CAG AGG           782                                                                        Met Asp Asn Gly Asn Gly Gly Ser Gly Leu Gl - #y Thr Glu Arg Gln Arg                        225      - #           230      - #           235                   - - GAG CAT CCG TTT ATC GTA ACG GAG CCT GGG GA - #A GTG GCA CGT GGC AAA           830                                                                        Glu His Pro Phe Ile Val Thr Glu Pro Gly Gl - #u Val Ala Arg Gly Lys                    240          - #       245          - #       250                       - - AAG AAC GGC TTA GAT TAT CTG TTC CAC TTG TA - #C GAA CAA TGC CGT GAG           878                                                                        Lys Asn Gly Leu Asp Tyr Leu Phe His Leu Ty - #r Glu Gln Cys Arg Glu                255              - #   260              - #   265                           - - TTC CTT CTT CAG GTC CAG ACA ATT GCT AAA GA - #C CGT GGC GAA AAA TGC           926                                                                        Phe Leu Leu Gln Val Gln Thr Ile Ala Lys As - #p Arg Gly Glu Lys Cys            270                 2 - #75                 2 - #80                 2 -       #85                                                                               - - CCC ACC AAG GTG ACG AAC CAA GTA TTC AGG TA - #C GCG AAG AAA TCA         GGA      974                                                                     Pro Thr Lys Val Thr Asn Gln Val Phe Arg Ty - #r Ala Lys Lys Ser Gly                           290  - #               295  - #               300               - - GCG AGT TAC ATA AAC AAG CCT AAA ATG CGA CA - #C TAC GTT CAC TGT TAC          1022                                                                        Ala Ser Tyr Ile Asn Lys Pro Lys Met Arg Hi - #s Tyr Val His Cys Tyr                        305      - #           310      - #           315                   - - GCT CTC CAC TGC CTA GAC GAA GAA GCT TCA AA - #T GCT CTC AGA AGA GCG          1070                                                                        Ala Leu His Cys Leu Asp Glu Glu Ala Ser As - #n Ala Leu Arg Arg Ala                    320          - #       325          - #       330                       - - TTT AAA GAA CGC GGT GAG AAC GTT GGC TCA TG - #G CGT CAG GCT TGT TAC          1118                                                                        Phe Lys Glu Arg Gly Glu Asn Val Gly Ser Tr - #p Arg Gln Ala Cys Tyr                335              - #   340              - #   345                           - - AAG CCA CTT GTG AAC ATC GCT TGT CGT CAT GG - #C TGG GAT ATA GAC GCC          1166                                                                        Lys Pro Leu Val Asn Ile Ala Cys Arg His Gl - #y Trp Asp Ile Asp Ala            350                 3 - #55                 3 - #60                 3 -       #65                                                                               - - GTC TTT AAC GCT CAT CCT CGT CTC TCT ATT TG - #G TAT GTT CCA ACA         AAG     1214                                                                     Val Phe Asn Ala His Pro Arg Leu Ser Ile Tr - #p Tyr Val Pro Thr Lys                           370  - #               375  - #               380               - - CTG CGT CAG CTT TGC CAT TTG GAG CGG AAC AA - #T GCG GTT GCT GCG GCT          1262                                                                        Leu Arg Gln Leu Cys His Leu Glu Arg Asn As - #n Ala Val Ala Ala Ala                        385      - #           390      - #           395                   - - GCG GCT TTA GTT GGC GGT ATT AGC TGT ACC GG - #A TCG TCG ACG TCT GGA          1310                                                                        Ala Ala Leu Val Gly Gly Ile Ser Cys Thr Gl - #y Ser Ser Thr Ser Gly                    400          - #       405          - #       410                       - - CGT GGT GGA TGC GGC GGC GAC GAC TTG CGT TT - #C TAGTTTGGTT TGGGTAGTT     G   1363                                                                        Arg Gly Gly Cys Gly Gly Asp Asp Leu Arg Ph - #e                                    415              - #   420                                                  - - TGGTTTGTTT AGTCGTTATC CTAATTAACT ATTAGTCTTT AATTTAGTCT TC -              #TTGGCTAA   1423                                                                  - - TTTATTTTTC TTTTTTTGTC AAAACCTTTA ATTTGTTATG GCTAATTTGT TA -             #TACACGCA   1483                                                                  - - GTTTTCTTAA TGCGTTA             - #                  - #                       - # 1500                                                                   - -  - - (2) INFORMATION FOR SEQ ID NO:16:                                     - -      (i) SEQUENCE CHARACTERISTICS:                                                  (A) LENGTH: 424 amino - #acids                                                 (B) TYPE: amino acid                                                           (D) TOPOLOGY: linear                                                  - -     (ii) MOLECULE TYPE: protein                                            - -     (xi) SEQUENCE DESCRIPTION: SEQ ID NO:16:                               - - Met Asp Pro Glu Gly Phe Thr Ser Gly Leu Ph - #e Arg Trp Asn Pro Thr         1               5 - #                 10 - #                 15               - - Arg Ala Leu Val Gln Ala Pro Pro Pro Val Pr - #o Pro Pro Leu Gln Gln                    20     - #             25     - #             30                   - - Gln Pro Val Thr Pro Gln Thr Ala Ala Phe Gl - #y Met Arg Leu Gly Gly                35         - #         40         - #         45                       - - Leu Glu Gly Leu Phe Gly Pro Tyr Gly Ile Ar - #g Phe Tyr Thr Ala Ala            50             - #     55             - #     60                           - - Lys Ile Ala Glu Leu Gly Phe Thr Ala Ser Th - #r Leu Val Gly Met Lys        65                 - # 70                 - # 75                 - # 80        - - Asp Glu Glu Leu Glu Glu Met Met Asn Ser Le - #u Ser His Ile Phe Arg                        85 - #                 90 - #                 95               - - Trp Glu Leu Leu Val Gly Glu Arg Tyr Gly Il - #e Lys Ala Ala Val Arg                   100      - #           105      - #           110                   - - Ala Glu Arg Arg Arg Leu Gln Glu Glu Glu Gl - #u Glu Glu Ser Ser Arg               115          - #       120          - #       125                       - - Arg Arg His Leu Leu Leu Ser Ala Ala Gly As - #p Ser Gly Thr His His           130              - #   135              - #   140                           - - Ala Leu Asp Ala Leu Ser Gln Glu Asp Asp Tr - #p Thr Gly Leu Ser Glu       145                 1 - #50                 1 - #55                 1 -       #60                                                                               - - Glu Pro Val Gln Gln Gln Asp Gln Thr Asp Al - #a Ala Gly Asn Asn         Gly                                                                                              165  - #               170  - #               175              - - Gly Gly Gly Ser Gly Tyr Trp Asp Ala Gly Gl - #n Gly Lys Met Lys Lys                   180      - #           185      - #           190                   - - Gln Gln Gln Gln Arg Arg Arg Lys Lys Pro Me - #t Leu Thr Ser Val Glu               195          - #       200          - #       205                       - - Thr Asp Glu Asp Val Asn Glu Gly Glu Asp As - #p Asp Gly Met Asp Asn           210              - #   215              - #   220                           - - Gly Asn Gly Gly Ser Gly Leu Gly Thr Glu Ar - #g Gln Arg Glu His Pro       225                 2 - #30                 2 - #35                 2 -       #40                                                                               - - Phe Ile Val Thr Glu Pro Gly Glu Val Ala Ar - #g Gly Lys Lys Asn         Gly                                                                                              245  - #               250  - #               255              - - Leu Asp Tyr Leu Phe His Leu Tyr Glu Gln Cy - #s Arg Glu Phe Leu Leu                   260      - #           265      - #           270                   - - Gln Val Gln Thr Ile Ala Lys Asp Arg Gly Gl - #u Lys Cys Pro Thr Lys               275          - #       280          - #       285                       - - Val Thr Asn Gln Val Phe Arg Tyr Ala Lys Ly - #s Ser Gly Ala Ser Tyr           290              - #   295              - #   300                           - - Ile Asn Lys Pro Lys Met Arg His Tyr Val Hi - #s Cys Tyr Ala Leu His       305                 3 - #10                 3 - #15                 3 -       #20                                                                               - - Cys Leu Asp Glu Glu Ala Ser Asn Ala Leu Ar - #g Arg Ala Phe Lys         Glu                                                                                              325  - #               330  - #               335              - - Arg Gly Glu Asn Val Gly Ser Trp Arg Gln Al - #a Cys Tyr Lys Pro Leu                   340      - #           345      - #           350                   - - Val Asn Ile Ala Cys Arg His Gly Trp Asp Il - #e Asp Ala Val Phe Asn               355          - #       360          - #       365                       - - Ala His Pro Arg Leu Ser Ile Trp Tyr Val Pr - #o Thr Lys Leu Arg Gln           370              - #   375              - #   380                           - - Leu Cys His Leu Glu Arg Asn Asn Ala Val Al - #a Ala Ala Ala Ala Leu       385                 3 - #90                 3 - #95                 4 -       #00                                                                               - - Val Gly Gly Ile Ser Cys Thr Gly Ser Ser Th - #r Ser Gly Arg Gly         Gly                                                                                              405  - #               410  - #               415              - - Cys Gly Gly Asp Asp Leu Arg Phe                                                       420                                                                 - -  - - (2) INFORMATION FOR SEQ ID NO:17:                                     - -      (i) SEQUENCE CHARACTERISTICS:                                                  (A) LENGTH: 1656 base - #pairs                                                 (B) TYPE: nucleic acid                                                         (C) STRANDEDNESS: double                                                       (D) TOPOLOGY: linear                                                  - -     (ix) FEATURE:                                                                   (A) NAME/KEY: CDS                                                              (B) LOCATION: 1..1651                                                 - -     (ix) FEATURE:                                                                   (A) NAME/KEY: misc.sub.-- - #feature                                           (B) LOCATION: 1..1656                                                          (D) OTHER INFORMATION: - #/note= "domain = ecdysone receptor                        ligand bi - #nding domain."                                      - -     (xi) SEQUENCE DESCRIPTION: SEQ ID NO:17:                               - - ATG CGG CCG GAA TGC GTC GTC CCG GAG AAC CA - #A TGT GCG ATG AAG CGG            48                                                                        Met Arg Pro Glu Cys Val Val Pro Glu Asn Gl - #n Cys Ala Met Lys Arg              1               5 - #                 10 - #                 15               - - CGC GAA AAG AAG GCC CAG AAG GAG AAG GAC AA - #A ATG ACC ACT TCG CCG            96                                                                        Arg Glu Lys Lys Ala Gln Lys Glu Lys Asp Ly - #s Met Thr Thr Ser Pro                         20     - #             25     - #             30                   - - AGC TCT CAG CAT GGC GGC AAT GGC AGC TTG GC - #C TCT GGT GGC GGC CAA           144                                                                        Ser Ser Gln His Gly Gly Asn Gly Ser Leu Al - #a Ser Gly Gly Gly Gln                     35         - #         40         - #         45                       - - GAC TTT GTT AAG AAG GAG ATT CTT GAC CTT AT - #G ACA TGC GAG CCG CCC           192                                                                        Asp Phe Val Lys Lys Glu Ile Leu Asp Leu Me - #t Thr Cys Glu Pro Pro                 50             - #     55             - #     60                           - - CAG CAT GCC ACT ATT CCG CTA CTA CCT GAT GA - #A ATA TTG GCC AAG TGT           240                                                                        Gln His Ala Thr Ile Pro Leu Leu Pro Asp Gl - #u Ile Leu Ala Lys Cys             65                 - # 70                 - # 75                 - # 80        - - CAA GCG CGC AAT ATA CCT TCC TTA ACG TAC AA - #T CAG TTG GCC GTT ATA           288                                                                        Gln Ala Arg Asn Ile Pro Ser Leu Thr Tyr As - #n Gln Leu Ala Val Ile                             85 - #                 90 - #                 95               - - TAC AAG TTA ATT TGG TAC CAG GAT GGC TAT GA - #G CAG CCA TCT GAA GAG           336                                                                        Tyr Lys Leu Ile Trp Tyr Gln Asp Gly Tyr Gl - #u Gln Pro Ser Glu Glu                        100      - #           105      - #           110                   - - GAT CTC AGG CGT ATA ATG AGT CAA CCC GAT GA - #G AAC GAG AGC CAA ACG           384                                                                        Asp Leu Arg Arg Ile Met Ser Gln Pro Asp Gl - #u Asn Glu Ser Gln Thr                    115          - #       120          - #       125                       - - GAC GTC AGC TTT CGG CAT ATA ACC GAG ATA AC - #C ATA CTC ACG GTC CAG           432                                                                        Asp Val Ser Phe Arg His Ile Thr Glu Ile Th - #r Ile Leu Thr Val Gln                130              - #   135              - #   140                           - - TTG ATT GTT GAG TTT GCT AAA GGT CTA CCA GC - #G TTT ACA AAG ATA CCC           480                                                                        Leu Ile Val Glu Phe Ala Lys Gly Leu Pro Al - #a Phe Thr Lys Ile Pro            145                 1 - #50                 1 - #55                 1 -       #60                                                                               - - CAG GAG GAC CAG ATC ACG TTA CTA AAG GCC TG - #C TCG TCG GAG GTG         ATG      528                                                                     Gln Glu Asp Gln Ile Thr Leu Leu Lys Ala Cy - #s Ser Ser Glu Val Met                           165  - #               170  - #               175               - - ATG CTG CGT ATG GCA CGA CGC TAT GAC CAC AG - #C TCG GAC TCA ATA TTC           576                                                                        Met Leu Arg Met Ala Arg Arg Tyr Asp His Se - #r Ser Asp Ser Ile Phe                        180      - #           185      - #           190                   - - TTC GCG AAT AAT AGA TCA TAT ACG CGG GAT TC - #T TAC AAA ATG GCC GGA           624                                                                        Phe Ala Asn Asn Arg Ser Tyr Thr Arg Asp Se - #r Tyr Lys Met Ala Gly                    195          - #       200          - #       205                       - - ATG GCT GAT AAC ATT GAA GAC CTG CTG CAT TT - #C TGC CGC CAA ATG TTC           672                                                                        Met Ala Asp Asn Ile Glu Asp Leu Leu His Ph - #e Cys Arg Gln Met Phe                210              - #   215              - #   220                           - - TCG ATG AAG GTG GAC AAC GTC GAA TAC GCG CT - #T CTC ACT GCC ATT GTG           720                                                                        Ser Met Lys Val Asp Asn Val Glu Tyr Ala Le - #u Leu Thr Ala Ile Val            225                 2 - #30                 2 - #35                 2 -       #40                                                                               - - ATC TTC TCG GAC CGG CCG GGC CTG GAG AAG GC - #C CAA CTA GTC GAA         GCG      768                                                                     Ile Phe Ser Asp Arg Pro Gly Leu Glu Lys Al - #a Gln Leu Val Glu Ala                           245  - #               250  - #               255               - - ATC CAG AGC TAC TAC ATC GAC ACG CTA CGC AT - #T TAT ATA CTC AAC CGC           816                                                                        Ile Gln Ser Tyr Tyr Ile Asp Thr Leu Arg Il - #e Tyr Ile Leu Asn Arg                        260      - #           265      - #           270                   - - CAC TGC GGC GAC TCA ATG AGC CTC GTC TTC TA - #C GCA AAG CTG CTC TCG           864                                                                        His Cys Gly Asp Ser Met Ser Leu Val Phe Ty - #r Ala Lys Leu Leu Ser                    275          - #       280          - #       285                       - - ATC CTC ACC GAG CTG CGT ACG CTG GGC AAC CA - #G AAC GCC GAG ATG TGT           912                                                                        Ile Leu Thr Glu Leu Arg Thr Leu Gly Asn Gl - #n Asn Ala Glu Met Cys                290              - #   295              - #   300                           - - TTC TCA CTA AAG CTC AAA AAC CGC AAA CTG CC - #C AAG TTC CTC GAG GAG           960                                                                        Phe Ser Leu Lys Leu Lys Asn Arg Lys Leu Pr - #o Lys Phe Leu Glu Glu            305                 3 - #10                 3 - #15                 3 -       #20                                                                               - - ATC TGG GAC GTT CAT GCC ATC CCG CCA TCG GT - #C CAG TCG CAC CTT         CAG     1008                                                                     Ile Trp Asp Val His Ala Ile Pro Pro Ser Va - #l Gln Ser His Leu Gln                           325  - #               330  - #               335               - - ATT ACC CAG GAG GAG AAC GAG CGT CTC GAG CG - #G GCT GAG CGT ATG CGG          1056                                                                        Ile Thr Gln Glu Glu Asn Glu Arg Leu Glu Ar - #g Ala Glu Arg Met Arg                        340      - #           345      - #           350                   - - GCA TCG GTT GGG GGC GCC ATT ACC GCC GGC AT - #T GAT TGC GAC TCT GCC          1104                                                                        Ala Ser Val Gly Gly Ala Ile Thr Ala Gly Il - #e Asp Cys Asp Ser Ala                    355          - #       360          - #       365                       - - TCC ACT TCG GCG GCG GCA GCC GCG GCC CAG CA - #T CAG CCT CAG CCT CAG          1152                                                                        Ser Thr Ser Ala Ala Ala Ala Ala Ala Gln Hi - #s Gln Pro Gln Pro Gln                370              - #   375              - #   380                           - - CCC CAG CCC CAA CCC TCC TCC CTG ACC CAG AA - #C GAT TCC CAG CAC CAG          1200                                                                        Pro Gln Pro Gln Pro Ser Ser Leu Thr Gln As - #n Asp Ser Gln His Gln            385                 3 - #90                 3 - #95                 4 -       #00                                                                               - - ACA CAG CCG CAG CTA CAA CCT CAG CTA CCA CC - #T CAG CTG CAA GGT         CAA     1248                                                                     Thr Gln Pro Gln Leu Gln Pro Gln Leu Pro Pr - #o Gln Leu Gln Gly Gln                           405  - #               410  - #               415               - - CTG CAA CCC CAG CTC CAA CCA CAG CTT CAG AC - #G CAA CTC CAG CCA CAG          1296                                                                        Leu Gln Pro Gln Leu Gln Pro Gln Leu Gln Th - #r Gln Leu Gln Pro Gln                        420      - #           425      - #           430                   - - ATT CAA CCA CAG CCA CAG CTC CTT CCC GTC TC - #C GCT CCC GTG CCC GCC          1344                                                                        Ile Gln Pro Gln Pro Gln Leu Leu Pro Val Se - #r Ala Pro Val Pro Ala                    435          - #       440          - #       445                       - - TCC GTA ACC GCA CCT GGT TCC TTG TCC GCG GT - #C AGT ACG AGC AGC GAA          1392                                                                        Ser Val Thr Ala Pro Gly Ser Leu Ser Ala Va - #l Ser Thr Ser Ser Glu                450              - #   455              - #   460                           - - TAC ATG GGC GGA AGT GCG GCC ATA GGA CCC AT - #C ACG CCG GCA ACC ACC          1440                                                                        Tyr Met Gly Gly Ser Ala Ala Ile Gly Pro Il - #e Thr Pro Ala Thr Thr            465                 4 - #70                 4 - #75                 4 -       #80                                                                               - - AGC AGT ATC ACG GCT GCC GTT ACC GCT AGC TC - #C ACC ACA TCA GCG         GTA     1488                                                                     Ser Ser Ile Thr Ala Ala Val Thr Ala Ser Se - #r Thr Thr Ser Ala Val                           485  - #               490  - #               495               - - CCG ATG GGC AAC GGA GTT GGA GTC GGT GTT GG - #G GTG GGC GGC AAC GTC          1536                                                                        Pro Met Gly Asn Gly Val Gly Val Gly Val Gl - #y Val Gly Gly Asn Val                        500      - #           505      - #           510                   - - AGC ATG TAT GCG AAC GCC CAG ACG GCG ATG GC - #C TTG ATG GGT GTA GCC          1584                                                                        Ser Met Tyr Ala Asn Ala Gln Thr Ala Met Al - #a Leu Met Gly Val Ala                    515          - #       520          - #       525                       - - CTG CAT TCG CAC CAA GAG CAG CTT ATC GGG GG - #A GTG GCG GTT AAG TCG          1632                                                                        Leu His Ser His Gln Glu Gln Leu Ile Gly Gl - #y Val Ala Val Lys Ser                530              - #   535              - #   540                           - - GAG CAC TCG ACG ACT GCA T AGCAG     - #                  - #                   1656                                                                      Glu His Ser Thr Thr Ala                                                        545                 5 - #50                                                     - -  - - (2) INFORMATION FOR SEQ ID NO:18:                                     - -      (i) SEQUENCE CHARACTERISTICS:                                                  (A) LENGTH: 550 amino - #acids                                                 (B) TYPE: amino acid                                                           (D) TOPOLOGY: linear                                                  - -     (ii) MOLECULE TYPE: protein                                            - -     (xi) SEQUENCE DESCRIPTION: SEQ ID NO:18:                               - - Met Arg Pro Glu Cys Val Val Pro Glu Asn Gl - #n Cys Ala Met Lys Arg         1               5 - #                 10 - #                 15               - - Arg Glu Lys Lys Ala Gln Lys Glu Lys Asp Ly - #s Met Thr Thr Ser Pro                    20     - #             25     - #             30                   - - Ser Ser Gln His Gly Gly Asn Gly Ser Leu Al - #a Ser Gly Gly Gly Gln                35         - #         40         - #         45                       - - Asp Phe Val Lys Lys Glu Ile Leu Asp Leu Me - #t Thr Cys Glu Pro Pro            50             - #     55             - #     60                           - - Gln His Ala Thr Ile Pro Leu Leu Pro Asp Gl - #u Ile Leu Ala Lys Cys        65                 - # 70                 - # 75                 - # 80        - - Gln Ala Arg Asn Ile Pro Ser Leu Thr Tyr As - #n Gln Leu Ala Val Ile                        85 - #                 90 - #                 95               - - Tyr Lys Leu Ile Trp Tyr Gln Asp Gly Tyr Gl - #u Gln Pro Ser Glu Glu                   100      - #           105      - #           110                   - - Asp Leu Arg Arg Ile Met Ser Gln Pro Asp Gl - #u Asn Glu Ser Gln Thr               115          - #       120          - #       125                       - - Asp Val Ser Phe Arg His Ile Thr Glu Ile Th - #r Ile Leu Thr Val Gln           130              - #   135              - #   140                           - - Leu Ile Val Glu Phe Ala Lys Gly Leu Pro Al - #a Phe Thr Lys Ile Pro       145                 1 - #50                 1 - #55                 1 -       #60                                                                               - - Gln Glu Asp Gln Ile Thr Leu Leu Lys Ala Cy - #s Ser Ser Glu Val         Met                                                                                              165  - #               170  - #               175              - - Met Leu Arg Met Ala Arg Arg Tyr Asp His Se - #r Ser Asp Ser Ile Phe                   180      - #           185      - #           190                   - - Phe Ala Asn Asn Arg Ser Tyr Thr Arg Asp Se - #r Tyr Lys Met Ala Gly               195          - #       200          - #       205                       - - Met Ala Asp Asn Ile Glu Asp Leu Leu His Ph - #e Cys Arg Gln Met Phe           210              - #   215              - #   220                           - - Ser Met Lys Val Asp Asn Val Glu Tyr Ala Le - #u Leu Thr Ala Ile Val       225                 2 - #30                 2 - #35                 2 -       #40                                                                               - - Ile Phe Ser Asp Arg Pro Gly Leu Glu Lys Al - #a Gln Leu Val Glu         Ala                                                                                              245  - #               250  - #               255              - - Ile Gln Ser Tyr Tyr Ile Asp Thr Leu Arg Il - #e Tyr Ile Leu Asn Arg                   260      - #           265      - #           270                   - - His Cys Gly Asp Ser Met Ser Leu Val Phe Ty - #r Ala Lys Leu Leu Ser               275          - #       280          - #       285                       - - Ile Leu Thr Glu Leu Arg Thr Leu Gly Asn Gl - #n Asn Ala Glu Met Cys           290              - #   295              - #   300                           - - Phe Ser Leu Lys Leu Lys Asn Arg Lys Leu Pr - #o Lys Phe Leu Glu Glu       305                 3 - #10                 3 - #15                 3 -       #20                                                                               - - Ile Trp Asp Val His Ala Ile Pro Pro Ser Va - #l Gln Ser His Leu         Gln                                                                                              325  - #               330  - #               335              - - Ile Thr Gln Glu Glu Asn Glu Arg Leu Glu Ar - #g Ala Glu Arg Met Arg                   340      - #           345      - #           350                   - - Ala Ser Val Gly Gly Ala Ile Thr Ala Gly Il - #e Asp Cys Asp Ser Ala               355          - #       360          - #       365                       - - Ser Thr Ser Ala Ala Ala Ala Ala Ala Gln Hi - #s Gln Pro Gln Pro Gln           370              - #   375              - #   380                           - - Pro Gln Pro Gln Pro Ser Ser Leu Thr Gln As - #n Asp Ser Gln His Gln       385                 3 - #90                 3 - #95                 4 -       #00                                                                               - - Thr Gln Pro Gln Leu Gln Pro Gln Leu Pro Pr - #o Gln Leu Gln Gly         Gln                                                                                              405  - #               410  - #               415              - - Leu Gln Pro Gln Leu Gln Pro Gln Leu Gln Th - #r Gln Leu Gln Pro Gln                   420      - #           425      - #           430                   - - Ile Gln Pro Gln Pro Gln Leu Leu Pro Val Se - #r Ala Pro Val Pro Ala               435          - #       440          - #       445                       - - Ser Val Thr Ala Pro Gly Ser Leu Ser Ala Va - #l Ser Thr Ser Ser Glu           450              - #   455              - #   460                           - - Tyr Met Gly Gly Ser Ala Ala Ile Gly Pro Il - #e Thr Pro Ala Thr Thr       465                 4 - #70                 4 - #75                 4 -       #80                                                                               - - Ser Ser Ile Thr Ala Ala Val Thr Ala Ser Se - #r Thr Thr Ser Ala         Val                                                                                              485  - #               490  - #               495              - - Pro Met Gly Asn Gly Val Gly Val Gly Val Gl - #y Val Gly Gly Asn Val                   500      - #           505      - #           510                   - - Ser Met Tyr Ala Asn Ala Gln Thr Ala Met Al - #a Leu Met Gly Val Ala               515          - #       520          - #       525                       - - Leu His Ser His Gln Glu Gln Leu Ile Gly Gl - #y Val Ala Val Lys Ser           530              - #   535              - #   540                           - - Glu His Ser Thr Thr Ala                                                   545                 5 - #50                                                     - -  - - (2) INFORMATION FOR SEQ ID NO:19:                                     - -      (i) SEQUENCE CHARACTERISTICS:                                                  (A) LENGTH: 855 base - #pairs                                                  (B) TYPE: nucleic acid                                                         (C) STRANDEDNESS: double                                                       (D) TOPOLOGY: linear                                                  - -     (ix) FEATURE:                                                                   (A) NAME/KEY: CDS                                                              (B) LOCATION: 1..853                                                  - -     (ix) FEATURE:                                                                   (A) NAME/KEY: misc.sub.-- - #feature                                           (B) LOCATION: 1..855                                                           (D) OTHER INFORMATION: - #/note= "domain = glucocorticoid                           receptor - #ligand binding domain."                              - -     (xi) SEQUENCE DESCRIPTION: SEQ ID NO:19:                               - - ACA AAG AAA AAA ATC AAA GGG ATT CAG CAA GC - #C ACT GCA GGA GTC TCA            48                                                                        Thr Lys Lys Lys Ile Lys Gly Ile Gln Gln Al - #a Thr Ala Gly Val Ser              1               5 - #                 10 - #                 15               - - CAA GAC ACT TCG GAA AAT CCT AAC AAA ACA AT - #A GTT CCT GCA GCA TTA            96                                                                        Gln Asp Thr Ser Glu Asn Pro Asn Lys Thr Il - #e Val Pro Ala Ala Leu                         20     - #             25     - #             30                   - - CCA CAG CTC ACC CCT ACC TTG GTG TCA CTG CT - #G GAG GTG ATT GAA CCC           144                                                                        Pro Gln Leu Thr Pro Thr Leu Val Ser Leu Le - #u Glu Val Ile Glu Pro                     35         - #         40         - #         45                       - - GAG GTG TTG TAT GCA GGA TAT GAT AGC TCT GT - #T CCA GAT TCA GCA TGG           192                                                                        Glu Val Leu Tyr Ala Gly Tyr Asp Ser Ser Va - #l Pro Asp Ser Ala Trp                 50             - #     55             - #     60                           - - AGA ATT ATG ACC ACA CTC AAC ATG TTA GGT GG - #G CGT CAA GTG ATT GCA           240                                                                        Arg Ile Met Thr Thr Leu Asn Met Leu Gly Gl - #y Arg Gln Val Ile Ala             65                 - # 70                 - # 75                 - # 80        - - GCA GTG AAA TGG GCA AAG GCG ATA CTA GGC TT - #G AGA AAC TTA CAC CTC           288                                                                        Ala Val Lys Trp Ala Lys Ala Ile Leu Gly Le - #u Arg Asn Leu His Leu                             85 - #                 90 - #                 95               - - GAT GAC CAA ATG ACC CTG CTA CAG TAC TCA TG - #G ATG TTT CTC ATG GCA           336                                                                        Asp Asp Gln Met Thr Leu Leu Gln Tyr Ser Tr - #p Met Phe Leu Met Ala                        100      - #           105      - #           110                   - - TTT GCC TTG GGT TGG AGA TCA TAC AGA CAA TC - #A AGC GGA AAC CTG CTC           384                                                                        Phe Ala Leu Gly Trp Arg Ser Tyr Arg Gln Se - #r Ser Gly Asn Leu Leu                    115          - #       120          - #       125                       - - TGC TTT GCT CCT GAT CTG ATT ATT AAT GAG CA - #G AGA ATG TCT CTA CCC           432                                                                        Cys Phe Ala Pro Asp Leu Ile Ile Asn Glu Gl - #n Arg Met Ser Leu Pro                130              - #   135              - #   140                           - - TGC ATG TAT GAC CAA TGT AAA CAC ATG CTG TT - #T GTC TCC TCT GAA TTA           480                                                                        Cys Met Tyr Asp Gln Cys Lys His Met Leu Ph - #e Val Ser Ser Glu Leu            145                 1 - #50                 1 - #55                 1 -       #60                                                                               - - CAA AGA TTG CAG GTA TCC TAT GAA GAG TAT CT - #C TGT ATG AAA ACC         TTA      528                                                                     Gln Arg Leu Gln Val Ser Tyr Glu Glu Tyr Le - #u Cys Met Lys Thr Leu                           165  - #               170  - #               175               - - CTG CTT CTC TCC TCA GTT GCT AAG GAA GGT CT - #G AAG AGC CAA GAG TTA           576                                                                        Leu Leu Leu Ser Ser Val Ala Lys Glu Gly Le - #u Lys Ser Gln Glu Leu                        180      - #           185      - #           190                   - - TTT GAT GAG ATT CGA ATG ACT TAT ATC AAA GA - #G CTA GGA AAA GCC ATC           624                                                                        Phe Asp Glu Ile Arg Met Thr Tyr Ile Lys Gl - #u Leu Gly Lys Ala Ile                    195          - #       200          - #       205                       - - GTC AAA AGG GAA GGG AAC TCC AGT CAG AAC TG - #G CAA CGG TTT TAC CAA           672                                                                        Val Lys Arg Glu Gly Asn Ser Ser Gln Asn Tr - #p Gln Arg Phe Tyr Gln                210              - #   215              - #   220                           - - CTG ACA AAG CTT CTG GAC TCC ATG CAT GAG GT - #G GTT GAG AAT CTC CTT           720                                                                        Leu Thr Lys Leu Leu Asp Ser Met His Glu Va - #l Val Glu Asn Leu Leu            225                 2 - #30                 2 - #35                 2 -       #40                                                                               - - ACC TAC TGC TTC CAG ACA TTT TTG GAT AAG AC - #C ATG AGT ATT GAA         TTC      768                                                                     Thr Tyr Cys Phe Gln Thr Phe Leu Asp Lys Th - #r Met Ser Ile Glu Phe                           245  - #               250  - #               255               - - CCA GAG ATG TTA GCT GAA ATC ATC ACT AAT CA - #G ATA CCA AAA TAT TCA           816                                                                        Pro Glu Met Leu Ala Glu Ile Ile Thr Asn Gl - #n Ile Pro Lys Tyr Ser                        260      - #           265      - #           270                   - - AAT GGA AAT ATC AAA AAG CTT CTG TTT CAT CA - #A AAA T GA                  - #    855                                                                     Asn Gly Asn Ile Lys Lys Leu Leu Phe His Gl - #n Lys                                    275          - #       280                                              - -  - - (2) INFORMATION FOR SEQ ID NO:20:                                     - -      (i) SEQUENCE CHARACTERISTICS:                                                  (A) LENGTH: 284 amino - #acids                                                 (B) TYPE: amino acid                                                           (D) TOPOLOGY: linear                                                  - -     (ii) MOLECULE TYPE: protein                                            - -     (xi) SEQUENCE DESCRIPTION: SEQ ID NO:20:                               - - Thr Lys Lys Lys Ile Lys Gly Ile Gln Gln Al - #a Thr Ala Gly Val Ser         1               5 - #                 10 - #                 15               - - Gln Asp Thr Ser Glu Asn Pro Asn Lys Thr Il - #e Val Pro Ala Ala Leu                    20     - #             25     - #             30                   - - Pro Gln Leu Thr Pro Thr Leu Val Ser Leu Le - #u Glu Val Ile Glu Pro                35         - #         40         - #         45                       - - Glu Val Leu Tyr Ala Gly Tyr Asp Ser Ser Va - #l Pro Asp Ser Ala Trp            50             - #     55             - #     60                           - - Arg Ile Met Thr Thr Leu Asn Met Leu Gly Gl - #y Arg Gln Val Ile Ala        65                 - # 70                 - # 75                 - # 80        - - Ala Val Lys Trp Ala Lys Ala Ile Leu Gly Le - #u Arg Asn Leu His Leu                        85 - #                 90 - #                 95               - - Asp Asp Gln Met Thr Leu Leu Gln Tyr Ser Tr - #p Met Phe Leu Met Ala                   100      - #           105      - #           110                   - - Phe Ala Leu Gly Trp Arg Ser Tyr Arg Gln Se - #r Ser Gly Asn Leu Leu               115          - #       120          - #       125                       - - Cys Phe Ala Pro Asp Leu Ile Ile Asn Glu Gl - #n Arg Met Ser Leu Pro           130              - #   135              - #   140                           - - Cys Met Tyr Asp Gln Cys Lys His Met Leu Ph - #e Val Ser Ser Glu Leu       145                 1 - #50                 1 - #55                 1 -       #60                                                                               - - Gln Arg Leu Gln Val Ser Tyr Glu Glu Tyr Le - #u Cys Met Lys Thr         Leu                                                                                              165  - #               170  - #               175              - - Leu Leu Leu Ser Ser Val Ala Lys Glu Gly Le - #u Lys Ser Gln Glu Leu                   180      - #           185      - #           190                   - - Phe Asp Glu Ile Arg Met Thr Tyr Ile Lys Gl - #u Leu Gly Lys Ala Ile               195          - #       200          - #       205                       - - Val Lys Arg Glu Gly Asn Ser Ser Gln Asn Tr - #p Gln Arg Phe Tyr Gln           210              - #   215              - #   220                           - - Leu Thr Lys Leu Leu Asp Ser Met His Glu Va - #l Val Glu Asn Leu Leu       225                 2 - #30                 2 - #35                 2 -       #40                                                                               - - Thr Tyr Cys Phe Gln Thr Phe Leu Asp Lys Th - #r Met Ser Ile Glu         Phe                                                                                              245  - #               250  - #               255              - - Pro Glu Met Leu Ala Glu Ile Ile Thr Asn Gl - #n Ile Pro Lys Tyr Ser                   260      - #           265      - #           270                   - - Asn Gly Asn Ile Lys Lys Leu Leu Phe His Gl - #n Lys                               275          - #       280                                              - -  - - (2) INFORMATION FOR SEQ ID NO:21:                                     - -      (i) SEQUENCE CHARACTERISTICS:                                                  (A) LENGTH: 50 base - #pairs                                                   (B) TYPE: nucleic acid                                                         (C) STRANDEDNESS: double                                                       (D) TOPOLOGY: linear                                                  - -     (ix) FEATURE:                                                                   (A) NAME/KEY: misc.sub.-- - #feature                                           (B) LOCATION: 1..50                                                            (D) OTHER INFORMATION: - #/note= "element = copper inducible                        regulatory - #element (ACE1 binding site)."                      - -     (xi) SEQUENCE DESCRIPTION: SEQ ID NO:21:                               - - AGCTTAGCGA TGCGTCTTTT CCGCTGAACC GTTCCAGCAA AAAAGACTAG  - #                   50                                                                          - -  - - (2) INFORMATION FOR SEQ ID NO:22:                                     - -      (i) SEQUENCE CHARACTERISTICS:                                                  (A) LENGTH: 19 base - #pairs                                                   (B) TYPE: nucleic acid                                                         (C) STRANDEDNESS: double                                                       (D) TOPOLOGY: linear                                                  - -     (ix) FEATURE:                                                                   (A) NAME/KEY: misc.sub.-- - #feature                                           (B) LOCATION: 1..19                                                            (D) OTHER INFORMATION: - #/note= "element = tet operator."            - -     (xi) SEQUENCE DESCRIPTION: SEQ ID NO:22:                               - - ACTCTATCAG TGATAGAGT             - #                  - #                       - # 19                                                                    - -  - - (2) INFORMATION FOR SEQ ID NO:23:                                     - -      (i) SEQUENCE CHARACTERISTICS:                                                  (A) LENGTH: 29 base - #pairs                                                   (B) TYPE: nucleic acid                                                         (C) STRANDEDNESS: double                                                       (D) TOPOLOGY: linear                                                  - -     (ix) FEATURE:                                                                   (A) NAME/KEY: misc.sub.-- - #feature                                           (B) LOCATION: 1..29                                                            (D) OTHER INFORMATION: - #/note= "element = ecdysone response                       element."                                                        - -     (xi) SEQUENCE DESCRIPTION: SEQ ID NO:23:                               - - GATCCGACAA GGGTTCAATG CACTTGTCA         - #                  - #                 29                                                                       - -  - - (2) INFORMATION FOR SEQ ID NO:24:                                     - -      (i) SEQUENCE CHARACTERISTICS:                                                  (A) LENGTH: 371 base - #pairs                                                  (B) TYPE: nucleic acid                                                         (C) STRANDEDNESS: double                                                       (D) TOPOLOGY: linear                                                  - -     (ix) FEATURE:                                                                   (A) NAME/KEY: misc.sub.-- - #feature                                           (B) LOCATION: 1..371                                                           (D) OTHER INFORMATION: - #/note= "element = heat shock                              inducible - #regulatory element (HSP81-1 promoter)."             - -     (xi) SEQUENCE DESCRIPTION: SEQ ID NO:24:                               - - GTGGAGTCTC GAAACGAAAA GAACTTTCTG GAATTCGTTT GCTCACAAAG CT -              #AAAAACGG     60                                                                  - - TTGATTTCAT CGAAATACGG CGTCGTTTTC AAAGAACAAT CCAGAAATCA CT -             #GGTTTTCC    120                                                                  - - TTTATTTCAA AAGAAGAGAC TAGAACTTTA TTTCTCCTCT ATAAAATCAC TT -             #TGTTTTTC    180                                                                  - - CCTCTCTTCT TCATAAATCA ACAAAACAAT CACAAATCTC TCGAAACGCT CT -             #CGAAGTTC    240                                                                  - - CAAATTTTCT CTTAGCATTC TCTTTCGTTT CTCGTTTGCG TTGAATCAAA GT -             #TCGTTGCG    300                                                                  - - ATGGCGGATG TTCAGATGGC TGATGCAGAG ACTTTTGCTT TCCAAGCTGA GA -             #TTAACCAG    360                                                                  - - CTTCTTAGCT T               - #                  - #                       - #      371                                                                   - -  - - (2) INFORMATION FOR SEQ ID NO:25:                                     - -      (i) SEQUENCE CHARACTERISTICS:                                                  (A) LENGTH: 29 base - #pairs                                                   (B) TYPE: nucleic acid                                                         (C) STRANDEDNESS: single                                                       (D) TOPOLOGY: linear                                                  - -     (xi) SEQUENCE DESCRIPTION: SEQ ID NO:25:                               - - GGATCCGGAT CAAAAATGGG AAGGGGTAG         - #                  - #                 29                                                                       - -  - - (2) INFORMATION FOR SEQ ID NO:26:                                     - -      (i) SEQUENCE CHARACTERISTICS:                                                  (A) LENGTH: 30 base - #pairs                                                   (B) TYPE: nucleic acid                                                         (C) STRANDEDNESS: single                                                       (D) TOPOLOGY: linear                                                  - -     (xi) SEQUENCE DESCRIPTION: SEQ ID NO:26:                               - - GGATCCGCTG CGGCGAAGCA GCCAAGGTTG         - #                  - #                30                                                                     __________________________________________________________________________ 

I claim:
 1. A recombinant nucleic acid molecule, comprising an inducible regulatory element operably linked to a nucleic acid molecule encoding CAULIFLOWER (CAL).
 2. The recombinant nucleic acid molecule of claim 1, wherein said inducible regulatory element is selected from the group consisting of a:copper inducible regulatory element; tetracycline inducible regulatory element; ecdysone inducible regulatory element; and heat-shock inducible regulatory element.
 3. The recombinant nucleic acid molecule of claim 2, wherein said CAL has an amino acid sequence selected from the group consisting of SEQ ID NO: 10 and SEQ ID NO:
 12. 4. A transgenic seed plant, comprising the recombinant nucleic acid molecule of claim
 1. 5. The transgenic seed plant of claim 4, wherein said seed plant is an angiosperm.
 6. The transgenic seed plant of claim 4, wherein said seed plant is a gymnosperm.
 7. A method of converting shoot meristem to floral meristem in an angiosperm, comprising the steps of:(a) introducing into said angiosperm a recombinant nucleic acid molecule comprising an inducible regulatory element operably linked to a nucleic acid molecule encoding CAULIFLOWER (CAL) to produce a transgenic angiosperm; and (b) contacting said transgenic angiosperm with an inducing agent, thereby increasing expression of said CAL and converting shoot meristem to floral meristem in said transgenic angiosperm.
 8. The method of claim 7, wherein said inducible regulatory element is selected from the group consisting of a:copper inducible regulatory element; tetracycline inducible regulatory element; ecdysone inducible regulatory element; and heat-shock inducible regulatory element.
 9. A method of promoting early reproductive development in a seed plant, comprising the steps of:(a) introducing into said seed plant a recombinant nucleic acid molecule comprising an inducible regulatory element operably linked to a nucleic acid molecule encoding CAULIFLOWER (CAL) to produce a transgenic seed plant; and (b) contacting said transgenic seed plant with an inducing agent, thereby increasing expression of said CAL and promoting early reproductive development in said transgenic seed plant.
 10. The method of claim 9, wherein said inducible regulatory element is selected from the group consisting of a:copper inducible regulatory element; tetracycline inducible regulatory element; ecdysone inducible regulatory element; and heat-shock inducible regulatory element.
 11. The method of claim 8, wherein said CAL has an amino acid sequence selected from the group consisting of SEQ ID NO: 10 and SEQ ID NO:
 12. 12. The method of claim 10, wherein said CAL has an amino acid sequence selected from the group consisting of SEQ ID NO: 10 and SEQ ID NO:
 12. 